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Abstract 
Health claims on food products facilitate communication of nutritional benefit of food 
products for the food industry and require regulatory approval.  The Association of Southeast 
Asian Nations (ASEAN) aims to achieve free movement of goods under the formation of 
ASEAN Economic Community in 2015.  Little is published about the structure and processes 
underpinning the regulatory frameworks for health claims on food in Southeast Asia (SEA) 
and the Asian consumers’ understanding of health claims.  The research topic of this thesis is 
on the health claims on food products in SEA.  The aim of the thesis is to develop clear 
situation awareness of how the information flow through the existing regulatory frameworks 
in SEA effectively communicates understanding to the consumers.  The objectives were, 
firstly, to review the existing regulations/ guidelines on health claims in SEA and major 
jurisdictions; secondly, to investigate the current practices and perspectives and the 
understanding of health claims in SEA through (a) semi-structured interviews with 15 key 
stakeholders and (b) focus groups among 48 Asian mothers in three SEA countries.  There 
were inconsistencies in the regulations and the types of evidence required for health claims 
application among the five SEA countries which currently have health claims regulations/ 
guidelines in place.  An analysis of the interviews among the key stakeholders yielded similar 
thinking and distinct perspectives on the challenges they faced.  The mothers recalled and 
trusted health claims on products but lacked full understanding of the functions of the 
nutrients.  The factors affecting the understanding on health claims among the mothers were 
identified.  The findings suggest that in order to ensure consumer confidence and 
understanding of health claims, active engagement with all key stakeholders together with 
consumer education efforts via public-private partnerships will be required in the future.  A 
conceptual harmonised regulatory framework was proposed to bridge the gaps between the 
regulatory frameworks for health claims in SEA.  This research provides clear direction for 
food industry and the regulatory community to better support innovation to increase trade in 
SEA region and insights to develop effective consumer communication. 
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Chapter 1 Introduction 
Our understanding of the role of food has evolved from providing nutrients for normal body 
function in the past to promoting and maintaining health (Roberfroid, 2002; European Food 
Information Council, n.d.).  The advancement in nutritional science and technology is 
progressing very rapidly.  There are more discoveries and development of food constituents 
and/ or new ingredients in foods which could have beneficial effects on physiological 
functions towards health.  Health claims on food products provide a valuable form of 
communication between the food industry, regulatory agencies and the consumers on the 
potential beneficial effects of a food constituent or food product.  Effective communication 
through health claims can help consumers make informed food choices in order to achieve a 
healthy diet.   
1.1 Definition of health claims  
Codex Alimentarius ‘Codex’ (1997, last amended in 2013) defines a health claim as ‘a 
representation that states, suggests, or implies a relationship exists between a food and 
health’.  Health claims are categorised into three groups: ‘nutrient function claims’, ‘other 
function claims’ and ‘reduction of disease risk claims’.  According to Codex, the definitions 
of the three types of health claims are as followed: 
a. ‘nutrient function claim’ describes the physiological role of the nutrient in growth, 
development and normal functions of the body  
b. ‘other function claim’ describes specific beneficial effects of the consumption of foods or 
their constituents, in the context of the total diet on normal functions or biological activities of 
the body 
c. ‘reduction of disease risk claim’ relates the consumption of a food or food constituent, in 
the context of the total diet, to the reduced risk of developing a disease or health-related 
condition. 
 
Figure 1.1 below provides an explanation on the Codex definitions of the three types of health 
claims with examples of authorised health claims from the European Food Safety Authority 
(EFSA).   
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Figure 1.1:  Codex definitions on the types of health claims 
Source: Codex Alimentarius (1997 (last amended in 2013); European Food Safety Authority 
(n.d.-a) 
1.2 Historical development of the health claims on food 
The development of health claims has been described as the renaissance of food science and it 
has been linked with the development of ‘functional foods’ (Hawkes, 2004).  The evolution of 
food science has led to a paradigm shift on the concept of food from providing ‘adequate 
nutrition’ to delivering ‘optimum nutrition’ among the people living in the major jurisdictions 
and more industrialised world in the 1980s and 1990s (Diplock et al., 1999).  In view of this, 
health authorities in many countries such as Japan and United States supported research on 
food components and health benefits.   
Japan was the first country to establish a regulatory framework, also known as ‘Foods for 
Specified Health Uses (FOSHU)’in 1991 by the Ministry of Health, Labour and Welfare 
(Shimizu, 2003).  This Japanese system approved statements on food labels concerning the 
effects of food on the body based on scientific evidence and it also aimed to reduce the 
occurrence of lifestyle-related diseases in the rapidly aging population in Japan (Arai, 1996).   
In the United States, health claims formed part of the Nutrition Labelling and Education Act 
(NLEA), passed by the United States Congress and President in 1990 (United States Food and 
Health Claim
Nutrient Function 
Claim
e.g. “Calcium is 
needed for the 
maintenance of 
normal bones.”
Describes the 
physiological role of 
the nutrient in growth, 
development and 
normal functions of 
the body 
Other Function 
Claim
e.g. ‘Beta- glucans 
contribute to the 
maintenance of normal 
blood cholesterol levels'. 
Describes specific 
beneficial effects of the 
consumption of foods or 
their constituents, in the 
context of the total diet on 
normal functions or 
biological activities of the 
body.
Reduction of Disease 
Risk Claim
e.g. ‘Plant stanol esters have 
been shown to reduce blood 
cholesterol. Blood 
cholesterol is a risk factor in 
the development of coronary 
heart disease.’
Relates the consumption of a 
food or food constituent, in 
the context of the total diet, 
to the reduced risk of 
developing a disease or 
health-related condition.
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Drug Adminstration, 2000).  The aim of the NLEA was to provide consistent and 
understandable food labels for the consumer to make healthy food choices and to encourage 
food manufacturers to produce better quality food (United States Food and Drug 
Adminstration, 2000).   
The global development in functional food had also prompted the European Commission to 
fund a project called the European Commission Concerted Action on Functional Food 
Science in Europe (FUFOSE) in 1995.  This 3-year project was managed by the International 
Life Science Institute (ILSI) Europe (Bellisle et al., 1998).  This initiative aimed to develop 
and establish a science-based approach for concepts in functional food science such as to 
critically assess the evidence required such as markers to support the nutrients that positively 
affect functions in the body.  The FUFOSE project focused on six areas: 1) growth, 
development and differentiation; 2) substrate metabolism; 3) defence against reactive 
oxidative species; 4) functional foods and the cardiovascular system; 5) gastrointestinal 
physiology and function; and 6) the effects of foods on behaviour and psychological 
performance (Diplock et al., 1999).  The work generated by the FUFOSE project served as a 
basis for the Process for the Assessment of Scientific Support for Claims on Foods 
(PASSCLAIM) project that ran between 2001 and 2005 (Aggett et al., 2005).  The main 
objective of the PASSCLAIM project was to produce a guidance tool to define the criteria for 
scientific substantiation of claims in food and food constituents.  These criteria included that 
the food or food constituent should be characterised, human studies are required to 
substantiate a claim, use of validated markers, totality of data and weight of evidence. The 
work from these two European projects was instrumental in the development of a harmonised 
regulatory process on health claims in the European Union in 2006 and had influenced the 
Codex Alimentarius guidelines which include establishing a common approach for 
substantiation of health claims (Richardson, 2012).   
The Codex Alimentarius Commission, ‘Codex’ first published guidelines on nutrition and 
health claims in 1997.  Prior to that, there was no internationally agreed definition of health 
claims. The Codex Alimentarius Commission is an inter-governmental body founded jointly 
by Food and Agriculture Organisation and World Health Organisation in 1961 for the purpose 
of protecting public health and to ensure fair practices in food trade.  The standards and 
guidelines established by Codex have a significant impact on global trade as these standards 
are recognised by World Trade Organisation under the agreement of sanitary and 
phytosanitary measure (SPS agreement) (World Trade Organisation).   The Codex guidelines 
on health claims have undergone several rounds of revision over the years ranging from re-
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defining the different types of health claims to adoption of the scientific substantiation on 
health claims in 2009 and refining the information in the guidelines (Codex Alimentarius, 
1997 (last amended in 2013).   
The development of health claims on food has progressed rapidly in Europe, Japan, the 
United States, Australia and New Zealand since 2000.  Both the United States and Japan 
introduced a new category of health claims known as ‘qualified health claims’ in 2003 and 
2005, respectively (United States Food and Drug Adminstration, 2003a; Yamada et al., 2008). 
Qualified health claims are claims that need to be accompanied by a disclaimer as the 
scientific evidence is considered insufficient.  In 2006, the European Commission issued the 
regulation on nutrition and health claims (EC1924/2006) (European Food Safety Authority, 
2006).  All health claims on food sold in Europe need to be authorised after the 
implementation of this regulation.  The European Food Safety Authority (EFSA) has 
established opinion on scientific substantiation and guidance documents to assist the 
applicants in preparing and submitting the health claims for scientific evaluation since 2010 
(European Food Safety Authority, n.d.-b).  The Food Standards Australia and New Zealand 
has also issued a regulation on nutrition and health claims in 2013 which came into force in 
2014 (Food Standards Australia and New Zealand, 2016b).   
The global development of health claims on food had some influence on the regulatory 
framework for health claims on food in Southeast Asia.  The food authority in the Philippines 
issued a circular to fully adopt the Codex guidelines on nutrition and health claims in 2007 
although there were no further details provided (Republic of the Philippines Food and Drug 
Administration).  The food authorities in Malaysia and Singapore each published a guide on 
food labelling and advertisement, including health claims on food in 2010 (Ministry of Health 
Malaysia, 2010; Agri-Food & Veterinary Authority, 2010 (with amendments to 2016)).  In 
2011, the Indonesian food authority issued the claims monitoring regulations (National 
Agency of Drug and Food Control of the Republic of Indonesia, 2011a; National Agency of 
Drug and Food Control of the Republic of Indonesia, 2011b).  The Thai food authority also 
issued the application on probiotics on food component which includes a definition of health 
claims and requirements for health claim applications for probiotics as food constituents in the 
same year (Ministry of Public Health Thailand, 2011).  The Vietnamese Food Authority has 
published a regulation on functional food that includes health claims on food and health 
supplements in late 2014 (Ministry of Health Vietnam, 2014).    
5 
 
Figure 1.2 illustrates the chronological order on the development of health claims in Codex 
Alimentarius and major jurisdictions such as Europe, the United States, Australia and New 
Zealand, Japan and in the Southeast Asia countries which have established health claims 
regulations and/ or guidelines.  The information on SEA is listed in bold in Figure 1.2. 
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Figure 1.2:  Chronological order on the development of health claims on food 
Source: Author constructed (Codex Alimentarius, 1997 (last amended in 2013; Diplock et al., 1999; United States Food and Drug 
Adminstration, 2000; Shimizu, 2002; European Food Safety Authority, 2006; Republic of the Philippines Food and Drug Administration, 2007; 
Yamada et al., 2008; Ministry of Health Malaysia, 2010; Agri-Food & Veterinary Authority, 2010 (with amendments to 2016); European Food 
Safety Authority, 2011b; Ministry of Public Health Thailand, 2011; National Agency of Drug and Food Control of the Republic of Indonesia, 
2011a; Food Standards Australia and New Zealand, 2013; Ministry of Health Vietnam, 2014; Association of Southeast Asian Nations (ASEAN) 
Secretariat, 2015b) 
Year 
1990: 
- United States (US): 
Nutrition Labelling 
and Education Act  
1967: 
ASEAN 
formed 
1991- 
- Japan: Food 
for Specified 
Health Uses 
(FOSHU) 
established  
1993 
- European 
Union (EU) 
formed 
1996:  
Europe: FUFOSE (3 years 
program: develop science-based 
approach for emerging concept in 
functional food development) 
1997- Codex 
guideline on 
nutrition and 
health claim 
2001: 
- Japan: FOSHU 
revised  
- Europe: PASSCLAIM 
(4 years programme to 
substantiate health 
claims) 
2003: 
US: Qualified Health 
Claim is allowed 
(Consumer Health 
Information for Better 
Nutrition Initiative) 
2004: 
Codex revision 
2005: 
- Japan permitted 
Qualified FOSHU 
2006:   
Europe: European Food 
Safety Authority (EFSA) 
Health Claim regulation 
(EU1924/2006) & 
misleading and 
comparative advertising 
(2006/114/EU) 
2007: 
signed ASEAN 
Economic Community 
-  The Philippines: 
adopted Codex 
Guidelines on Nutrition 
and Health Claims 
2009: 
Codex adopted 
health claim 
scientific 
substantiation  
2010:  
- Europe: EFSA 
issued opinion on 
scientific 
substantiation 
- Malaysia (Dec) & 
Singapore (Feb): A 
guide on food 
labelling and 
advertisement 
available 
2008- 2013 Codex document on  
Health Claim amended  
2011: 
Europe: EFSA develop 
guidance papers incl. 
evaluation of health 
claims  
- Indonesia:  Claim 
monitoring regulation 
(Dec) 
- Thailand:  application 
of probiotics as food 
component  (Jun) 
2013: 
Australia & New 
Zealand (ANZ): 
FANZ issued 
Standard 1.2.7 
Nutrition, Health 
and related 
claims 
2014: 
Vietnam: 
circular on 
functional food 
2015: 
- Japan: 
introduced food 
with functional 
claims 
- US: revised 
health claims 
requirements 
2016: 
-Europe: EFSA 
revise guidance 
documents 
- ANZ: revise 
application 
process 
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1.3 Existing systems in major jurisdictions for regulating health claims  
The changes in regulatory frameworks for health claims in major jurisdictions and the 
establishment of Codex guidelines on nutrition and health claims in 1997 led to the 
development of the regulatory systems for health claims on food products worldwide.  Health 
claims on food are subjected to pre-market approval from food regulatory agencies in major 
jurisdictions such as Europe, the United States, Japan, Australia and New Zealand (United 
States Food and Drug Adminstration, 1994 (revised January 2013); European Food Safety 
Authority, 2006; Consumer Affairs Agency, 2011; Food Standards Australia and New 
Zealand, as of 18 January 2016).  Each food authority has their scientific regulatory 
framework to administer and evaluate health claims.  The following paragraphs will briefly 
describe the systems in Europe, the United States (US), Japan and Australia and New 
Zealand.  These systems have a longer history of health claims and have been discussed 
among the scientific and regulatory community previously (Aggett et al., 2005; Asp and 
Bryngelsson, 2008; Yamada et al., 2008; Ellwood et al., 2010; Gilsenan, 2011; Lalor and 
Wall, 2011). 
1.3.1 European Union 
The regulation on nutrition and health claims on food products (EC 1924/ 2006) was issued 
on 20 December 2006 and was implemented on 1 July 2007 in Europe (European Food Safety 
Authority, 2006).  Under this regulation, health claims in Europe are classified into three 
categories: 1) Function health claims that describe the role of nutrient/ other substances in 
growth, development and function of the body, psychological functions, weight-control based 
on general accepted scientific evidence and well-understood by consumers (Article 13.1) and 
claims based on newly developed scientific evidence (Article 13.5); 2) Reduction of disease 
risk claims (Article 14.1a) and 3) Claims relating to children’s development and health 
(Article 14.1b).  The scope of this regulation applies to the use of claims in labelling, 
presentation and advertising of food.     
All health claims on food products sold in Europe are required to be authorised by the 
European Commission (EC) before health claims can be communicated to the consumer.  The 
European Food Safety Authority (EFSA) is responsible for evaluating the scientific evidence 
supporting each health claim.  The health claim applications were submitted (preferably in 
English) to EFSA via the food authority of each member state in the European Union.  EFSA 
would conduct a completeness check on the application dossier within 30 working days upon 
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receiving the application before they decided whether the dossier can proceed to scientific 
assessment by the Panel of Dietetics products, Nutrition and Allergies (NDA Panel) 
(European Food Safety Authority, 2016a).  This completeness check of the application dossier 
aims to look out for administrative compliance and the information required for scientific 
assessment.   Firstly, a dossier is required to be completed based on the EFSA application 
form for health claims.  Secondly, the critical information required for scientific assessment of 
health claims needs to be present in the application.  This information includes clear 
identification of the food/ constituent about which the claim is made, clear definition of the 
claimed effect, identification of risk factors for disease risk reduction claims, and definition of 
the conditions of use (European Food Safety Authority, 2016b).  The key criteria for EFSA 
health claims evaluation include (i) the food/constituent is defined and characterised; (ii) the 
claimed effect is based on the essentiality of a nutrient; or the claimed effect is defined and is 
a beneficial physiological effect for the target population, and can be measured in humans; 
(iii) a cause and effect relationship is established between the consumption of the 
food/constituent and the claimed effect (for the target group under the proposed conditions of 
use) (European Food Safety Authority, 2016b).  The opinion of the NDA panel on the health 
claims should be issued within 5 months from the start of the scientific assessment (excluding 
the time required for the applicants to provide answers to questions from EFSA, if needed).  
The opinions on the health claims are published on the EFSA website within 15 working days 
and all submitted health claims (authorised and unauthorised) are published in the public EU 
register of claims (European Food Safety Authority, 2016b).  Figure 1.3 depicts the 
application process for health claims in Europe.   
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European Food Safety Authority
Actors Submission Evaluation Outcome
Applicant
National competent 
authority of Member
states
European Food 
Safety Authority
Panel on Dietetic 
Products, Nutrition 
and Allergies
European Food 
Safety Authority and 
European
Commission
Member States: 
Receipt application 
Scientific assessment
14 days
Adopt 
opinion 
Prepare & submit 
dossier in softcopy
5 months+ 
request for 
addition 
information
EFSA – Validation process
Publication on EFSA website 
and EU journal 
30 working days
15 working days
Inform & make available application to Commission and other 
members states and assign official question number 
 
Figure 1.3:  Application process for health claims in Europe 
Source: adapted from EFSA website  (European Food Safety Authority, 2016a) 
1.3.2 United States  
In the United States (US), there are two different types of health claims; 1) health claims 
based on significant scientific agreement (SSA) and 2) qualified health claims.  Health claims 
in the US need to contain two elements; 1. a substance and 2. a disease or health-related 
conditions (United States Food and Drug Adminstration, 1994 (revised January 2013)).  
Health claims are limited to disease risk reduction and cannot treat, prevent or cure disease.  
The scope of the US regulation of health claims applies to conventional food labels and 
dietary supplement labels (United States Food and Drug Adminstration, 1994 (revised 
January 2013)).  Any claims made in advertising are under the purview of another federal 
agency, the Federal Trade Commission (Federal Trade Commission, 1994).  Any food 
product with health claim should not exceed the disqualifying nutrient levels of 13g of fat, 4g 
of saturated fat, 60 mg of cholesterol or 480 mg of sodium per serving size (United States 
Food and Drug Adminstration, Revised as of 1 April 2015a).   All health claims need to be 
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submitted to the US Food and Drug Administration (US FDA) for evaluation before 
communicating to the consumers.       
The health claim needs to meet the significant scientific agreement (SSA) standards under the 
Nutrition Labelling and Education Act of 1990.  That means that the qualified experts in the 
field agreed that there is strong scientific evidence to support the relationship between a 
substance and a disease for the health claim (United States Food and Drug Adminstration, 
2009).  The food company can also submit health claims based on an authoritative statement 
by a US government scientific body  such as ‘diets rich in whole grain foods and other plant 
foods and low in total fat, saturated fat, and cholesterol may reduce the risk of heart disease 
and some cancers’(United States Food and Drug Adminstration, 1994 (revised January 
2013)).  In contrast, qualified health claims are based on scientific evidence that is credible 
but that does not meet the SSA standards.  Qualified Health Claim must be accompanied by a 
disclaimer to indicate that the scientific evidence for the claim is not conclusive and the US 
FDA does not endorse the claim.   
Qualified health claims were allowed in 2003 under the Consumer Health Information for 
Better Nutrition Initiative.  This initiative aimed to improve availability and consumer 
understanding of up-to-date scientific information to aid their purchases.  This also came 
about after the US FDA was challenged in a series of lawsuits on violating commercial speech 
doctrine (United States Food and Drug Adminstration, 2003a).  In the case of qualified health 
claims, the US FDA will not take enforcement action against a manufacturer that has labelled 
its product with a qualified health claim as the agency has issued an enforcement discretion 
letter (United States Food and Drug Adminstration, 1994 (revised January 2013)).   
The application process and requirements for health claims based on SSA and qualified health 
claims are quite similar except for the duration of the application process (Ellwood et al., 
2010).  The health claims based on SSA applications take 540 days to complete while the 
qualified health claims applications take 270 days (United States Food and Drug 
Adminstration, 1994 (revised January 2013)).   Figure 1.4 and Figure 1.5 illustrate the 
processes involved in applying for health claims in the US (United States Food and Drug 
Adminstration, Revised as of 1 April 2015a; United States Food and Drug Adminstration, 
Revised as of 1 April 2015b).  
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United States:  Health Claims
Process Submission Evaluation Outcome of results
Applicant
USFDA
USFDA/  
Experts & 
Public 
Check 
content 
Notified receipt  
Comprehensive 
review (SSA)
15 days
Result 
Prepare & 
submit petition
Yes 
Yes 
No with reason 
No. with reasons 
provided  
Approve
Final rule 
publish 
540 days
Yes 
Make public the 
filed petition for 
public review
100 days
270 days 
(FDA can 
require <90 
days 
extension)
 
Figure 1.4:  Application process for health claims based on SSA in the United States 
Source: Author’s construction drawing based on information from US FDA United States 
Food and Drug Adminstration (Revised as of 1 April 2015a);  United States Food and Drug 
Adminstration (Revised as of 1 April 2015b) 
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United States: Qualified Health Claims
Actors Submission Evaluation Outcome of results
Applicant
US FDA
Public comment
USFDA/ other 
agencies
Notified receipt  
File for 
comprehensive 
review 
15 days
Prepare & 
submit petition
270 
days
No 
FDA screen 
petition 
45 days
(optional: FDA can require 
30-60 days extension)
Post petition on 
website for 
public 
comments
Close petition
Pursue 
options for 
scientific 
review 
(internal or 
third party)  
Report on 
Outcome 
(optional
) Consult 
other 
agencies
Notify 
outcome
Issue enforcement discretion 
60 days
120 days
 
Figure 1.5:  Application process for Qualified Health Claims in the United States 
Source: Author’s construction drawing based on information from US FDA United States 
Food and Drug Adminstration (Revised as of 1 April 2015a);  United States Food and Drug 
Adminstration (Revised as of 1 April 2015b) 
The health claim applications in the US need to justify the benefit of health claims based on a 
clear definition of the relationship between the substance and disease using relevant human 
studies, reliable and recognised surrogate endpoints, totality of publicly available scientific 
evidence, claim supported by significant scientific agreement among recognised body of 
qualified experts and the prevalence of the disease or health-related condition relevant to the 
US population (Ellwood et al., 2010; United States Food and Drug Adminstration, Revised as 
of 1 April 2015b).  Due to limited resources, the FDA can prioritise petitions based on several 
factors such as a significant impact to the US population, strength of evidence and consumer 
research to show that the claim is not misleading (United States Food and Drug 
Adminstration, 2003b).    
One point to note, a structure function claim that refers to a function of the body and does not 
make reference to a disease, is not considered as a health claim.  Hence the structure function 
claim on food does not need to be authorised by the US FDA (United States Food and Drug 
Adminstration, 1994 (revised January 2013)).  Examples of structure function claims in the 
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US are ‘calcium builds strong bones’ or ‘antioxidants maintain cell integrity’ (United States 
Food and Drug Adminstration, 2016).  This varies from the definition of Codex Alimentarius 
when nutrition function claims and other function claims are classified as health claims.  
1.3.3 Japan 
The Japanese regulatory system of health claims comprises two categories of health claims: 1) 
Food for Nutrient Function Claims (FNFC) and 2) Food for Specified Health Uses (FOSHU) 
(Masuda, 2014).  The FNFC is similar to the Codex nutrient function claims.  These claims do 
not require regulatory approval based on the nutrition labelling standards values (Hayashi, 
2015).  This is currently limited to 12 vitamins and 5 minerals that are widely accepted by 
experts (Masuda, 2015).  FOSHU are food containing ingredients that provide beneficial 
effects on physiological functions on the body and are intended to maintain and promote 
health for healthy people who wish to control their health conditions (Ministry of Health 
Labour Welfare Japan, n.d.).  The health claims were classified into 8 groups; gastro- 
intestinal conditions, mineral absorption, blood pressure, blood glucose, blood fat, blood 
cholesterol, bone health and dental health (Yamada et al., 2008).   
There have been several changes in the FOSHU programme since 2001.  The FOSHU 
programme accepted different forms of health food such as capsules and tablets, in addition to 
conventional foods in 2001 (Shimizu, 2002).  Since 2005, there are three new groups of 
FOSHU such as the Standardised FOSHU, Reduction of disease risk FOSHU and Qualified 
FOSHU based on the strength of evidence (Yamada et al., 2008).  The expansion of the 
FOSHU categories was to align with the Codex guidelines pertaining to the ‘disease risk 
reduction claims’ and to meet the request from the manufacturers (Shimizu, 2014).   Figure 
1.6 below provides the explanation on the categories of FOSHU and is from the Consumer 
Affairs Agency (CAA) website (Consumer Affairs Agency, 2011).   
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Categories of Food for Specified Health Uses (FOSHU) 
FOSHU 
- Requires detailed review process with scientific evidence for each 
application. 
 
Standardized FOSHU 
- No requirement of detailed review process for food products 
meeting the established standards and specifications. 
- Must be accompanied by sufficient accumulation of scientific 
evidence. 
- For efficiency: short cut process for products whose safety of use 
already approved. 
 
Reduction of disease risk FOSHU 
- Requires detailed review process with scientific evidence for each 
application. 
- Permitted for products whose ingredients clinically and nutritionally 
established to reduce a risk of certain disease (i.e. calcium for 
osteoporosis and folic acid for neural tube defects)   
Qualified FOSHU 
- Requires detailed review process with scientific evidence for each 
application. 
- Permitted for products with ingredients showing certain health 
effects but not reaching the established standards for FOSHU 
approval. 
- Labelled as ‘Qualified Food for Specified Health Uses’.  
 
Figure 1.6:  Categories of Food for Specified Health Uses (FOSHU) in Japan 
Source: Consumer Affairs Agency (2011) 
Food labels with health claims need to declare notice and warning on adverse effects due to 
overdosing and should not imply prevention, treatment and diagnosis of diseases.  In addition, 
the products with Qualified FOSHU need to indicate that the scientific evidence of the health 
claim is inconclusive on the labels (Yamada et al., 2008).  To help consumers differentiate the 
different categories of FOSHU, the Qualified FOSHU logo is different compared with the 
other FOSHU logo.  
Each FOSHU application is evaluated by expert panels in the government and it is approved 
individually by the CAA which was set up in 2009 to protect the interest of consumers 
(Masuda, 2014).   The approvals of FOSHU are based on demanding requirements such as the 
effectiveness  of the product based on scientific evidence, the safety of the product with safety 
studies and history of use, the analytical determination of the effective substance, 
compatibility with product specification and reasonable duration of consumption (Shimizu, 
2014).  This approval process for each FOSHU application takes 6 months to 3 years as they 
have to undergo rigorous review on safety and efficacy (Hayashi, 2015).   Figure 1.7 
15 
 
illustrates the application flow for FOSHU application in Japan (Consumer Affairs Agency, 
2011).   
Japan:  Food for Specified Health Uses (FOSHU)
Actors Submission Evaluation Outcome
Applicant
Consumer Affairs Agency, 
Food  labelling division
Consumer Commission, 
Assessment and evaluation 
for novel food 
Food Safety Commission, 
Expert Assessment Group 
for novel food 
Consumer Commission, 
Assessment and evaluation 
for novel food 
Ministry of Health, Labour, 
Welfare
Consumer Affairs Agency
Food labelling 
Prepare & submit 
dossier in softcopy
Review efficacy
Review safety
Review efficacy and 
safety comprehensively
Check  whether labelling 
violates Pharmaceutical 
Affairs Acts
Approval
 
Figure 1.7:  Procedure flow for Food with Specified Health Uses (FOSHU) 
Source: Consumer Affairs Agency (2011) 
In April 2015, the CAA established a new category of health claim labelling known as the 
food with functional claims (FFC).  This new category aims to increase the number of foods 
with functional claims and to promote healthy, longer lived population and it was part of the 
Japan Revitalisation Strategy (also as known as ‘Abenomics’).  The new FFC registration 
process is faster and more affordable for food manufacturers.  These claims are not 
individually approved by the CAA and the manufacturers are required to provide CAA with 
the required information 60 days prior to the launch of the FFC-labelled product.  The 
manufacturers bear the responsibilities on the scientific accuracy of the health claims under 
the FFC.  The guidelines on labelling such as the amount of the effective food constituent 
required, warning and disclaimer statement must be strictly followed (Hayashi, 2015).  
1.3.4 Australia and New Zealand  
The Food Standards Australia New Zealand (FSANZ) issued the regulation on nutrition, 
health and related claims on 18 January 2013 (Standard 1.2.7) after 10 years of work (Food 
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Standards Australia and New Zealand, 2013).  Food businesses were provided with a 3-year 
transition period to comply with the regulation by 18 January 2016 (Food Standards Australia 
and New Zealand, as of 18 January 2016).  The scope of this regulation includes claims made 
on labels and advertisements made on food.  There are two types of health claims in Australia 
and New Zealand (ANZ), namely; 1) general level health claims (GLHC) and 2) high level 
health claims (HLHC) (Food Standards Australia and New Zealand, as of 18 January 2016).  
The main difference between these two health claims in ANZ is that HLHC refer to a disease 
or biomarker of a disease and GLHC do not.  The definition of HLHC and GLHC are listed 
below: 
1.  HLHC refers to a nutrient/ substance in food and its relationship to a serious disease or to a 
biomarker of a serious disease such as ‘Diets high in calcium may reduce the risk of 
osteoporosis in people 65 years and over’.   
2.   GLHC refers to a nutrient/ substance in a food and its effect on health such as ‘calcium is 
necessary for normal teeth and bone structure’.   
The food carrying a general or high level health claim must meet the nutrient profiling score 
criterion (NPSC) and the health claims are not allowed for foods high in saturated fat, sugar or 
salt (Food Standards Australia and New Zealand, as of 18 January 2016). The health claims 
must include the statements on the form of the food and dietary context statement as indicated 
in the regulation (Food Standards Australia and New Zealand, as of 18 January 2016).   
All health claims must be supported by an established food and health relationship that is 
substantiated using systematic review.  The systematic review needs to include the search 
strategy (include the inclusion and exclusion criteria), a table with key information of each 
included study, assessment of the quality of each included study, demonstrate a consistent 
association between the food and health effect based on high quality studies, show the amount 
of food to achieve the health effect can be consumed based on a normal diet of Australian and 
New Zealand populations (Food Standards Australia and New Zealand, as of 18 January 
2016).   
Food businesses are required to notify FSANZ before making GLHC (Food Standards 
Australia and New Zealand, 2015c).  However, these GLHC do not require the approval of 
the Food Standard Australia and New Zealand.  The records of the systematic review should 
be provided to the enforcement authority in Australia and New Zealand, if requested by the 
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authority to check for compliance.  Figure 1.8 illustrated the process involved in notifying 
FSANZ on the use of GLHC (Food Standards Australia and New Zealand, 2015c) . 
 
Figure 1.8:  Notification process on the use of General Level of Health Claims 
Source: Author’s construction drawing based on information from FSANZ website (Food 
Standards Australia and New Zealand, 2015c) 
New high level health claims or variations in the pre-approved health claims are subjected to 
‘High Level Claims Variation Procedure’ which takes 9 months from the start of the 
assessment (refer to Figure 1.9 below) (Food Standards Australia and New Zealand, 2016a).  
The health claims scientific advisory group provides advice to FSANZ on technical and 
scientific matters to assess the food health –relationship underpinning general or high level 
claims (Food Standards Australia and New Zealand, 2015a).  In March 2016, FSANZ has 
started to charge the applicant a fee of AUD50k – 125K for a high-level claim variation 
procedure to recover their costs.  The amount varies depending on the number of hours 
FSANZ spend to evaluate the application.  The applicant can also opt to pay more to expedite 
the assessment process instead of the application being put in the ‘queue’ for assessment 
(Food Standards Australia and New Zealand, 2016a).   
ANZ:	General	level	health	claims	(via	notification)
Actor Submission
Applicant (senior officer of 
company)
FSANZ
Notify CEO ANZ on details of a 
relationship between a food or
property of food and a health 
effect that has been established by 
a process of systematic review
5 days
Publish the name  & 
person making claims 
on FSANZ website 
Acknowledge receipt & 
check info against list of 
approved claims
Submit systematic 
review upon request by 
enforcement agency
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ANZ: High Level Health Claims
Actor Submission Evaluation Outcome of results
Applicant
FSANZ 
High Level Health 
Claim committee 
(HLHC) & Food 
Regulation 
Standing 
Committee 
(FRSC)
Public 
FSANZ
HLHC & FRSC
FSANZ Board 
Receipt 
Application   
15 working 
days
Prepare & 
submit petition
10 working days
20 working days
Notify  applicant and HLHC committee & FRSC
No public notification until gazette 
Notify applicant & seek 
recommendations from  HLHC & FRSC
Approve? 
Est. 9 months
(exclude ‘stop the 
clock’ 
Admin assessment 
Accept?
No 
Yes 
Public notification 
(decided by the applicant) 
Public SubmissionNo Public Submission
Recommendation from HLHC & comments from FRSC
Notify applicant, Public notification* & seek 
recommendations from HLHC & FRSC
Notify forum Public notification* 
Prepare draft variation
No Public notification 
 
Figure 1.9:  High Level Claim Variation Procedure 
Source: Food Standards Australia and New Zealand (2016a) 
1.4 Issues with the existing systems of frameworks in major jurisdictions 
Clearly, there are differences in the regulatory frameworks among the major jurisdictions such 
as Europe, the United States, Japan, Australia and New Zealand (United States Food and 
Drug Adminstration, 1994 (revised January 2013); European Food Safety Authority, 2006; 
Consumer Affairs Agency, 2011; Food Standards Australia and New Zealand, as of 18 
January 2016).  These differences include the scope, the procedures on applying for new 
health claims and the evidence required to substantiate the health claims. Both the 
frameworks from the United States and Japan are deemed to be more industry- friendly as 
qualifying statements are allowed.  This has helped the food industry in these countries to 
introduce food products with health claims faster to consumers (Lalor and Wall, 2011). 
The scientific substantiation and evaluation of health claims have been subjected to debates 
between the food industry and EFSA.  The food industry in Europe raised concerns about the 
lack of certainty, transparency and clarity on the criteria for health claims substantiation and 
the lexicality of the claims (Gallagher, 2011; Richardson, 2012).  The food industry has spent 
large amounts of money conducting research and development to generate evidence to 
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substantiate health claims, only to have their submissions rejected by EFSA.  To date, the EU 
register of nutrition and health claims (last checked on 11 Jun 2016) showed that 8 of 100 
new health claim applications submitted to EFSA have been rejected (European Food Safety 
Authority, n.d.-a).  The health claims based on newly developed scientific evidence (Art 13.5) 
have the least number of claims authorised by EFSA and only two out of 95 submitted claims 
on this category were approved.  In contrast, the nutrient claims based on generally accepted 
scientific evidence (Article 13.1) have the most number of claims being authorised.  This 
could potentially stifle innovation.   
1.5 Consumer understanding about health claims 
Knowledge of the consumers’ understanding about health claims is limited, though the health 
claim is aimed at benefitting the consumers’ decision- making process to achieve a healthy 
diet.  Most of the studies which have investigated this are conducted in Western countries and 
are focused on consumers’ responses to and perceptions of nutrition and health claims.   It is 
challenging to measure understanding about health claims as processing of information by 
consumers is complex.  There is a constant interaction between externally obtained 
information and internal knowledge present in the memory (Leathwood et al., 2007).  Many 
consumer studies (Nocella and Kennedy, 2012; Lähteenmäki, 2013; Wills et al., 2012) have 
suggested that the understanding of health claims is multi-factorial.   
Several review papers have reported that the factors influencing the perception of health 
claims are personal characteristics such as gender, age, education, personal relevance, 
attitudes towards health and nutrition, socio-economic status, familiarity with the ingredient, 
knowledge on nutrition issues, wording of the claims, length of exposure of health claims and 
the difference in country and cultures (Nocella and Kennedy, 2012; Lähteenmäki, 2013).   
Previous studies suggested that consumers in Belgium understood and preferred more 
context-specific health claims (Verbeke et al., 2009) while a study among Irish consumers 
suggested that they preferred simpler nutrition and health claims such as structure-function 
and content claims (Lynam et al., 2011).  Studies have shown that more females read food 
label more frequently and were more favourable towards health claims due to general interest 
in health and for the health of their family (Lalor et al., 2011; Lynam et al., 2011; Nocella and 
Kennedy, 2012; Wills et al., 2012).  Sverderberg and Wendin (2011) showed that concerns 
for family health among a group of Swedish consumers influenced their decision to read and 
understand health claims. The effectiveness of communication of health claims could be 
improved by the use of visual aids such as graphics and concise messaging in prominent 
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locations on the packaging (Geiger, 1998; Hooker and Teratanavat, 2008).  The carrier 
product used to test health claims has an influence on the understanding of the health claims 
and health claims were accepted and perceived positively on food products with healthier 
image such as bread, yoghurt, and breakfast cereal instead of meat replacers, biscuits and ice-
cream (Dean et al., 2011; Wills et al., 2012; Lähteenmäki, 2013).     
Consumer understanding of nutrition and health claims and perception of benefits differed 
substantially by country in a large- scale cross national study in Italy, Germany, the UK and 
the US (van Trijp and van der Lans, 2007).  The study found that the UK consumers could not 
understand the claims on stress but the US consumers could understand the claim on stress.  
The German consumers could easily understand the claims on infection whereas the rest of 
other countries did not find these claims to be easily understood.  The study also found that 
the US was the only country where the credibility of nutrition and health claims was slightly 
lower than the credibility of a taste claim.  Another study conducted in Germany measured the 
understanding of health claims on yoghurt using open answers (Grunert et al., 2011).  The 
team found that respondents with positive attitudes to functional foods had a scientifically 
inaccurate understanding about health claims compared to respondents with neutral or 
negative attitudes.  This would suggest that higher motivation leads to deeper processing of 
message and inferences beyond what is being said in the claims (Grunert et al., 2011).   Many 
studies have reported that attitudes to functional food and health vary in different countries 
(Bech-Larsen and Grunert, 2003; van Trijp and van der Lans, 2007).   
1.6 Research focus on Southeast Asia (SEA) 
The Association of South East Asian Nations (ASEAN) aims to be a single market to allow 
free movement of goods, services and manpower under the formal establishment of the 
ASEAN Economic Community in 2015 (Association of Southeast Asian Nations (ASEAN) 
Secretariat, 2015b).  ASEAN consists of ten countries in Southeast Asia, namely, Brunei 
Darussalam, Cambodia, Indonesia, Lao People’s Democratic Republic, Malaysia, Myanmar, 
the Philippines, Singapore, Thailand, and Vietnam, and with a combined population of over 
622 million with a multitude of cultures and languages (Association of Southeast Asian 
Nations (ASEAN) Secretariat, 2015b; Association of Southeast Asian Nations (ASEAN) 
Secretariat, n.d.).  The existing regulatory frameworks for health claims on food in SEA are 
unclear as it is difficult to have access to the regulations of some SEA countries.  This is due 
to the different languages used in SEA.  In addition, there is limited knowledge on the 
regulatory frameworks for substantiating and approving health claims in this region.  The 
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regulations or guidelines on health claims in some SEA countries are issued without further 
details or guidance documents to help the applicants to prepare the health claim application.   
The current thinking and practices on the regulations and/ guidelines on health claims are 
unknown to the food industry and the scientific community.  This lack of information, could 
potentially create challenges for the food industry and scientific community to generate 
evidence to support health claims application, and could restrict the food industry from selling 
the products with health claims in SEA.  This issue contradicts the aim of AEC which is to 
have free movement of goods and trade across Southeast Asia.  Eventually, the consumers in 
the SEA region could be deprived of the opportunities to have access to foods of better 
nutritional quality, supported by the use of relevant health claims on packaging. 
Due to the recent advent of health claims in the region, there is also a knowledge gap on the 
Asian consumers’understanding of health claims.  There is a need for research in this area as 
it has the potential to discover the current status on the understanding on health claim and 
regulatory frameworks in SEA region.  This knowledge could assist the food industry to 
better communicate the benefits of food and the constituents effectively to the SEA 
consumers.  In due course, health claims should benefit the consumers and help to ensure they 
are able to make informed food choices.   
Both the regulatory frameworks and the understanding about health claims on food affect the 
availability and intended purpose of health claims in SEA.  Currently, there is a lack of 
information on how health claims are regulated and approved in Southeast Asia and whether 
the Asian consumers understand health claims. The Asian mothers were selected for this 
research as the earlier studies have reported that more females esp. those with families tended 
to read food labels as compared to males (Williams, 2005; Lalor et al., 2011; Svederberg and 
Wendin, 2011).  In SEA, the milk powder for children display health claims on their food 
labels.  Thereby it is more relevant to find out the understanding on health claims among the 
major purchasing demographic.  These ‘gaps’ in knowledge have implications for the 
consumers, for the regulatory community, food industry and researchers as it impacts trade in 
the Southeast Asia region, limits the communication on nutritional benefits of food, and also 
potentially discourages innovation to develop specialised food products with potential health 
benefits for the Southeast Asian consumers.  It is currently uncertain whether the existing 
regulatory frameworks on health claims in SEA are either industry-friendly, consumer-
friendly, neither or both. 
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1.7 Research aims and objectives 
The research topic is on the health claims on food products in SEA.   This research, funded by 
the Singapore Economic Development Board and Danone Asia Pacific Holding Pte Ltd, aims 
to answer the following two research questions: 
‘How are health claims on food products in SEA substantiated and evaluated in SEA?’ and  
‘Do the Asian consumers understand health claims on food?’   
The research questions guided the formulation of the aims and objectives of this research 
which are as follows: 
Overall aim:   To have a better understanding on how the information flow through the 
existing regulatory frameworks in SEA effectively communicates understanding to the 
consumers. 
Aim 1:   To review the health claim regulations in SEA and from major jurisdiction such as 
European Union, United States, Australia and New Zealand, Japan.   
Objectives: 
a) Understand how health claims are administered in various countries, including 
substantiation and evaluation 
b) Identify the convergences and divergences between the regulatory frameworks for 
health claims in SEA, Codex and major jurisdictions 
Aim 2:  Investigate the current practices and perspectives of the regulatory frameworks for 
new health claim applications in SEA.   
Objectives: 
a) Understand the processes of health claim substantiation and evaluation in various SEA 
countries; 
b) Identify the factors affecting the approval of health claims; and  
c) Understand the challenges faced by the clusters of stakeholders such as food 
regulators, key opinion leaders, policy makers and representatives from food 
associations and scientific organisations  
Aim 3: Investigate Asian mothers’ understanding of health claims and the settings of local 
regulatory frameworks  
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Objectives: 
a) Understand the current status of the knowledge, perception and attitudes towards 
health claims 
b) Identify the mothers’ current knowledge and trust of the regulatory process and 
framework;  
c) Identify factors affecting the understanding of health claims 
Aim 4:  Propose a conceptual harmonised regulatory framework on health claims for foods in 
SEA 
Objectives: 
a) Provide a clear and transparent structure which provides confidence for the food 
consumers in health claims  
b) Encourage innovation in the food industry in the development of healthy food choices 
c) Provide a common basis for the regulatory community in SEA to discuss on a 
harmonised approach to administer health claims which could facilitate free trade in 
the SEA region 
1.8 Introduction to methodological approach 
This research consists of three methods namely review, semi- structured interviews and focus 
groups.   First, a review of the literature, available regulations and guidelines on health claims 
in major jurisdictions and SEA countries, was conducted to better understand the existing 
regulatory frameworks and identify the barriers that impact the health claim applications such 
as different processes, requirements of the scientific evidence and evaluation criteria (Chapter 
2).  The convergences and divergences between the regulatory frameworks on health claims 
in SEA and the frameworks from the developed countries were compared using the collected 
information.  Lalor and Wall (2011) applied the above method to review and compare the 
scientific and regulatory environments for nutrition and health claims on foodstuffs in the 
USA, Japan and the European Union.   
Second, semi- structured interviews on scientific substantiation of health claims and their 
evaluation were conducted among the different clusters of key stakeholders who have 
experience with health claim application and evaluation in the SEA region based on the flow 
of health claim applications (Chapter 3).  Stakeholders ranged from representatives from the 
food association filling in the application, to the regulators involved in the administration, to 
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the key opinion leaders, policy makers, and representatives from scientific organisations 
involved in the evaluation of health claims in the country.  Detailed information was gathered 
from these key stakeholders to understand the practices and perspectives on health claim 
evaluation (Chapter 3).  Interviews are commonly applied by sociology and/ policy studies to 
understand the current situation and gather perspectives from different stakeholders (Massa 
and Testa, 2008; Miguel et al., 2014).  For instance, Massa and Testa (2008) interviewed 
stakeholders such as entrepreneurs, academics, and policy makers in Italy to investigate their 
perspectives on innovation to provide new insight into an issue while  Miguel et al. (2014) 
interviewed pharmacists from five European countries to compare policies and practices on 
how prescription-only medicine was dispensed across Europe. 
Third, focus group discussions were conducted among Asian mothers to assess their 
understanding about health claims and factors affecting the understanding of health claims 
(Chapter 5).  The Asian mothers were selected based on two reasons.  Firstly, there is 
currently no or limited data on this research topic amongst Asian populations.  Hence this 
research focused on a specific group of consumers, Asian mothers, using qualitative method 
(focus groups) to provide an in-depth understanding of this topic. Secondly, health claims are 
commonly found on milk powder for children in SEA.  These mothers were selected based on 
the fact that they bought milk powder for their child aged 3 years and above1 and claimed to 
read food labels.  It was important to find out whether these Asian mothers who claimed to 
read food labels, could understand health claims.  This could help understanding whether 
health claims on food aid consumers to make informed food choices for their children.  The 
understanding of the health claim statement was measured based on how the mothers would 
explain a claim to their friends via open- ended questions.  This approach to measuring the 
understanding on health claims was adapted from the Consumer Understanding Test method 
that was developed by Danone, based on principles recommended by the International Life 
Science Institute (Grunert et al., 2011).    
Both qualitative methods such as the semi-structured interviews and focus group discussions, 
provided in-depth and rich insights on the regulatory frameworks for health claims in SEA 
and the Asian mothers understanding on health claims which are currently understudied.  
Figure 1.10 describes the details of this research.  
 
                                                 
1 (to satisfy the Indonesian regulation on health claims where health claims are not permitted on food for 
children aged less than 3 years). 
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Figure 1.10:   Schematic representation of this study 
1.9 Outline of this thesis 
The thesis begins with the landscape analysis of the existing regulatory frameworks on health 
claims in SEA (Chapter 2).  The barriers and opportunities in the various frameworks in SEA 
are highlighted in the same chapter.  Chapter 3 reports the findings on the current practices 
and perspectives on health claims substantiation and evaluation in SEA from the interviews 
with the key stakeholders in SEA.  Chapter 4 focuses on the Asian mothers’ understanding 
about health claims.  Chapter 5 is concerned with the proposed conceptual framework on the 
regulatory framework on health claims for SEA region. The final chapter summarises the 
main findings of this research project, anticipates the future of health claims, discusses the 
implications of the findings and makes recommendations for future research.  
  
Propose a conceptual harmonised ASEAN Regulatory Framework on 
Health Claims
Review the health 
claim regulation 
from major 
jurisdictions & in 
SEA
Desk-top research
Understand how health 
claims are 
administered in 
various countries, 
including 
substantiation 
evaluation 
Identify the 
convergences and 
divergences of the 
different systems
Understand the 
current status on 
regulations/  in SEA 
Interview with 15 key 
stakeholders in SEA 
using semi-structured 
interview
-Understand the 
processes of health 
claim substantiation and 
evaluation;
- Identify the factors 
affecting the approval 
of health claims;
- Understand the 
challenges faced by the 
key stakeholders.  
Investigate Asian mothers’ 
understanding of health 
claims and the regulatory 
settings of local regulatory 
framework in SEA.  
48 mothers in three SEA 
countries using 
semi-structured focus group 
- Understand the current 
status of the knowledge, 
perception and attitudes 
towards health claims 
- Identify the mothers’ 
current knowledge and trust 
of the regulatory process 
and framework; 
- Identify factors affecting 
the understanding of health 
claims using three selected 
nutrients, calcium, iron and 
vitamin A as case studies
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Chapter 2 Health Claims on food products: the regulatory frameworks, 
barriers and opportunities in Southeast Asia2  
2.1 Abstract 
The Association of South East Asian Nations (ASEAN) aims to act as a single market and 
allow free movement of goods, services and manpower by Year 2015.  The purpose of this 
paper is to present an overview of the current regulatory framework on health claims in 
Southeast Asia (SEA) and to highlight the current barriers and opportunities in the regulatory 
frameworks in the ASEAN.  To date, six countries in SEA, i.e. Indonesia, Malaysia, the 
Philippines, Singapore, Thailand and Vietnam have regulations and guidelines to permit the 
use of health claims on food products.   There are inconsistencies in the regulations and the 
types of evidence required for health claim application in these countries.  A clear 
understanding of the regulatory frameworks in these countries may help to increase trade in 
this fast-growing region, and to provide directions for food industry and the regulatory 
community to develop and market food products with better nutritional quality tailored to 
needs of the Southeast Asian consumers.   
Key words:  Health claims, regulatory frameworks, Southeast Asia, food trade, food industry 
  
                                                 
2 This chapter has been published in Nutrition Reviews.  The content in this chapter is expanded from the paper 
to include discussion on Vietnam which was not available when the paper was published.   
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2.2 Introduction 
The Association of South East Asian Nations (ASEAN), made up of a collective population 
of 622 million, consists of ten countries in Southeast Asia (SEA) namely Brunei Darussalam, 
Cambodia, Indonesia, Laos PDR, Malaysia, Myanmar, the Philippines, Singapore, Thailand 
and Vietnam (Association of Southeast Asian Nations (ASEAN) Secretariat, 2015b).   The 
ASEAN has an overarching integration objective to be a single market to allow free 
movement of goods, services and manpower by the Year 2015 (Association of Southeast 
Asian Nations (ASEAN) Secretariat, 2015b).  The ASEAN Trade in Goods Agreement 
(ATIGA) was signed by the 10 SEA countries since 2009. The agreement which aims to 
achieve free flow of goods in ASEAN, includes tariff liberalisation, removal of non-tariff 
barriers, trade facilitation, customs under the agreement (Association of Southeast Asian 
Nations (ASEAN) Secretariat, 2009b).    
All the 10 SEA countries are members of the World Trade Organisation (World Trade 
Organisation, n.d.-a).   The World Trade Organisation under the Sanitary and Phytosanitary 
Measures Agreement recognised the Codex Alimentarius Commission as the relevant 
standard-setting organization for international food safety (World Trade Organisation, n.d.-b).  
The Codex Alimentarius Commission (the “Codex”) is an inter-government body established 
by the Food and Agriculture Organisation and the World Health Organisation in 1961.  The 
Codex Alimentarius is a collection of international food safety standards, guidelines and code 
of practices adopted by the Codex Alimentarius Commission to protect the health of 
consumers and ensure fair practices in the international food trade (Codex Alimentarius, n.d.).  
To facilitate international trade and a freer movement of goods among the countries, it is 
important for the countries to harmonise food regulation and adopt internationally agreed 
standards such as those developed by the Codex Alimentarius.  Codex guidelines on Nutrition 
and Health claims have been adopted in 1997 and the recent revision updated in 2013 (Codex 
Alimentarius, 1997 (last amended in 2013).   
The regulatory frameworks on health claims encompass several different aspects of food 
regulations such as the procedures to apply for new health claim, the types of scientific 
evidence required for health claims substantiation, the process for evaluating the scientific 
evidence which lead to approval or rejection of the new health claims, and the enforcement 
actions in place to ensure that the health claims on food comply with local food regulations.  
To date, there is limited or no knowledge of the regulatory frameworks in SEA and the 
process for implementing food regulations.  This lack of information could potentially restrict 
the free movement of goods across SEA, thereby restricting access of consumers in this 
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region to foods of better nutritional quality.  The purpose of this chapter is to provide an 
overview of the regulatory frameworks on health claims on food products in SEA and to 
highlight the current barriers and opportunities in the various regulatory frameworks in the 
ASEAN setting.   
2.3 Existing regulatory frameworks for the health claims for food products in SEA   
To date, six countries in SEA namely Indonesia, Malaysia, the Philippines, Singapore, 
Thailand and Vietnam each permit the use of some forms of health claims on food products 
today (Ministry of Health Vietnam, 2014; Tee, 2014).   Regulations and guidelines on health 
claims have been published for each of these five countries except the Philippines which, as 
indicated on the official website of the Philippines Food and Drug Administration, have 
adopted the full standards on nutrition and health claims issued by the Codex Alimentarius 
Commission (Republic of the Philippines Food and Drug Administration, 2007).  Three SEA 
countries, Indonesia, Malaysia and Singapore have published application forms for new health 
claims (Ministry of Health Malaysia, 2010; National Agency of Drug and Food Control of the 
Republic of Indonesia, 2011a; Agri-Food and Veterinary Authority of Singapore (n.d-b)).  
The application forms apply to all types of health claims applications such as nutrient function 
claims, other function claims etc.  The health claim application forms for Indonesia, Malaysia 
and Singapore are available in Appendix 1.  There is no official guideline on health claims 
issued in the rest of the four SEA countries belonging to ASEAN.  Hence the procedures for 
approval and regulation of health claims on food products in these countries are unclear.  This 
lack of information could lead to different approaches and practices (Aggett et al., 2012). 
2.4 Differences among the existing frameworks in SEA  
There are several areas of divergences within the existing regulation and guidelines governing 
health claims in the six SEA countries that have them.  This could affect food trade among the 
countries in the SEA region as different food regulations potentially create barriers for the 
food products to be sold across the different markets because of differing labelling 
requirement, permitted health claims etc. 
2.4.1 Different definitions, scopes and objectives  
Codex Alimentarius (1997) defines a health claim as ‘a representation that states, suggests, or 
implies a relationship exists between a food and health’ (Codex Alimentarius, 1997 (last 
amended in 2013).   Health claims are categorised into three groups: (1) nutrient function 
claims, (2) other function claims and (3) reduction of disease risk claims.  The Codex 
Alimentarius also states that ‘health claims must be consistent with national health policy, 
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including nutrition policy, as well as support for such policies’(Codex Alimentarius, 1997 
(last amended in 2013).  In general, health claims on food products aim to help consumers 
make informed food choices to achieve a healthy diet.   
Table 2.1 and Table 2.2 show some of the inconsistencies in the definitions of health claim as 
well as the scope and objectives of the regulations and guidelines for health claims in the six 
SEA countries that have them.  
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Standard/ 
country 
Definition of health claim Types of health claims Others References 
Codex 
standard 
Any representation that states, 
suggests, or implies that a 
relationship exists between a food 
or a constituent of that food and 
health 
Nutrient function 
Other function 
Reduction of disease risk 
Nil (Codex Alimentarius, 1997 (last amended 
in 2013; Republic of the Philippines Food 
and Drug Administration, 2007) 
Indonesia Claim state the relationship of food 
or substances contained in food to 
health 
Nutrient function 
Other function 
Reduction of disease risk 
Nil (National Agency of Drug and Food 
Control of the Republic of Indonesia, 
2011a; National Agency of Drug and 
Food Control of the Republic of 
Indonesia, 2011b) 
Malaysia No definition Nil “Nutrient function” claims 
and “other function” claims 
classified under “Nutrition” 
claims 
(Ministry of Health Malaysia, 2010) 
The 
Philippines, 
Singapore 
Any representation that states, 
suggests, or implies that a 
relationship exists between a food 
or a constituent of that food and 
health 
Nutrient function 
Other function 
Reduction of disease risk 
Nil (Republic of the Philippines Food and 
Drug Administration, 2007; Agri-Food & 
Veterinary Authority, 2010 (with 
amendments to 2016)) 
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Thailand Image illustration, picture, artificial 
mark, mark, trademark, or any 
statements appeared on the label in 
connection with food, food 
component, or nutrient that are 
associated directly and indirectly 
with health 
Nutrient function 
Other function 
Reduction of disease risk 
Nil (Ministry of Public Health Thailand, 
2011) 
Vietnam No definition Not listed  Nil (Ministry of Health Vietnam, 2014) 
Table 2.1 Summary of health claim definitions in Southeast Asia countries 
 
Standard/ 
country 
Scope Objectives References 
Codex All foods 
Food labels 
Advertisement (if required by local 
authorities) 
To provide truthful and non-misleading information to 
aid consumers in choosing healthful diets 
(Codex Alimentarius, 1997 (last amended in 
2013) 
Indonesia Processed foods with claim 
declaration 
Includes labels and advertisements 
To protect the public from misleading claims on labels 
and advertising of processed foods 
(National Agency of Drug and Food Control 
of the Republic of Indonesia, 2011a) 
Malaysia Unavailable Unclear (Ministry of Health Malaysia, 2010) 
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Standard/ 
country 
Scope Objectives References 
Singapore Food labels and advertisements Provide food importers, manufacturers and retailers 
with a better understanding of the labelling 
requirements of the Food Regulations, as well as the 
permitted and prohibited claims for use in food labels 
and advertisements 
(Agri-Food & Veterinary Authority, 2010 
(with amendments to 2016)) 
Thailand Unavailable Unavailable (Ministry of Public Health Thailand, 2011) 
Vietnam Functional foods consisting of 
supplemented food, health 
supplement, medical food and food 
for special dietary uses 
Regulate activities of manufacture, trade, product 
announcement, labelling and instruction for use  
(Ministry of Health Vietnam, 2014) 
Table 2.2 Scope and objectives of health claim regulations and guidelines in Southeast Asia countries 
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The Vietnam regulation on functional food does not have the definitions or types of health 
claims (Ministry of Health Vietnam, 2014).  Malaysia does not have a health claim definition 
and the ‘nutrient function claim’ and ‘other function claims’ are classified under ‘nutrition 
claims’.  The reduction of the disease risk claim is not permitted in Malaysia (Ministry of 
Health Malaysia, 2010).  This classification of the ‘nutrient function’ and ‘other function’ 
claims as nutrition claims in Malaysia differs from the classification of health claims in the 
Codex standards.  Indonesia is the only country among the six SEA countries with regulation 
on health claims that stated the scope and objectives of the regulation.  The objective of the 
Indonesian regulation is mainly to protect consumers from misleading claims (National 
Agency of Drug and Food Control of the Republic of Indonesia, 2011a).  These ambiguities 
in the regulations and guidelines could potentially affect how the regulations are enforced in 
practice.   
The Codex Alimentarius Commission and food authorities from the major jurisdictions such 
as the European Food Safety Authority (EFSA), the United States Food and Drug 
Administration (USFDA), the Food Standards Australia & New Zealand and the Japanese 
Consumer Affairs Agency each have their established regulatory frameworks through which 
to approve health claims (United States Food and Drug Adminstration, 1994 (revised January 
2013); Codex Alimentarius, 1997 (last amended in 2013; European Food Safety Authority, 
2006; Food Standards Australia and New Zealand, as of 18 January 2016).  These regulatory 
frameworks are well-recognised as these frameworks have been widely discussed within the 
scientific community as well as within the regulatory community (Asp and Bryngelsson, 
2008; Hasler, 2008; Gallagher, 2011; Gilsenan, 2011; Lalor and Wall, 2011; Flynn, 2012).   
The definitions, scopes and objectives in the major jurisdictions where health claims are more 
established, are clearly stated within the regulations.  The scope of the health claim 
regulations in these major jurisdictions cover food labels and advertisement.  The objectives 
of their regulations are to protect the consumers and to facilitate informed food choices and 
encourage food innovation within the food industry and to permit free movement of foods 
across countries.  Nevertheless, there are differences among the definitions of the health 
claims issued by regulatory agencies in these countries.  
The European Union (EU) which currently consists of 27 countries, implemented a 
framework on nutrition and health claims in January 2007.  Developed by the EFSA 
(European Food Safety Authority, 2006), the framework aims to provide a high degree of 
protection for consumers to ensure clear and accurate information on food products and to 
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facilitate free movement of goods within the European Union.  All health claims used or to be 
used on food products have to be submitted for scientific evaluation by EFSA.  Since 2006, 
health claims are classified into three categories; Type 1, which include claims based on 
generally accepted scientific evidence well understood by consumers (covered by Article 
13.1), and claims based on newly developed scientific evidence (covered by Article 13.5),; 
Type 2, which include claims on reduction of disease risk (covered by Article 14.1a) and 
Type 3, which include claims on children’s development and health (covered by Article 
14.1b)  (European Food Safety Authority, 2006).    
The United States (US) Food and Drug Administration has authorized health claims for labels 
of food products since 1993.  Health Claims characterise the relationship between a substance 
(food or food component) and a disease or health-related condition.  Most health claims are 
scientifically reviewed and must meet the significant scientific agreement standards (SSA) 
(e.g., strong evidence) before such a claim can be used on a food product.  Qualified Health 
Claims are based on scientific evidence that does not meet the SSA standard, and therefore 
qualifying language is included as part of the claim to reflect the level of scientific evidence.   
Qualified health claims also undergo premarket scientific review (United States Food and 
Drug Adminstration, 1994 (revised January 2013)). 
Food Standards Australia and New Zealand (FSANZ) published Standard 1.2.7, Nutrition, 
Health and Related claims, in January 2013.  The new standard has classified health claims 
into two categories such as general level health claim and high level health claims. High level 
health claims refer to a nutrient or substance in a food and its relationship to a serious disease 
or to a biomarker of a serious disease. High level health claim require pre-market approval 
from FSANZ (Food Standards Australia and New Zealand, as of 18 January 2016).    
Putting things in a wider perspective, the differences between the definitions, the scopes and 
the objectives of health claim regulations could affect the free movement of the food product 
within the Southeast Asia or the export of foods to other countries if such claims violate 
World Trade Organisation Agreement (Aggett et al., 2012).  
2.4.2 Principles of health claims and the languages used on health claims  
Details on the principles of health claim in Indonesia, Malaysia, Singapore, Thailand and 
Vietnam are listed in Table 2.3 (Ministry of Health Malaysia, 2010; Agri-Food & Veterinary 
Authority, 2010 (with amendments to 2016); Ministry of Public Health Thailand, 2011; 
National Agency of Drug and Food Control of the Republic of Indonesia, 2011a; Ministry of 
Health Vietnam, 2014).  The principles of health claims vary among the five SEA countries 
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compared with Codex Alimentarius.  There were also differences in the principles of health 
claims in SEA when compared with those recommended by EFSA as shown in Table 2.4.  It 
could be challenging to align every stakeholders involved if there is no clear, common 
principles for the health claims.  Indonesia and the Philippines have adopted most of the 
health claim principles from Codex Alimentarius which states that health claims need to be 
consistent with national health policy including nutrition policy and the claims should 
contribute to the consumption of a balanced diet (Ministry of Health Malaysia, 2010; Agri-
Food & Veterinary Authority, 2010 (with amendments to 2016); Ministry of Public Health 
Thailand, 2011; National Agency of Drug and Food Control of the Republic of Indonesia, 
2011a; Ministry of Health Vietnam, 2014).  
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Codex 
Principles*  
Consistent with 
national health 
policy 
Supported by a 
sound and sufficient 
body of scientific 
evidence to 
substantiate the 
claim 
Provide truthful and 
non-misleading 
information to aid 
consumers in 
choosing healthful 
diets and be 
supported by specific 
consumer education 
Not associated 
with treatment 
and prevention 
of diseases 
Do not lead to 
wrong 
consumption 
patterns 
Contribute to 
the 
consumption of 
a balanced diet 
References 
 
(Codex Alimentarius, 
1997 (last amended 
in 2013) 
Indonesia   ^ 
 
   (National Agency of 
Drug and Food 
Control of the 
Republic of 
Indonesia, 2011a) 
Malaysia  X  
 
X  
 
X X (Ministry of Health 
Malaysia, 2010) 
Singapore  X  
 
^ 
 
 
 
X ^ 
 
(Agri-Food & 
Veterinary Authority, 
2010 (with 
amendments to 
2016))` 
Thailand  X  
 
X  
 
X X (Ministry of Public 
Health Thailand, 
2011) 
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Codex 
Principles*  
Consistent with 
national health 
policy 
Supported by a 
sound and sufficient 
body of scientific 
evidence to 
substantiate the 
claim 
Provide truthful and 
non-misleading 
information to aid 
consumers in 
choosing healthful 
diets and be 
supported by specific 
consumer education 
Not associated 
with treatment 
and prevention 
of diseases 
Do not lead to 
wrong 
consumption 
patterns 
Contribute to 
the 
consumption of 
a balanced diet 
References 
 
(Codex Alimentarius, 
1997 (last amended 
in 2013) 
Vietnam X ^ 
 
X 
 
X X X (Ministry of Health 
Vietnam, 2014) 
Table 2.3 Comparison between principles of health claims in 6 Southeast Asian countries and Codex Alimentarius 
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EFSA 
Principles*  
A nutrient or other 
constituent has been 
shown to have a 
beneficial 
nutritional or 
physiological effect, 
as established by 
generally accepted 
scientific evidence; 
False, 
ambiguous or 
misleading; 
Average consumer 
can be expected to 
understand the 
beneficial effects as 
expressed in the 
claim 
Do not give rise 
to doubt or fear 
about the safety 
and/or the 
nutritional 
adequacy of 
other foods, 
either textually 
or through 
pictorial, graphic 
or symbolic 
representations 
Do not encourage or 
condone excess 
consumption of a 
food; or  
state, suggest or 
imply that a 
balanced and varied 
diet cannot provide 
appropriate 
quantities of 
nutrients in general 
References 
 
(European Food 
Safety Authority, 
2006) 
Indonesia  ^ 
 
X   (National Agency 
of Drug and Food 
Control of the 
Republic of 
Indonesia, 2011a) 
Malaysia   
 
X X 
 
X X (Ministry of 
Health Malaysia, 
2010) 
Singapore   
 
^ 
 
X 
 
X ^ 
 
(Agri-Food & 
Veterinary 
Authority, 2010 
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EFSA 
Principles*  
A nutrient or other 
constituent has been 
shown to have a 
beneficial 
nutritional or 
physiological effect, 
as established by 
generally accepted 
scientific evidence; 
False, 
ambiguous or 
misleading; 
Average consumer 
can be expected to 
understand the 
beneficial effects as 
expressed in the 
claim 
Do not give rise 
to doubt or fear 
about the safety 
and/or the 
nutritional 
adequacy of 
other foods, 
either textually 
or through 
pictorial, graphic 
or symbolic 
representations 
Do not encourage or 
condone excess 
consumption of a 
food; or  
state, suggest or 
imply that a 
balanced and varied 
diet cannot provide 
appropriate 
quantities of 
nutrients in general 
References 
 
(European Food 
Safety Authority, 
2006) 
(with amendments 
to 2016))` 
Thailand   
 
X X 
 
X X (Ministry of 
Public Health 
Thailand, 2011) 
Vietnam ^ 
 
X 
 
X X X (Ministry of 
Health Vietnam, 
2014) 
Table 2.4 Comparison between principles of health claims in 6 Southeast Asian countries and European Food Safety Authority 
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The health claims displayed on food products in these countries are required to be stated in 
the national languages in Indonesia, Malaysia, Thailand, Vietnam and the business language 
(English) in Singapore which is outlined in Table 2.5 (Ministry of Health Malaysia, 2010; 
Ministry of Public Health Thailand, 2011; National Agency of Drug and Food Control of the 
Republic of Indonesia, 2011a).   This could help the consumers in the local markets to utilise 
the health claims and make informed food choices. 
Country Language References 
Indonesia  Bahasa Indonesian (National Agency of Drug and 
Food Control of the Republic 
of Indonesia, 2011a) 
Malaysia  Bahasa Malaysia 
 
Imported products in Bahasa 
Malaysia/ English 
 
(Ministry of Health Malaysia, 
2010) 
Singapore  English (Agri-Food & Veterinary 
Authority, 2010 (with 
amendments to 2016)) 
Thailand Thai 
 
(Ministry of Public Health 
Thailand, 2011) 
Vietnam  Vietnamese (Ministry of Health Vietnam, 
2014) 
Table 2.5 Language of health claims used by the 5 Southeast Asian countries with 
independent guidelines or regulations 
2.4.3 Scientific substantiation and evaluation of health claims  
The inclusion of data from human intervention studies is the most common requirement for 
health claims applications in the SEA countries that permits health claims (Ministry of Health 
Malaysia, 2010; Ministry of Public Health Thailand, 2011; National Agency of Drug and 
Food Control of the Republic of Indonesia, 2011a; Agri-Food and Veterinary Authority of 
Singapore, n.d.-b).  Clear inconsistencies are reported in the types and the amount of evidence 
required for health claim substantiation in these countries such as requirements that the 
evaluation be conducted by independent institutions or that the claim be substantiated by at 
least five independent peer-reviewed reports.  The inconsistencies in the types of scientific 
evidence required make it difficult and costly for the food industry to apply for health claims.   
Table 2.6 summarizes the scientific data required for a health claim application in these SEA 
countries (Ministry of Health Malaysia, 2010; Ministry of Public Health Thailand, 2011; 
National Agency of Drug and Food Control of the Republic of Indonesia, 2011a; Agri-Food 
and Veterinary Authority of Singapore, n.d.-b).  
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Country  Types of data Supporting 
knowledge 
References 
Indonesia  Human 
studies such 
as 
randomized 
controlled 
trials (RCT) 
or 
observational 
studies if 
experimental 
research is 
not possible. 
 
Published in 
scientific 
journals.  
 
Research 
conducted by 
independent 
researchers 
or 
institutions 
are preferred.  
 
In vitro and 
animal studies 
can be 
submitted to 
support the 
petition. 
(National 
Agency of 
Drug and 
Food 
Control of 
the Republic 
of 
Indonesia, 
2011a) 
Malaysia Human 
intervention 
trials  
 
 
Published in 
refereed 
journals. 
 
 
Studies 
should 
include those 
conducted by 
other 
organizations 
or institution. 
 
Epidemiological 
and 
experimental 
studies and 
reviewed papers 
may be included 
as supportive 
evidence. 
 
(Ministry of 
Health 
Malaysia, 
2010) 
Singapore  Well- 
designed 
human 
intervention 
studies 
 
At least five 
independent 
peer-
reviewed 
reports of 
studies, 
preferably 
published in 
the last 10 
years. 
 
Nil Human 
observation 
studies, animal 
model studies, 
ex-vivo and in-
vitro studies can 
be submitted. 
 
(Agri-Food 
& 
Veterinary 
Authority, 
2010 (with 
amendments 
to 2016); 
Agri-Food 
and 
Veterinary 
Authority of 
Singapore, 
n.d.-b) 
 
Thailand  At least two 
appropriate-
designed 
human 
intervention 
studies with 
adequate 
samples for 
the 
consideration 
of probiotic 
efficiency 
Nil Nil Data 
unavailable 
(Ministry of 
Public 
Health 
Thailand, 
2011) 
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Country  Types of data Supporting 
knowledge 
References 
Vietnam Human 
studies on 
efficacy  
Conducted 
by 
authorised 
local 
institutions  
For overseas 
studies: 
conducted by 
institutions 
accepted by 
local 
authorities or 
published in 
scientific 
journals 
Data 
unavailable 
(Ministry of 
Health 
Vietnam, 
2014) 
Table 2.6 Types of scientific data required for health claim application in the 4 
Southeast Asian countries with independent guidelines or regulations 
The Indonesian regulatory agency has published a list of principles for the assessment of new 
health claims and require six months to evaluate a new claim (National Agency of Drug and 
Food Control of the Republic of Indonesia, 2011a).  The criteria for the evaluation of health 
claims and the timelines for approving new health claims in most of the five SEA countries 
are also not sufficiently clear.  The lack of clear guidance and criteria in the different 
countries makes it challenging for the food industry and the research community to develop 
and launch innovative products for the consumers in this region.  At the same time, the 
consumers in SEA find it difficult to understand how the health claims are approved in the 
various SEA countries.  
The scientific substantiation and evaluation of health claims has been a subject of debate 
between the food industry and the EFSA.  This is worth noting that the Codex Guidelines on 
Nutrition and Health Claims is derived from the two previous projects conducted in Europe 
namely, the ‘Process for the Assessment of Scientific Support for Claims on Foods 
(PASSCLAIM)’ carried out from 1 April 2001 – 1 April 2005 and the project ‘Functional 
Food Science in Europe (FUFOSE)’ which was the basis for PASSCLAIM (Cummings et al., 
2003).  The main aims of these two European Union projects were to develop a guidance tool 
to assess scientific support for claims on foods and food components and the common criteria 
for assessment of the scientific substantiation (Aggett et al., 2005).   To date, eight out of 10 
health claim applications on newly developed scientific evidence, child development and 
reduction of disease risk submitted to EFSA have been rejected.  Misreporting of the studies 
and the quality of the human studies were two of the main issues that arose during the review 
of the scientific evidence (Martin, 2013).   The food industry in Europe has raised concerns 
about the lack of clarity on the criteria for substantiating health claims and the wording of the 
claims (Gallagher, 2011; Richardson, 2012).  Binns (2009) criticised the regulation for stifling 
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innovation.  EFSA adopted the pharmaceutically accepted evidence-based medicine approach 
to evaluate health claims on foods.   
The frameworks from the United States and Japan are considered to be more industry friendly 
than that in Europe, since qualifying statements under the Qualified Health Claims are 
allowed (Lalor and Wall, 2011).  Qualified Health Claims were introduced in US in 2003 and 
were defined as claims that have passed a premarket scientific review but which emerging 
evidence does not meet the Significant Scientific Agreement standards.  For such claims, a 
qualifying statement must be included when evidence is limited (Lalor and Wall, 2011).   In 
2005, the Japanese Food for Special Health Uses (FOSHU) system introduced the qualified 
FOSHU.  Food in the qualified FOSHU scheme can be sold in the market with a qualifying 
statement stating ‘evidence has not necessarily been established’ and/ or with words like 
‘possibly’ as part of the approved health claim (Shimizu, 2003; Ohama et al., 2006; Yamada 
et al., 2008).  This use of qualified statements has helped the food industry expedite the 
introduction of specific food products to consumers in both the US and Japan. 
Results from the randomised placebo- controlled double-blind studies, rather than results from 
epidemiological and observational studies, are considered as the strongest form of evidence in 
EU, US and ANZ.  Data from epidemiological and observational studies, however, are usually 
used for nutrition research for some obvious reasons (Binns, 2009).   Well- designed 
controlled nutrition studies may be used to show the cause-effect relationship of the food but 
the placebo controlled studies are often not possible because the control product should also 
be nutritious.  This rigorous, more pharmaceutical approach poses difficulty, impracticality, 
and very high cost for the food industry to achieve the level of evidence required, that is if 
possible at all since nutrition research, in which complex foods or nutrient combinations are 
investigated, is very different from pharmaceutical research (Tapsell, 2008; Richardson, 
2012).  Food and medicine are also essentially different because medicine is given to treat 
medical conditions while food is consumed to support general well-being.  This could 
potentially influence the availability of food products with better nutritional quality for 
consumers since the difficulties in meeting the requirements for health claims might 
discourage innovation in the food industry.  The lack of approved health claims will not make 
it easier for the consumers to make informed choices as not all foods are the same.  
2.5 Opportunities to harmonise health claims regulations in SEA  
Despite the differences, there are some convergences among these five SEA countries such as 
Indonesia, Malaysia, Singapore, Thailand and Vietnam since there are existing regulatory 
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frameworks in these countries (see Table 2.7 (Ministry of Health Malaysia, 2010; Agri-Food 
& Veterinary Authority, 2010 (with amendments to 2016); Ministry of Public Health 
Thailand, 2011; National Agency of Drug and Food Control of the Republic of Indonesia, 
2011a; Agri-Food and Veterinary Authority of Singapore, n.d.-b; Agri-Food and Veterinary 
Authority of Singapore, n.d.-a).  The Philippines is excluded in this context, since no further 
information on health claim in Philippines can be found on the available English literature.   
Indonesia, Malaysia, Singapore and Thailand state that health claims should not be associated 
with treatment and prevention of disease (Ministry of Health Malaysia, 2010; Agri-Food & 
Veterinary Authority, 2010 (with amendments to 2016); Ministry of Public Health Thailand, 
2011; National Agency of Drug and Food Control of the Republic of Indonesia, 2011a).  This 
clearly indicates that the role of food is to promote and maintain health.  In these countries, all 
claims needs to be scientifically substantiated with sound and sufficient evidence (preferable 
human intervention studies) and the regulatory status and/ or approval by national or 
international regulatory body is required as part of the health claim application (Ministry of 
Health Malaysia, 2010; Agri-Food & Veterinary Authority, 2010 (with amendments to 2016); 
Ministry of Public Health Thailand, 2011; Agri-Food and Veterinary Authority of Singapore, 
n.d.-b).  
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Country List of approved 
Nutrient Function 
Claims 
 
List of approved 
Other Function 
Claims 
 
List of 
approved 
Reduction of 
Disease Risk 
Claims 
 
An example of the 
approved Nutrient 
Function Claims in four 
countries: 
 
- Vitamin C 
Require 
regulatory 
status of 
Health 
Claim by 
other 
countries 
Expert 
committee 
to evaluate 
Health 
Claims 
 
References 
Indonesia    
12 nutrients 
 
 
2 food 
components  
  
 
7 nutrients/ food 
components 
Vitamin C plays a role in 
the formation and 
maintenance of collagen 
tissues. 
  (National Agency of Drug 
and Food Control of the 
Republic of Indonesia, 
2011a) 
Malaysia  
16 nutrients 
 
 
14 food 
components 
X Vitamin C enhances 
absorption of iron from 
non-meat source. 
  (Ministry of Health 
Malaysia, 2010) 
Singapore   
22 nutrients 
 
 
 
4 food 
components 
 
1 food 
component  
Vitamin C enhances 
absorption of iron from 
non- meat products. 
 
  (Agri-Food & Veterinary 
Authority, 2010 (with 
amendments to 2016); 
Agri-Food and Veterinary 
Authority of Singapore, 
n.d.-b; Agri-Food and 
Veterinary Authority of 
Singapore, n.d.-a) 
 
Thailand   
29 nutrients  
X 
 
X To regenerate collagen and 
cartilage tissues. 
 
Unavailable  Unavailable (Ministry of Public Health 
Thailand, 2011) 
Vietnam Unavailable Unavailable Unavailable Unavailable   (Ministry of Health 
Vietnam, 2014) 
   -  refers to ‘have’ 
 X -  refers to ‘do not have’ 
(Note: Some nutrients have a few approved claim statements which can be used.) 
 
Table 2.7: Areas of convergence among health claims in Southeast Asian countries
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2.5.1 List of approved health claims and expert committees in Southeast Asia 
All these countries, with the exception of the Philippines and Vietnam have a positive list of 
permitted nutrient function claims, other function claims and reduction of disease risk claims 
(Tee, 2014).  Expert committees have also been established in Indonesia, Malaysia and 
Singapore (Ministry of Health Malaysia, 2010; National Agency of Drug and Food Control of 
the Republic of Indonesia, 2011a; Agri-Food and Veterinary Authority of Singapore, n.d.-a).    
The committees have been tasked with evaluating the health claim applications on the basis of 
the scientific data submitted and providing recommendations to the local food authorities 
(Ministry of Health Malaysia, 2010; National Agency of Drug and Food Control of the 
Republic of Indonesia, 2011a; Agri-Food and Veterinary Authority of Singapore, n.d.-a).  
2.5.2 Other considerations on the regulatory frameworks in SEA 
The regulatory agencies and the food industry play equally important roles with an aim to 
benefit food consumers.  The regulatory agencies aim to protect consumers from misleading 
information, while the food industry aims to communicate the proposed benefits to consumers 
to help them make informed food choices.   
During the literature search, however, no published review paper or discussion on the 
regulatory framework for health claims in SEA was identified.  The emerging issues are the 
difficulties and high cost for food industry to register new health claims throughout SEA and 
to meet the different regulatory requirements and approaches across these countries, as there 
is not a single approach for the approval of health claims (Itkor., 2014).  This could create 
major barriers for new product development and food trade within this region and dampen the 
interest of investors to invest in new markets.  There is a need for collaboration among the 
stakeholders to address the lack of transparency surrounding the evaluation of health claims.   
Inconsistent communication about the health benefits of specific food could cause confusion 
about the beneficial effects of the food components.  Consumers in SEA are not able to find 
the beneficial effects of the food constituent on the relevant food products sold in their 
countries, even though sources of information such as health authorities, scientific journals, 
health magazines, health-related websites etc. have been educating on the effects of the food 
constituent.  These Asian consumers might not know that health claim on food products in 
SEA requires regulatory approval, unlike the health information available on mass media.  
The regulations on health claims have an important role in facilitating the free movement of 
goods including food among ASEAN nations.  Several fundamental issues that need to be 
addressed by all the stakeholders affected by health claims, including members of the food 
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industry, the regulators and the consumers. These issues include: 1) What are the principles, 
the scope and the objectives of health claims?; 2)  How should the ten SEA countries work 
together when the regulatory status and development differs among the ten member states in 
SEA? ; 3) What should be the best approach for SEA since the SEA region has diverse 
cultures and languages?; and 4) How can the balance between consumer-friendly health 
claims and industry-friendly processes for developing health claims be achieved to benefit 
consumers in ASEAN countries? 
2.6 Conclusion 
In the light of the goal to be an integrated ASEAN Economic Community by end of 2015, it is 
timely to understand the regulatory framework for health claims in SEA, since there is 
currently no unified approach.  Clear guidance could provide directions for the food industry 
and the regulatory community to support food innovation, and to make food products 
available with better nutritional quality for the Southeast Asian market.  In addition, a clear, 
consistent regulatory framework has the potential to increase trade in this fast-growing region 
and it will provide directions for the food industry and the regulatory community to make 
food products with better nutritional quality to the Southeast Asian consumers.   
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Chapter 3 Health claim approval in Southeast Asia:  Current practices 
and perspectives from food regulators, key opinion leaders, policy 
makers and representatives from the scientific organisations and food 
associations 
3.1 Executive Summary  
All new health claims need to be approved by the local food authority in each country before 
such claims can be stated on the product labels and sold in Indonesia, Malaysia, Singapore, 
the Philippines and Thailand.  We aimed to investigate the current practices and perspectives 
of the regulatory frameworks for new health claims applications in Southeast Asia (SEA).  
The objectives seek to understand the following three points:  1) the processes of health claim 
substantiation and evaluation; 2) factors affecting the approval of health claims; and 3) the 
challenges faced by the key stakeholders engaged in health claims regulation.  The objectives 
were achieved by gathering detailed information from the regulators, key opinion leaders 
from the scientific community, public health policymakers and representatives from scientific 
organisations and food associations. Semi-structured one-to-one interviews were conducted 
with 15 key stakeholders who have direct influence on the approval and use of health claims 
on food in several SEA countries.  Practices and perspectives in the substantiation and 
evaluation of health claims were comparable among stakeholders who participated in this 
study.  More specifically, the health claim application dossiers need to explain the rationale to 
consume the food constituent clearly and demonstrate the cause-effect relationship between 
the constituent and a specific health outcome.  In general, the guidelines on nutrition and 
health claims established by Codex Alimentarius served as a basis to evaluate health claims 
by all the countries surveyed in this study.  The quality of the supporting evidence from 
(human) studies in particular (i.e. evidence from well-designed human intervention studies), 
wording of the proposed health claim, condition of use (realistic amount of the constituent to 
be consumed in the diet and how it would fit into food matrix), were key considerations for 
any application.  More regular and open communications and collaboration among different 
stakeholders can make the process of development of relevant food product with 
understandable health claims more efficient.   
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3.2 Introduction 
The establishment of the Association of Southeast Asian Nations (ASEAN) Economic 
Community (AEC) in 2015 envisions the free movement of goods (Association of Southeast 
Asian Nations (ASEAN) Secretariat, 2015a).  The ASEAN consists of ten countries in 
Southeast Asia; Brunei Darussalam, Cambodia, Indonesia, Lao People’s Democratic 
Republic, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam with a total 
population of over 622 million people (Association of Southeast Asian Nations (ASEAN) 
Secretariat, 2015b).  To date, only six  out of these 10 Southeast Asia countries (SEA) namely 
Indonesia, Malaysia, Singapore, Thailand, the Philippines and Vietnam have health claim 
regulations and guidelines (Republic of the Philippines Food and Drug Administration; 
Ministry of Health Malaysia, 2010; Agri-Food & Veterinary Authority, 2010 (with 
amendments to 2016); Ministry of Public Health Thailand, 2011; National Agency of Drug 
and Food Control of the Republic of Indonesia, 2011a; Ministry of Health Vietnam, 2014).  
All new health claims need to be approved by the food regulators in each individual SEA 
country before they can be stated on a product label sold in these SEA countries.  A recent 
review showed there were inconsistencies in the regulations and the types of evidence 
required for health claim applications as reported in Chapter 2 (Tan et al., 2015).   This could 
potentially hinder the free trade of goods under the ASEAN Economic Community.   
In Indonesia, the regulation of health claims published by the National Agency of Drug and 
Food Control of the Republic of Indonesia (NA-DFC) in 2011.  The regulation has the most 
comprehensive information on health claims application in a single document in SEA 
(National Agency of Drug and Food Control of the Republic of Indonesia, 2011a).  The 
regulations include the application process, the information required in health claim 
applications and a list of principles on assessing new claims, similar with Codex guidelines 
for use of nutrition and health claims.  Indonesia is also the only SEA country to establish the 
principles on assessing new health claims such as clear characterization of food constituents, 
design of human intervention studies, appropriate statistical analysis, relevant to country 
populations, and totality of relevant available studies (National Agency of Drug and Food 
Control of the Republic of Indonesia, 2011a).  All health claim applications in Indonesia will 
be screened by an official in the Indonesian food authority to check for comprehensiveness of 
data before the application is accepted for evaluation.  Each application takes a maximum of 6 
months (excluding time involved for receipt of additional data requested) to be evaluated by 
the expert committee and approved by the head of NA-DFC (National Agency of Drug and 
Food Control of the Republic of Indonesia, 2011a).  The expert committee consist of  
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professionals with different backgrounds such as nutritionists, chemists, paediatricians, food 
technologists, pharmacologists etc. (Maemunah, 2015).   Figure 3.1 indicates the health claims 
procedure in Indonesia with key actors indicated. 
Indonesia
Actor Submission Evaluation Outcome
Applicant
NA-DFC
Mitra Bestari Team 
(Peer Reviewer 
experts committee) 
Head of NA- DFC 
Complete 
info
Check 
completeness
Evaluate
1 day
Recommend
ation
Prepare & 
submit petition
Questions
Yes 
Yes 
No 
Approve
Apply 
claim
Max 6 
months
No 
 
Figure 3.1: Health Claim application procedure in Indonesia 
Source: adapted from National Agency of Drug and Food Control of the Republic of 
Indonesia (2011a) 
To date, Malaysia has the most number of approved ‘other function’ claims among the SEA 
countries with health claims regulations or guidelines.  The Malaysian guide to nutrition 
labelling and claims was published in December 2010 (Ministry of Health Malaysia, 2010).  
The health claim application in Malaysia has to include published data from at least 5 clinical 
trials to substantiate the relationship of the nutrient/ food constituent with health.  In addition, 
the chemical structure, analytical method and daily intake of the constituent and any evidence 
of the approval of the claim from other countries are required as part of the application 
(Ministry of Health Malaysia, 2010; Eksan, 2015).  The duration of the application process 
for each application is not stated in the Malaysian guidelines.  The gazettement for new 
nutrition claims involves several key actors such as an expert committee, an advisory 
committee, public comments, a legal department and a health minister (Sulong and Tee, 2012; 
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Eksan, 2015).  The expert committee consists of representatives from academic, government 
officers from the Ministry of Health (MOH), research institutes, the Malaysian palm oil board 
and health professionals from multi-disciplinary backgrounds such as Paediatrics, dietetics, 
nutrition and pharmacy (Ministry of Health Malaysia, 2010).  Figure 3.2 illustrates the health 
claim application process in Malaysia.   
Malaysia
Actor Submission Evaluation Outcome
Applicant
MOH Food Safety
and Quality 
Division
(Secretariat)
Expert Working
Committee (EWC)
Advisory Committee
of Food Regulations 
(ACFR)
Public
MOH legal advisor 
& Health Minister
Satisfact
ory
Preliminary 
review
Evaluate
Prepare & 
submit petition
question
Yes, provide 20 copies 
No 
Yes
AdequateReject
questionEndorsedReject
Public 
Comments
Stakeholders 
(web, email, mail)
Comments/ 
concerns
Prepare draft for 
gazettement
Submit to legal 
advisor & health 
minister to sign 
Clarification
Yes 
Send draft 
regulation for 
printing and 
gazettement
 
Figure 3.2: Health Claim application process in Malaysia 
Source: Author’s construction drawing based on Eksan (2015); Sulong and Tee (2012)  
In Singapore, the Agri-Food Veterinary Authority (AVA) established the guide to food 
labelling and advertisements (including health claims) in 2010 to provide food businesses 
with a better understanding of the food labelling requirements and approved claims for use in 
food labels and advertisements (Agri-Food & Veterinary Authority, 2010 (with amendments 
to 2016)).  This guide has undergone several revisions over the years and it includes the 
positive list of health claims permitted in Singapore and the requirements on how to apply for 
new health claims.  The requirements include the characteristics of the nutrient/ food 
constituent, the proposed wording of the claims, and that the claim has to be supported by >5 
independent peer-reviewed human intervention studies published in the last 10 years.  The 
52 
 
applicant is required to use the AVA health claim application form for new applications 
(Agri-Food and Veterinary Authority of Singapore, n.d.-b).  As described in Figure 3.3, each 
application will be screened for relevant evidence by the AVA secretariat based on the Codex 
Guidelines on Scientific Substantiation of health claims before forwarding to the Advisory 
Committee for evaluation (Neo, 2015).  The Advisory Committee comprises of the scientific 
experts with relevant professional training and experience. The members are mainly from the 
government bodies, tertiary institutions, consumer associations and industry associations 
(Agri-Food and Veterinary Authority of Singapore, n.d.-a).  Other than making 
recommendation to AVA on health claim applications, one of the main tasks of this 
committee is to establish the framework and the principles for evaluation of health claims in 
Singapore (Agri-Food and Veterinary Authority of Singapore, n.d.-a).  The applicant will be 
informed of the result before all approved health claims are published on the AVA website or 
food regulations gazette.  The estimated time for the whole cycle is 9 months depending on 
the complexity of the claims and turnaround time by the advisory committee (Neo, 2015).  To 
date, the AVA has received 28 new health claim applications over 6 years and only 6 claims 
were approved (Neo, 2015). 
Singapore
Actor Submission Evaluation Outcome
Applicant
AVA (serves as 
secretariat) 
Advisory Committee 
on evaluation of 
health claim 
AVA Secretariat
AVA Management
Relevant 
evidence 
Screen info, guided 
by Codex 
Evaluate
Prepare & 
submit petition
Yes 
No 
Approve
Inform applicant on result 
(suggest amendment on the 
wording of claims)
Agree 
Consolidate responses 
from members and 
contribute to evaluation
Recommend
List approved claim 
on AVA  website/ 
Gazette 
Est. 9 
months
 
Figure 3.3: Health Claim application in Singapore 
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Source: Author’s construction drawing based on Neo (2015) 
The Ministry of Public Health in Thailand issued a notification specifically on probiotics as 
food constituent in 2011 (Ministry of Public Health Thailand, 2011).  The notification states 
the definition of health claims and the requirements for submitting health claim applications 
on probiotics.  Each application needs to be supported by at least two well-designed, 
appropriate human intervention studies to demonstrate the efficacy of the probiotics.  The 
details of the studies such as study group, control group, adequate duration of exposure, the 
amount of food constituent to be consumed to have the intended effect, the influence of the 
food matrix, and the statistical power to test the hypothesis should be included.  The health 
claim application in Thailand has only one process which described for probiotics, and no 
further information was provided on the evaluation of the applications.  Separately, the Thai 
Ministry of Public Health has also published a list of approved nutrient function claims for 29 
nutrients.    
The Philippines food and drug administration (FDA) announced in a circular in 2007 the full 
adoption of the Codex guidelines on nutrition and health claims in evaluating the use of the 
health claims in labelling and advertisement of food products (Republic of the Philippines 
Food and Drug Administration).  There is no further information on the regulatory framework 
on health claims and how the claims are administrated or evaluated in the Philippines.   
Vietnam is the latest country among the SEA countries to release regulations on functional 
foods in late 2014 which took effect from 15 January 2015 (Ministry of Health Vietnam, 
2014).  The scope includes labelling, manufacturing and commercial activities on ordinary 
food with additional ingredients beneficial to health which are termed as ‘supplemented food’, 
health supplements in different forms of presentation, medical foods and foods for special 
dietary uses.  The regulation defines scientific evidence as the information and documents 
obtained from ‘research accepted by state institutions or published by national or international 
scientific journals; or documentation of traditional medicine, medicinal herb and traditional 
remedy published in scientific printed materials’ (Ministry of Health Vietnam, 2014).  
Evidence from human studies is required in new health claim applications to support the 
safety and beneficial effects of the food/ constituent on health.  In addition, the target 
audience of the products and recommended intake has to be exactly as the amount and 
subjects stated in the scientific supporting documents.  Studies that are conducted outside of 
Vietnam will be accepted, provided the institutions conducting the studies are recognised by 
the Vietnamese local authorities or the studies are published in scientific journals.  A 
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Scientific Council consisting of experts from relevant fields has been established to assess the 
scientific evidence in the application.  The beneficial food constituent needs to be analysed for 
the content in the product by the testing institutions in Vietnam.  For food constituent which 
the testing method is unavailable in Vietnam, the content of the ingredient needs to be 
justified in the application dossier (Ministry of Health Vietnam, 2014).  There is no further 
information on the regulatory process as this Vietnamese system is relatively new.   
To date, there is limited or no information on how the health claim applications are evaluated 
and the key factors affecting the approval of the health claims in the SEA countries.  The lack 
of this information results in uncertainty for the applicant when applying for health claims, 
and the investment involved in generating evidence to support the health claim application 
might not justify the return of investment for the applicant.  This could negatively affect the 
motivation for the food industry to support innovation, if most health claims applications have 
been rejected.  In addition, the Asian consumers could have restricted access to food products 
of better nutritional quality.   
This chapter aims to investigate the current practices and perspectives of the regulatory 
frameworks of new health claims applications in Southeast Asia (SEA).   The objectives were 
to understand the following three points: 1) the processes of health claim substantiation and 
evaluation; 2) factors affecting the approval of health claims; and 3) the challenges faced by 
the key stakeholders.  The objectives were achieved by gathering detailed information from 
the different clusters of stakeholders in SEA such as food regulators, key opinion leaders, 
policy makers, and representatives from scientific organisations and food associations.   
3.3 Materials and methods 
3.3.1 Participants 
The aim was to gather information from individuals regarded as key stakeholders involved in 
health claims are residing in SEA.  The chosen stakeholders were grouped into different 
clusters based on the flow of health claim application to understand the current situation on 
how health claim applications are applied and processed in the different SEA countries.  The 
participants included representatives from the food associations filing the applications, 
regulators involved in the administration process, policy makers, key opinion leaders from the 
scientific community, and representatives from scientific organisations involved in the 
evaluation of health claims in the country.   All participants had direct influence on the 
availability of health claims on food in the various SEA countries when interviewed and were 
science-trained.  Most participants held high-ranking positions in their institutions, and/or 
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were independent, well-respected experts.  The different clusters of participants identified, 
were selected to capture a broader comprehension into the opinion and insight of this research 
topic.  
3.3.2 Recruitment of participants 
Purposive sampling was applied in the selection of the participants for this study.  To gain a 
deeper understanding of the research topic being studied, it was more important to target the 
selected participants with a range of backgrounds and job responsibilities, and avoid repetition 
of information by reaching out to people with similar backgrounds and responsibilities.  They 
were considered as the spokesperson for the respective cluster as they could have the 
authority to influence the health claim regulations/ guidelines in their respective countries.  
The targeted participants across the 10 ASEAN countries were identified after performing an 
exhaustive web search, and via networking through the researcher’s contacts and with key 
informants to ensure the potential participants had direct influence on health claims policies in 
their countries in terms of drafting the health claims regulations/ guidelines in the country, 
evaluating health claim applications or having a voice in the relevant committees.   
Participants were invited to participate in this study via email and/or were approached face-to-
face.  More background and information about the study and the interview questions were 
sent to the potential participants, prior to any interviews.  Reminder emails were sent to 
increase participation in the study.  Food regulators from all of the ten Southeast Asia 
countries were invited to participate in this study initally.  The research invitations were 
extended to the representatives from the other backgrounds and clusters, in order to broaden 
the understanding and to provide different insights on the research topic (Massa and Testa, 
2008; Miguel et al., 2014).  
3.3.3 Interview guide development  
An interview guide with a set of specific questions was developed, based on the research 
objectives and the identified gaps in the existing local regulations and guidelines on health 
claims issued by the local food regulatory agencies in SEA as identified in chapter 2.  The 
interviews involved four key sections: 1) to identify and confirm their roles in the country; 2) 
to gather information on the details of health claims regulations/ guidelines processes of 
applying for health claims, and the criteria in selecting the expert committee, 3) to gather 
information on how health claim applications are reviewed and to identify the factors 
affecting the approval of health claims application and 4) to gather information on the 
challenges faced and explore potential suggestions to mitigate the challenges.  The questions 
were tailored for each interview depending on the available time and the job responsibilities 
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of the interviewee.  All questions were pre-tested among experts such as former and current 
food regulators who are familiar with this research topic to check if the questions were clearly 
worded and to minimise the risk of cross-cultural misunderstanding.  The interview guide is 
available in Appendix 2.    
3.3.4 Data collection  
Semi-structured interviews were conducted among participants, who accepted the invitation to 
participate in the study.   Most interviews were conducted in English by a single designated 
researcher in a face-to-face manner at the participants’ workplaces in the various SEA 
countries.  Each interview session was estimated to last for about one hour.  Four participants 
completed the questions electronically via email, due to their busy schedule.   
3.3.5 Ethical approval  
Ethical approval for this study was obtained from Newcastle University Faculty of Science, 
Agriculture and Engineering Research Ethics Committee.  Prior to data collection, the 
participants were briefed on the purpose of the study, their rights as participants and the 
assurance of confidentiality.  Each participant gave their written informed consent to take part 
in this study.  All interviews were audiotaped with the permission from the participants and 
then destroyed after transcription.   
3.3.6 Data analysis  
All the interviews were transcribed verbatim using qualitative software programme NVivo 
version 10 (QSR International Pty Ltd, Australia).  The completed questionnaires from the 
participants sent via email, were also input into NVivo for analysis. Each participant was 
allocated a number such as P1, P2 to ensure participant anonymity.  Thematic analysis was 
applied to analyse the data.  The transcripts were read thoroughly several times so that the 
researchers were familiar with the data before coding (Braun and Clarke, 2006).  The data 
were analysed in an inductive process which began with open coding, based on the specific 
research questions and extended to the emerging issues presented in the data.  The patterns or 
‘themes’ were generated and identified from the data.  The themes in a transcript were 
constantly compared and contrasted with other transcripts to look for similarities, differences 
and relationship between the themes before further coding (Glaser, 1965).  For example, the 
perspectives on the objectives of health claims and the challenges faced by the different 
clusters of stakeholders were compared between the different transcripts to provide an 
accurate reflection of the content in the dataset.   
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3.4 Results  
The findings of this study were gathered from a total of 15 participants who are known within 
the regulatory community and food associations to be the key stakeholders involved with 
health claims in SEA.  The participants were from the different clusters; namely the regulators 
(5 participants), key opinion leaders from scientific community (3 participants), public health 
policymakers (2 participants), representatives from the scientific organisations (2 participants) 
and food industry associations (3 participants).  Responses were obtained from six out of ten 
SEA countries, with the exception of Brunei Darussalam, Cambodia, Lao People’s 
Democratic Republic and Myanmar.  Despite repeated attempts, representatives from the four 
countries were unavailable for interview.  The four countries omitted, did not have health 
claims regulations/ guidelines during the study.  The demographics of the participants are 
presented in Table 3.1. 
Country Position/ Role 
Indonesia Food Regulator 
Indonesia Key Opinion Leader (Academic)  
Malaysia Key Opinion Leader (Regulatory/ Scientific)   
The Philippines Food Regulator 
Singapore  Food Regulator 
Singapore Director, Scientific Organisation 
Singapore Representative of Local Food Industry Association 
Singapore  Representative of Regional Industry Association 
Thailand Food Regulator 
Thailand Public Health Policymaker 
Thailand Key Opinion Leader (Regulatory) 
Thailand Representative of Local Food Association 
Vietnam Food Regulator 
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Country Position/ Role 
Vietnam Public Health Policymaker  
Vietnam Chairman, Scientific Organisation (Medical) 
Table 3.1:  Background information on interviewees 
The results are divided into sub-topics to create clarity on the current practices on health 
claims applications in SEA, e.g. claim substantiation and evaluation, and factors affecting 
health claim approval or challenges faced by the different stakeholders in that process.  The 
term ‘food constituent’ will be used throughout this chapter for consistency.  The term is used 
to refer to a whole food or a constituent of that food such as energy, specific nutrients, related 
substances, ingredients, and any other feature of a food, a whole food, or a category of foods 
that has the potential to have beneficial effects to health and on which a health claim could be 
based.  The perspectives gathered from the different stakeholders were incorporated to 
provide insights on potential issues and opportunities.  Based on the interview feedback, 
practices and perspectives in the substantiation and evaluation of health claims were 
comparable between the SEA countries evaluated.   
Key actors relevant for health claims evaluation were the regulatory setting including the 
organisation of food regulatory agencies such as the NA-DFC, AVA, in the SEA countries 
and the involvement of expert committees.    In each country, the role of expert committees is 
to provide scientific expertise to evaluate the scientific evidence for new health claims 
applications, and to provide recommendations to the food regulatory agency on application 
approval or rejection.  Table 3.2 summarises the details of expert committees in the SEA 
countries that participated in this research.  The expert committees mostly consisted of local 
scientific and technical experts with multi-disciplinary scientific education and experience 
such as nutrition, food science/ technology and medicine, and the knowledge related to the 
submitted claims.  The experts were mainly from the government agencies, local tertiary 
institutions, healthcare professional organisations and research institutions.  Most SEA 
countries had committees that consisted of a core team of experts.  Depending on the nature of 
the claims, other experts with relevant knowledge and experience could be consulted on a 
case-by-case basis.  
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Country Indonesia  Malaysia  Singapore  Thailand  The Philippines Vietnam 
Name of 
expert 
committee 
Mitra Bestari Team 
(Peer Reviewer 
experts)  
Expert Committee 
on Nutrition, Health 
Claims and 
Advertisement 
Advisory Committee 
on evaluation of 
health claim  
Expert Committee Expert Committee Scientific 
committee  
Member-
ship  
Representatives from 
internal government 
departments and 
health professionals 
such as nutritionist, 
chemist, 
paediatrician, food 
technologist, 
pharmacist 
(Maemunah, 2015)   
Experts from 
academia, 
representatives from 
Ministry of Health 
(MOH), research 
institutes, and health 
professionals such as 
medical doctors, 
dietician, nutritionist 
and food scientists/ 
technologists. 
(Ministry of Health 
Malaysia, 2010) 
Experts from 
academia, 
representatives from 
multi-government 
agencies, consumers 
association, food 
industry (Agri-Food 
and Veterinary 
Authority of 
Singapore, n.d.-a) 
Experts from 
academia with 
direct experience/ 
research related to 
claims, government 
agencies or 
industrial 
associations 
(interview) 
Experts who are 
independent from 
industry, and 
internal experts 
from FDA 
(interview) 
Experts from 
academic, health 
professions, 
government 
agencies 
(interview) 
Co-opt 
members 
Yes, depending on 
the submitted claim 
Yes, depending on 
the submitted claim 
Yes, may consider Unknown Yes, depending on 
the submitted claim 
Yes, depending 
on the submitted 
claim 
Table 3.2: Details of the expert committees in the selected SEA countries 
60 
 
3.4.1 Congruent opinion on the objectives and principles of health claims 
Most participants had similar opinion on the objectives and principles of health claims.  
Health claims were regarded as assisting the consumers in making informed food choices to 
achieve a well-balanced diet.  Claims also serve as a form of communication between 
manufacturers and consumers on the relationship of the food constituent and health.   
‘Health claims products are aimed to communicate to consumers about the relevance of any 
benefits or properties of food or constituent of that food to consumers' health’ - P4 
‘Consumers should have the right to know and the company should have the right to 
communicate to the consumers. That is the fundamental on claims.’- P15 
Some of the participants commented that health claims motivated the industry to continue 
innovation to develop healthful products; the industry stakeholders similarly commented (in 
part 1 of the interview) that health claims provided competitiveness in their businesses by 
helping the consumers to differentiate between products of the same food group.   
‘Health claims help consumers to make informed food choice and encourage the industry to 
continue innovate new healthful products for consumers.’- P3 
‘One is for consumer education when consumer can understand why this nutrient is added 
and what is the function; and the other for the industry benefit is for them to differentiate from 
one another.’ – P13   
One participant held the view that for industry, it was less about innovation and more about 
using health claims as part of their marketing strategy.   
‘Marketing strategies is one main objective on the point of food industry on health claims.’- 
P2  
All participants agreed that health claims had to be evidence-based and scientifically- 
substantiated.  In addition, the regulators specifically stated that claims have to be perceived 
holistically in the context of a balanced diet for the general population.  Above all, health 
claims should not treat, cure and prevent medical conditions linked to diseases.  Some were 
wary that the consumers would perceive the food with these claims as a ‘quick fix’ or 
‘miracle food’.  They reasoned that the role of food is for normal body maintenance.   
‘Approval of health claims should be viewed holistically to ensure that consumers continue to 
consume a balanced and varied diet.’ – P3 
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‘Health claim for food should be for maintaining well-being.  We eat food when we are 
healthy.  For example, iron is not for anaemia.  It is required for the production of the red 
blood cells.’- P8  
‘No health claim is absolute.  It should not be seen as a quick fix to your health. [..] You need 
to do that too, together with that.’ - P8 
Table 3.3 summarises the scope of the health claims regulations and guidelines in SEA 
countries.  Most regulators were unclear on the scope of the health claims regulations/ 
guidelines.   Most responded by sharing the definitions of health claims when asked about the 
scope of health claims regulations and guidelines.  The scopes of health claims are listed in 
the health claims regulations/ guidelines with the exception of Malaysia, but the objectives of 
the health claims were unclear in the health claims regulations/ guidelines in the six countries.  
For example, the scope of the Indonesian and Thailand regulation includes labels and 
advertisement of processed food with nutrition and health claims (National Agency of Drug 
and Food Control of the Republic of Indonesia, 2011a), and Vietnamese health claims 
regulation regulate labelling, marketing activities and instruction for use of functional foods 
(Ministry of Health Vietnam, 2014).  
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Country Indonesia  Malaysia  Singapore  Thailand  The Philippines Vietnam 
Scope  Processed food with 
claim declaration.   
Apply to label and 
advertisement of 
processed food and 
food with health claim. 
(National Agency of 
Drug and Food 
Control of the 
Republic of Indonesia, 
2011a) 
 
Not stated/ unclear 
(Ministry of Health 
Malaysia, 2010) 
Food label and 
advertisements 
(Agri-Food & 
Veterinary 
Authority, 2010 
(with amendments 
to 2016)) 
Representation of 
pictures, photograph, 
invented designs, mark, 
trade mark or any texts 
on labels that states a 
relationship existed 
between a food or 
constituent and health 
(Ministry of Public 
Health Thailand, 2011) 
Labelling and 
advertisement of 
consumer 
products.(Republic of 
the Philippines Food and 
Drug Administration, 
2007) 
Regulate labelling, 
marketing activities, and 
instruction for use of 
functional foods. 
(Ministry of Health 
Vietnam, 2014) 
Table 3.3:  Scope of health claims regulations and guidelines in the selected SEA countries 
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3.4.2 Health claims substantiation and evaluation 
All the regulators declared that they used the Codex standard on health claims substantiation 
and evaluation, and their existing regulation/ guidelines of the requirements on the claims 
substantiation.  All the regulators, as well as key opinion leaders and scientific organisations 
consistently emphasized that the food or food constituent had to be safe for human 
consumption and within the food jurisdiction.   They also stated that food constituent must be 
characterised and quantifiable.  The rationale as to why there is a need to consume the food 
constituent must be clear, and the effectiveness and efficacy of the food constituent and to a 
specific health outcome ‘also known as the cause- effect relationship’, had to be substantiated 
by scientific evidence in the submitted application.   
‘Safety, evidence- scientific substantiation.  Evidence to show the cause that has the 
properties or the functions. Human data to demonstrate the cause- effect relationship. They 
[food regulators] will always ask you to state the amount to show the effect e.g. 1gram, 3 
gram or 5 gram.  Hence you need to be able to measure the component. Example if you are 
claiming for the whole food, your studies should show based on the consumption of the whole 
food rather than certain component.’- P11   
All the regulators, key opinion leaders and policy makers noted that they looked for 
‘comprehensiveness of data’ in the applications. The term ‘comprehensiveness of data’ refers 
to the required data as stated in the application forms for new claims in each country such as 
human intervention data, quantity to consume, target group etc.  These data had to sufficiently 
demonstrate the effectiveness and efficacy of the food constituent and the benefits to health, 
also known as the cause-effect relationship.   
‘It goes to what they want to want.  We are not asking for information beyond to the claim 
they want to say.’- P1  
‘One example is that all the information for the required 18 items in the form are provided.’-
P7  
3.4.2.1 Codex Alimentarius   
All regulators but also key opinion leaders mentioned the Codex guidelines for the use of 
nutrition and health claims as the basis to evaluate new health claim applications.  However, 
to date, only the Indonesian regulations on health claims state the principles of evaluation for 
approval explicitly in their guidance materials.    
‘We follow other countries and Codex guidelines.’- P1   
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‘Evaluations are based on the Codex Guidelines on Scientific Evaluation of claims.’- P2 
‘Applicants should also ensure that the studies submitted best substantiate the proposed 
health claims. This is as recommended by Codex under the ‘Guidelines for Use of Nutrition 
and Health Claims. The guiding principles are based on the recommendation made by 
Codex.’- P3 
The key information required for the health claim applications are similar to the key 
parameters used to evaluate health claims.  The key parameters to evaluate health claim 
applications were the presence of human intervention studies, the quality of human studies, 
the proposed wording of the claim and a clear scientific rationale on the condition of use such 
as the realistic amount of the food constituent to consume in a given food matrix that will be 
discussed in the subsequent paragraphs.  Figure 3.4 provides an overview on the data required 
to substantiate the new health claim application based on the interviews and the existing 
regulations, guidelines or application forms published by the following SEA countries: 
Indonesia, Malaysia, Singapore and Thailand (with the critical information for health claim 
substantiation in bold).
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Figure 3.4: Summary of data requirements for claim substantiation 
Source:  Author’s construction drawing upon data from the interviews; and Ministry of Health Malaysia (2010); National Agency of Drug and 
Food Control of the Republic of Indonesia (2011a); Agri-Food & Veterinary Authority (2010 (with amendments to 2016)); Agri-Food and 
Veterinary Authority of Singapore (n.d.-b); Ministry of Public Health Thailand (2011); Ministry of Health Vietnam (2014)
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3.4.2.2 Quality of the human studies  
Primarily, good quality of scientific studies is a pre-requisite before any application can be 
considered for evaluation.  Based on the feedback of a few participants, it seems that the 
quality of human studies was reviewed based on criteria such as the type of human studies, 
sample size, selection of subjects, quantity of the constituent required to consume, and the 
endpoints or biomarkers measured in the studies.  Well-designed human intervention studies 
such as Randomised Controlled Trials (RCT) were repeatedly quoted as the type of high -
level quality evidence that is needed by the regulators, but also by some key opinion leaders 
and most policy makers.  These human intervention studies were expected to be included as 
evidence in the new applications.  Finally, the subjects participating in these intervention 
studies should reflect the intended target audience of the product/ food constituent.     
‘The main principles are: the randomized placebo-control trial be of sound design (sample 
size, selection of subjects, how nutrient/food component is given to subjects, parameters 
measured); scientific data must be in line with the proposed claim wordings; clear scientific 
rationale of the proposed minimum amount that must be present; subjects studied must be 
similar to intended targets of the product’ –P7 
3.4.2.3 Human intervention data to demonstrate health efficacy 
Human intervention data are compulsory to demonstrate the cause-effect relationship of the 
food constituent to health in all countries.  Studies to be submitted in application dossiers 
were preferred to be peer-reviewed and published data from studies that were conducted 
within the past ten years by reliable, recognised institutions such as governments’ ministries, 
and academia.  Human intervention studies conducted in other countries and/or by the 
industry, were accepted by the regulators, provided that these studies were well-designed, 
peer-reviewed published and conducted using good research practices.  Human intervention 
studies were also required for claims on foods with a long history of use, such as ginger or 
garlic in all SEA countries, not just for novel food constituents. 
‘They should be obtained from human studies, which may supplemented by data from non-
clinical studies. Furthermore, these data should come from the reliable resources or 
publications that are generally recognized in academics or research fields.’ – P4 
‘The company showed scientific results from other countries.  For example, Singapore, 
America, Europe are good.  But some developing countries are not accepted, so the result is 
not considered. Some studies from [Country X] can be good but must be supervised by 
government offices or other countries, organisations from Europe/ developed countries.’- P5 
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‘In the current system, foods with limited scientific evidence are not likely to be accepted to 
make health claims, although they may have a long history of use. This is especially if long 
history of use is not well documented.’- P7  
Non- human intervention studies may not substantially contribute to a higher likelihood of 
approval as the evidence was considered supporting and secondary.  Human observational 
data which are commonly used for nutrition research, were considered as supporting evidence 
in most SEA countries.  Animal studies, in-vitro studies, and medical textbooks were also 
classified as supporting evidence.  Supporting evidence was a ‘good- to- have’ piece of 
information, if there were no human intervention data available.   
‘Human observation studies may be used to provide further support to strengthen 
applications. If an application has only human observation studies, it will likely not be 
accepted by the Committee.’- P7  
‘Human intervention data is a must. Human observation data is used as supporting evidence, 
not a primary data used to substantiate.’ - P11 
3.4.2.4 Proposed wording of claims  
Most participants stated that the proposed wording of claims should not extend to other 
benefits and it must clearly explain only the benefit of the constituents.  Participants from the 
food associations echoed similar responses with the regulators and key opinion leaders in that 
claims should be truthful and be evidence- based.  The understanding (by consumers) of 
claims was not an immediate consideration by the interviewees, until they were being further 
asked. 
‘The benefits are showed and demonstrated.  It is exactly the results and no extrapolation.  
With that, it will be easy to approve. The product for this group, the formula is the same and 
formula used is the same, so no extrapolation beyond the conditions of the studies.’- P8 
‘Industry should only claim on what they have’- P14 
3.4.2.5 Condition of use  
The quantity required to consume to achieve any beneficial effect should be at a realistic 
amount of the food constituent which does not lead to overconsumption of certain products.  
Most countries accepted data on the food or food constituent, provided the matrix of the food/ 
vehicle does not change the physical or chemical properties of the active ingredients.   The 
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vehicle of consumption should be part of food matrix and able to fit into the local dietary 
pattern.  
‘Let's say we are talking about cheese, people in western countries eat cheese like eating 
crackers.  Do we eat cheese in that way? That means we need to take into consideration that 
situation. Maybe they will take up the dosage higher or more frequent, or the consumption 
maybe little.’ P1 
3.4.2.6 Totality of the evidence  
The expert committees established in Indonesia, Malaysia, Singapore, conducted holistic 
evaluation for the new health claims based on the totality of available evidence.  Each new 
claim application dossier is required to include all available studies regardless of positive or 
negative results (Ministry of Health Malaysia, 2010; National Agency of Drug and Food 
Control of the Republic of Indonesia, 2011a; Agri-Food and Veterinary Authority of 
Singapore, n.d.-b).  The Philippines regulatory agency differed from the rest of the SEA 
countries as they conducted their own evaluation to assess the totality of evidence by 
searching the literature, rather than relying on the information provided in the dossier and 
assuming it is complete. 
The rationale for some SEA countries such as Malaysia, Singapore, Thailand to request for a 
specific number of studies in the application dossier is to ensure that there was sufficient 
evidence, and that there were consistent outcomes from the studies to demonstrate the benefits 
of the food constituent to health as claimed.  Some commented that the quality of the studies 
was more important than dictating a certain number of studies to be submitted.   
‘The number of studies is important to establish consistency on the findings to support the 
claims.’- P2 
‘This is to display consistency in the outcome of the studies. Applicants should also ensure 
that the studies submitted best substantiate the proposed health claims.’- P3 
 ‘But I think they just want to make sure that you have enough.  If you have one and only one 
study or published papers from the same old story, same study, then it might not so 
representative. […] To them, it is not like it must be five, it must be seven. It is basically 
telling you must have the evidence.  If you only have one study, there is no point to apply the 
information.’- P11 
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‘There is no minimum number of studies that is required. A loose guide is 5 clinical studies. 
What is more important is the quality of the studies.’- P7  
3.4.2.7 Approval/ status of claim applications in major jurisdictions 
The approval and status of a new claim in other jurisdictions such as European Union, United 
States, Australia and New Zealand provided a reference for the Asian regulators on how the 
claim could be viewed by the regulatory agencies in non- ASEAN countries.  Most 
participants mentioned that the information coming from other jurisdictions, did not influence 
the approval of the claim application in their country, but that this information was required in 
the applications.  Some participants commented that the ASEAN regulators could feel more 
confident about the claim, knowing that the particular claim had been screened or approved 
by other competent authorities from major jurisdictions such as European Food Safety 
Authority (EFSA), Food Standards Australia and New Zealand (FSANZ).   
‘We have requested for applicants to indicate if the claim has been evaluated by other 
national regulatory bodies (whether accepted or rejected). This is to provide a holistic view 
and opinion of the proposed claim and not as a deciding factor to approve or reject a claim 
application.’- P3 
‘To see how the other countries regulate health claims in their countries [.. ].’- P4 
‘It is only for reference, to determine how other countries view the intended claim. It does not 
necessarily follow that if another country has approved a claim, we will follow suit. It also 
does not mean that if no country has approved a claim applied, we will also not approve. The 
committee views the evidence on its own merit.’- P7  
‘So this has been screened or approved by another competent authorities like FSANZ or 
EFSA. They will feel a bit more relaxed, knowing that someone has reviewed the evidence so 
they can actually look at the summary reviewed by these countries and draw their own 
conclusion.’  - P11  
3.4.3 Factors affecting the approval of health claims 
Two key factors affecting the approval of new health claims involved the comprehensiveness 
of the scientific evidence and the common errors in the application dossiers.  The health claim 
application had to be substantiated with a comprehensive and consistent body of evidence to 
demonstrate the relationship between the food constituent and health, or otherwise it would be 
rejected during the evaluation.  The common errors mentioned by the regulators and key 
opinion leaders were: i) inadequately and ill- prepared application dossiers, such as poor 
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explanation on the scientific substantiation; ii) lack of strong scientific data to substantiate the 
claims such as non-human data, or outdated data (more than 10 years old); iii) the food 
constituent was not well-characterised with no clear unique characteristics; iv) the wordings 
of the claims did not match with the study findings or a mismatch and/ or extrapolation of 
information from the human studies, e.g different target audience, studies using ‘pure’ 
constituent(s)  consumed as a supplement, but a claim on the constituent in a food matrix; and 
v) proposed claims that implied treatment of medical conditions and/or diseases such as 
constipation, lower blood pressure, which are all outside the jurisdiction of food regulations in 
the countries examined.  
‘the documents, sometime we ask for current documents, but maybe they prepare documents 
many years ago or the studies are not with the subjects they want to explore  (target of the 
people).[..]  If the way to consume the products like certain way. If it is put in biscuit, would it 
be useful?  Sometime the consumers' way to consume, have link on the benefits that is 
mentioned that. Maybe the studies were conducted on the certain pill, they want to put in milk 
in whatever.  Would it have the same benefit? If the study is only on certain groups, now they 
want to claim people.  We cannot say that it is related. Sometime certain component cannot 
be generalised, depending on the metabolism.’- P1 
‘Completeness of the application is an important factor. Incomplete applications could delay 
the application process.  In recent years, several applications have been submitted based on 
pure food components taken as supplement. They have not yet been incorporated in to food 
products/matrices. Members felt that these components should be evaluated as supplements 
rather than nutrients/components added to food. Wordings for claims bordering on disease 
reduction e.g. lowering blood pressure, constipation, diarrhoea.’ – P7 
Interestingly, the response rate from the expert committees was described as a factor which 
delayed the approval timeline.  Some participants raised concerns on the availability of 
experts in Asia to evaluate health claims.     
‘Timeline of the health claim evaluation is dependent on several factors like the complexity of 
the case, response from the Committee on Evaluation of Health Claims (which is made up of 
mainly external experts working on a pro-bono basis) and availability of evidence.’- P3 
 ‘Because when a country has lot of experts, they can afford to do it fast.  But unfortunately in 
ASEAN, I think this is a major problem faced by many countries.  There are not enough 
experts in the countries.  They have experts but not enough.  They might have that few experts 
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which they re-used many times. And the people also have their full-time jobs. If they are 
experts, they are also involved in many other committees.  So this is difficult. Let's say there 
have 100 experts just like Europe. They don't have to use the experts many times again.’- P11 
 ‘the question is very few reviewers.  That's why I propose FDA limit.   So we are going to 
have public organisation to review outside FDA under supervision of FDA. Maybe next year.   
Because I don’t think the government can recruit experts.  Company have to pay for review 
and we need to build more experts at universities ready to review.  I think not only from 
Thailand, maybe recruit from everybody.  We want to be International. Because limit 
manpower, limit knowledge.’ – P9 
3.4.4 Challenges faced by the SEA stakeholders 
3.4.4.1 Regulators and Policymakers 
Some regulators faced difficulties in differentiating between health claims and medical claims 
in more complex applications.  There is marginal difference between food and drug/ 
supplement in some cases, such as the creativity or innovation of adding non-food constituent 
into food.   
‘The claims that are closely to medical claim. As mentioned above no medical claims are 
permitted, so the challenge is how we should do to prevent consumers misunderstanding that 
the claimed food products have therapeutic action.’- P4 
‘First, we put the regulation draft. Food is not a drug; Supplement we have to say not to cure, 
prevent or treat the disease. I like the labelling, warning on the supplement. But the food and 
drug is very narrow. Now the food put Coenzyme Q10. It is very difficult for every 
government. ’ P9 
The regulators found it challenging to allow more compelling health claims and to show 
flexibility in rewording the approved health claims for commercial viability.  Some feared 
that rewording of claims could mislead the consumers to interpret the claims in different 
ways.  One participant described that they were in a difficult position and they were unsure on 
how to achieve a balance between business-friendly and consumer protection. 
‘They want the claims to bombardise and catchy.  That is one of the challenges.  This is true, 
just say the study saying it is approved.    If we put that to the consumer in the labelling or 
advertisement, we want to make sure do people understand or do they apply in the right way.  
Or they may exaggerate from the claims or they may expect too much from that claim.’ P1  
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‘Industrial push for more flexibility on rewording of claims for commercial viability, leading 
to potential truncation of approved claims.’ – P3  
‘Not just the committee, NGO (non-governmental organisation), consumer groups, they want 
to challenge.  I like the challenge. You (Academia), company, NGO, FDA debate and get the 
conclusion.   Platform is at the food committee.   […] I prefer the balance.  You know I like 
everybody come and balance.   I am in the middle of [..], very difficult. –P9   
3.4.4.2 Key Opinion Leaders 
The key opinion leaders from the scientific community expressed difficulty in evaluating new 
health claim applications.  They reported that most applications were not well-prepared and 
lacked strong evidence to substantiate the proposed health claim.   In addition, some 
applications were based on pure food components consumed as supplements but were 
intended to be made in a novel food containing the constituent.   One participant commented 
on the difficulty on agreeing on whether there was sufficient evidence for a claim and that 
there was inconsistency on making a decision when the members in the committee change 
during the evaluation process.   
‘Document not well prepared, lack of quality strong evidence.  The completeness of the 
submission documents, the quality of evidence, experts review’-P6 
‘One of the main challenges is agreeing on what constitute sufficient evidence for approval of 
an application. It is important to make consistent decisions; however this is difficult. It is not 
something that we can quantitate. When members in the committee change, then the decision 
becomes even more varied.’- P7  
3.4.4.3 Representatives from food associations 
The participants from the food associations consistently raised that the rigorous, 
pharmaceutical- like approach to substantiate health claims for food, was very challenging to 
achieve.  They held the view that a food is not a drug, and that scientific evidence should not 
stringently follow the pharmaceutical standards, which are also mainly for treatment of a 
medical condition and not for use in an otherwise healthy population.  These stringent 
requirements could include well-designed human intervention studies in a healthy population, 
or in specific subgroups in which it is preferable to use the same products but without the 
constituent as applied to drug standards.   
‘Food is not a medicine. I do not agree why just to make a claim that a food product will help 
support healthy condition of the consumers, would need a clinical trial. Requirement of “Well 
73 
 
designed Human Intervention Study” done with the product in a specific group of 
population.’ – P14 
One participant indicated that it was unrealistic to request for independent studies and a 
certain (minimal) number of studies for each new application.   
‘It (clinical trials) should be independent and ideally not be funded by the company.  So that 
is ironical.  [.. ] Of course, they [the company] need to collaborate with the company which 
has the ingredient that can engage a third party academic to do the trial.   I think they [the 
regulators] should not focus so much on that, rather they should focus on the merit of the 
study. Not many companies can do that to submit five human intervention studies on an 
ingredient to make a claim.  That cause a barrier for company to consider submitting new 
claim.’- P13 
Another participant commented that there was a need for the authority to change the mindset 
that does not allow nutrients without recommended dietary intakes (RDI) to carry a health 
claim.   
‘Mindset of authority that does not allow nutrients without RDI to carry a health claim.’- P14 
The industry requested for transparency in the health claim evaluation.  They found it difficult 
to understand some decisions on application rejections, as no clear explanations were 
provided.  The industry suggested that it would be better to work with a list of approved 
health claims, and that they would appreciate it if more health claims and some flexibility in 
wording could be approved for communication.  
‘We do not know what is going on with the evaluation.  I think because it comprises of lots of 
academia, agencies which gives comments. [..] Unfortunately we do not know what is the 
reason of the rejection.  So sometime the details of the comments from the committee or 
rationales behind it.’ – P13 
3.4.5 Key country differences  
3.4.5.1 Local data required in Indonesia for prebiotic and probiotic claims 
Claim applications specifically for prebiotics and probiotics in Indonesia have to be supported 
by human intervention studies conducted in the local Indonesian population as the function is 
assumed to be dependent on the unique flora of the indigenous populations.  
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3.4.5.2 Developments in health claims regulations and guidelines 
The development of regulations and guidelines for health claims are at different stages across 
the SEA territory.  Indonesia, Malaysia and Singapore had written documents to provide 
reference for industry in filing of new health claim applications.  These documents include 
application forms, the description of processes and lists of approved health claims (Ministry 
of Health Malaysia, 2010; Agri-Food & Veterinary Authority, 2010 (with amendments to 
2016); National Agency of Drug and Food Control of the Republic of Indonesia, 2011a; Agri-
Food and Veterinary Authority of Singapore, n.d.-b).  These SEA countries also expected the 
scientific substantiation to have more complete information than officially required.  In 
contrast, Vietnam, which did not have any official health claim regulations at the time of 
interview, was more receptive to approving health claims as long as the evidence was from 
credible sources such as the Vietnamese National Institute of Nutrition, and/ or peer- 
reviewed scientific publications.   The Vietnamese regulatory agency also permitted health 
claims on foods that had a long history of use, provided the scientific substantiation was from 
widely-referenced and established textbooks, such as the encyclopaedia of traditional 
medicines.    
3.4.5.3 Expectations on the scientific substantiation depending on types of claims 
Some key opinion leaders and representatives from scientific organisations expressed 
different expectations on the robustness and rigor of scientific evidence depending on the 
types of health claims submitted.  According to Codex Alimentarius, health claims are 
categorised into three categories; nutrient function claims, other function claims and reduction 
of disease risk claims (Codex Alimentarius, 1997 (last amended in 2013).  Reduction of 
disease risk claims can be considered as the highest level health claim, compared with nutrient 
function or other function claims.  Some participants suggested that more stringent, rigorous 
scientific evidence such as Randomised Controlled Trials were required to substantiate these 
high- level claims, while nutrient function claims required only scientific information from 
well-established recognised textbooks.  The participants also suggested that other function 
claims could be considered a hybrid between a nutrient function claim and a reduction of 
disease risk claim, and also required evidence from human intervention studies to substantiate 
the effectiveness of the food constituent to a health outcome.   
‘Need to be human intervention data. It depends on the level of health claims. Disease risk 
reduction claim definitely need human intervention trials.  Unlike nutrient function claims 
that are very well-established nutrients such as the textbooks, recommendation from health 
authority. then you don’t need to have.  Example:  Calcium in the strengthening of bone 
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functions, you don’t need to conduct another study to demonstrate this effect as it is quite 
established.  Other function claims also need human intervention trial as they are not the 
traditional nutrients. They could be novel ingredient and they need to demonstrate that.  
Observation studies do not give you strong enough data to show the effects’.- P11 
‘let’s say they only say ‘the product contains’, mainly we ask for the certificate of analysis.  
They have the certain amount. If they say help to maintain digestive system, they have to give 
us a study on that issue. Behind that, we would like to understand if the study does it once, or 
do it on certain group of people, do it for a range of age.  Deepness of the claims may go to 
what they want to achieve.’-  P1 
3.4.5.4 Time of the health claim approval process 
The time notification on the outcome of health claim applications varied considerably.  Only 
the Indonesian regulations stated a time frame of a maximum of 6 months, which was 
confirmed by the interviewee but this was subject to the availability of the scientific evidence  
(National Agency of Drug and Food Control of the Republic of Indonesia, 2011a).  In the 
Philippines and Singapore, the review process typically took one week to one month and 9-12 
months respectively from the time of complete submission to relay of the evaluation outcome 
to the applicant.  In Malaysia, the whole process took ‘several months’ without a specific time 
frame indicated.   The Thai authority took around 1-2 years to process an application before 
the applications for new health claims on food in Thailand was stalled without further notice 
(obtained from several interviews).  No information was available for Vietnam at the time of 
the interviews, as the Vietnamese health claim system was newly established in January 2015. 
3.5 Discussion  
The interviews conducted with the various stakeholders in SEA clearly indicated that all 
regulators and key opinion leaders used the Codex Alimentarius guideline on health claims as 
a basis for their scientific substantiation and evaluation of health claims.  This common base 
will have a positive influence on trade opportunities in ASEAN region which is in line with 
the intention of the ASEAN Economic Community to provide more access to nutritious food 
for all SEA consumers by providing a level playing field for food companies which operate 
across SEA.  The findings of this qualitative study show that the current thinking on 
substantiation of health claims and the evaluation criteria were quite similar among the 
stakeholders across the SEA countries.  This includes the need for high quality well- designed 
human intervention studies, conducted in the target groups, using clearly characterised food 
constituents, indicating the conditions of use (quantity to consume and pattern of diet) to 
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demonstrate the ‘cause- effect relationship’ and the application could be accompanied with 
the approval or status of the claims in other major jurisdictions.  To a large extent, the 
approach is in line with other major jurisdictions such as the European Food Safety Authority 
(EFSA), the United States Food and Drug Administration (USFDA), and the Food Standards 
Australia and New Zealand (FSANZ) (Codex Alimentarius, 1997 (last amended in 2013; 
European Food Safety Authority, 2006; Food Standards Australia and New Zealand, as of 18 
January 2016; United States Food and Drug Adminstration, Revised as of 1 April 2015a).  
This common understanding also provides a base for the food industry to prepare clear 
application dossiers for regulatory submission and approval in multi- SEA countries.   
Clearly, there are different expectations on the different types of scientific evidence required 
to substantiate the different types of health claims, especially human intervention studies are 
required for ‘other function ’ and ‘reduction in disease risk’ claims, which could have an 
influence on the approval of health claims.  This difference in the weight of the evidence is 
similar to the situation at the EFSA which has established a hierarchy of studies to evaluate 
health claims (European Food Safety Authority, 2011b).  Some research has suggested that 
health claims can be divided into two groups; generic and product- specific or disease-related 
when preparing scientific substantiation (Cummings et al., 2003; Asp and Bryngelsson, 2008; 
Lalor and Wall, 2011).  Several review papers on health claims in Europe and the United 
States reported that the scientific substantiation of health claims ranged from the well- 
established evidence accepted by scientific bodies for nutrient function claims to multiple 
well- designed human intervention studies with consistent results for reduction of disease risk 
claims (Cummings et al., 2003; Binns, 2009; Richardson, 2012).  In the recent scientific 
guidance documents established by EFSA, the evaluation panel has approved health claims on 
essential nutrients based on a large body of scientific evidence which includes case reports of 
clinical studies and animal studies (European Food Safety Authority, 2016b).  This approach 
by EFSA is aligned with PASSCLAIM and the Codex recommendation which suggests that 
nutrient function claims can be substantiated by well-established information (Codex 
Alimentarius, 1997 (last amended in 2013; Aggett et al., 2005).  This explains why there are 
generally more approved nutrient function claims compared with other types of health claims 
by EFSA.  This study also suggested culture could influence the acceptance of different types 
of scientific information such as in Vietnam.  For example, the health claims on food with 
long history of use can be supported by the encyclopaedia of tradition medicines in Vietnam.  
This could be due to the fact that the consumption of traditional herbs is seen as part of the 
normal Vietnamese diet and culture (Nguyen and Nguyen, 2008).   
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The key parameters to evaluate health claims and the common errors on the application faced 
in SEA were similar with those faced by EFSA.  In EFSA, the quality of the study is 
important and this is assessed by the quality of reporting in the studies (Martin, 2015).  Each 
application was evaluated by matching the target population of the submitted claim, the 
condition of use such as the amount to consume to be part of balanced diet and the wording 
reflecting the scientific evidence.  In addition, the totality of evidence is weighed to look for 
the cause-effect relationship between food constituent and health (Martin, 2015).  Most health 
claims applications on children development in Europe were rejected due to the limitations of 
research studies in paediatric nutrition, too generic benefits such as gastrointestinal health, 
immune system, wide range of tests for different aspects of development and extrapolating 
results in different populations from diseased population to the target group (Valtueña 
Martínez and Agostoni, 2013).   Harmonisation on the research methodology was suggested 
to overcome the research limitations and it can be achieved by communication and consensus 
among research community (Valtueña Martínez and Agostoni, 2013).  Most recently, the 
EFSA has recognised the limitations in obtaining the biological plausibility such as 
mechanism and bioavailability of the essential nutrients from human randomised controlled 
trials due to ethical considerations and the nature of repletion human studies (European Food 
Safety Authority, 2016b).  This suggests that the human intervention studies for health claim 
applications are difficult to achieve. 
Well-designed human observation studies should be considered as high quality scientific 
information that can be used to substantiate generic health claims.  This study has shown that 
human observation studies were viewed as only supporting evidence and was considered less 
credible compared with human intervention studies.  This creates challenges for the research 
community and the food industry to generate data to support health claim applications.  It is 
clear that the nature of food and nutrition studies in humans is different from those required 
for drugs.  Foods provide a matrix containing multiple nutrients and the consumption in diets 
makes it difficult to single out the specific benefits of any particular food constituent (Aggett 
et al., 2005; Binns, 2009; Aggett et al., 2012; Richardson, 2012).  Therefore, most of the 
nutritional research has historically been mainly through human observation studies.  A more 
pharmaceutical- approach to investigate the benefit of any food constituent is difficult to 
achieve, generating high costs for the food industry (Binns, 2009; Aggett et al., 2012; 
Richardson, 2012; Richardson and Eggersdorfer, 2015).  The representatives from food 
associations in SEA shared similar concerns.  In SEA, human observation studies are accepted 
for scientific substantiation of ‘other function’ claims and ‘reduction of disease risk’ claims 
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according to the recently-launched ASEAN Harmonisation on health claims for traditional 
medicine and health supplements which follows the Codex classification of health claims on 
food (Association of Southeast Asian Nations (ASEAN), 2015).  It can be worthwhile to take 
reference from the disciplines related to nutrition such as health supplements to mitigate 
issues which exist in food and nutrition area.  For instance, it could be useful to understand 
the rationale why the human observation studies are accepted to substantiate health claims on 
traditional medicine and health supplements.  This could help the regulators and key opinion 
leaders to decide on the types of human studies acceptable for health claim substantiation in 
food, knowing the limitations of nutrition studies. 
The phrasing and choice of words in health claims application are important because they 
differentiate between health claims on food and medicinal claims, and clearly influence how 
the health claims will be classified.  The evaluation of the health claim application process 
clearly indicates that the appropriate wording needs to be used when formulating new health 
claims for regulatory approval.  In Europe, it is reported that there is a risk of overlap between 
health and medicinal claims due to the beneficial health effects and end point measured and 
the wording used (Flynn, 2012).  For instance in Europe, the benefit of ‘maintaining 
cholesterol’ is classified under Article 13.1 (General or function claims) while the claim of 
‘reducing cholesterol’ is classified under Article 14 (Reduction of disease risk claims) (Binns, 
2009).  The wording of the health claims can also indirectly impact the scientific 
substantiation required.  A reduction of disease risk claim requires more rigorous and 
stringent human intervention data compared with a nutrient function claim.  However the 
consumer-friendly wording is not under the purview of the EFSA NDA panel (Martin, 2015).  
With the evolving scientific insight, some food constituents may have multiple benefits and/or 
even drug-like functions.  A clear question to raise here is what is the balance between non- 
misleading and consumer-friendly wording of claims?  In addition, the wording of claims can 
have different meaning in different cultures which influence their understanding and also the 
subtities of the English language makes interpretation difficult for lay consumers.  Several 
review papers have highlighted how the impact of the wording of claims and different 
cultures influences the understanding of the claims (Dean et al., 2011; Nocella and Kennedy, 
2012; Lähteenmäki, 2013). A recent focus group study conducted among SEA mothers 
(Chapter 4) demonstrates that the choice of words, phrasing, length of claims and the use of 
scientific terms such as haemoglobin, carotenes, antioxidants etc., were clearly barriers to the 
understanding of health claims (Tan et al., 2016).  Other studies in Europe have also shown 
that scientific terms on claims such as ‘connective tissues’, ‘platelet aggregation’ were not 
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understood (Richardson and Eggersdorfer, 2015).  In a cross- country study conducted in 
Denmark and the United States, the Danish consumers responded more positively towards the 
soft framing of information while the American consumers preferred the scientific framing of 
information (Aschemann-Witzel and Grunert, 2015).  The wording of the claim can affect 
both the application and understanding of health claims.   
The two emerging issues of requiring human intervention data in local populations and the 
mindset of rejecting claims on nutrients which do not have RDI, are considered good ways to 
protect consumers, but may prevent consumers from having access to foods that could support 
their health.   Both issues may also provide a hurdle for the industry to develop innovative, 
healthier, nutritious product due to the high cost of generating supporting scientific evidence, 
the time lag in developing this evidence and the legal processes associated with acquiring a 
claim for regulatory approval.    
The establishment of experts committees from multi- disciplinary backgrounds to evaluate 
new health claims can be seen as a solid base.  These committees work based on the key 
concepts and guidance provided by Codex in line with other major jurisdictions on scientific 
substantiation and evaluation, the availability of application processes, and the positive list of 
approved health claims.  This use of Codex as key references and provision of processes 
provides robustness and transparency on how health claims are approved in the countries for 
the industry and consumers, and this also creates certain level of consistency that can facilitate 
food trade.  Two key areas that could improve were unclear or outdated regulations and 
guidelines and irregular communication across the different clusters of stakeholders.   
An opportunity for improvement lies in the clarity in the regulations/ guidelines and the 
availability of established guidelines documents for health claim applications.  These could 
include further guidance on the scope, objectives and principles of the regulations/ guidelines 
and the required materials such as food labels, advertisements that require pre-market 
approval.  Guidance documents can be a way to align among stakeholders.  The checklists on 
scientific documents required and the guidance documents such as scientific and technical 
guidance on scientific substantiation could be included to facilitate the process.  These 
documents can be updated, as and when the scientific insights and regulations change.  For 
instance, food authorities from the major jurisdictions such as EFSA, USFDA, FSANZ, and, 
Health Canada publish official guidance documents (United States Food and Drug 
Adminstration, 1994 (revised January 2013); Health Canada, 2009; European Food Safety 
Authority, 2016b; Food Standards Australia and New Zealand, 2016a).  At present, equivalent 
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information is either unavailable or not as complete in SEA.   This would also bring more 
clarity to potential applicants on the requirements for regulatory approval on new health 
claims. 
The different perspectives and viewpoints on the challenges faced by the stakeholders within 
the same clusters, could have resulted from the job responsibilities, different professional 
training and/ or field of expertise of the stakeholders, and not competencies.  All of the 
interviewees were science-trained.  A study in Italy reported that the diverging goals among 
the stakeholders such as entrepreneurs, academics and policy makers, resulted in different 
perspectives on innovations and the perspectives deeply influenced behaviours (Massa and 
Testa, 2008).  A cautious and consumer-protection mindset of the regulators was observed 
when the adoption of Codex guidelines on health claim was stalled for several years (Hawkes, 
2004).  This suspension on the establishment of the Codex guidelines on health claim was 
mainly due to the disagreement over reduction of disease risk claims among the member 
states and the fear that the food could imply curative, therapeutic properties (Hawkes, 2004).  
It is understandable that the different clusters of stakeholders have different perspectives as 
the key objective of the regulators is to protect consumers from being misled, while the key 
opinion leaders is to uphold highest scientific standards and the food industry is to provide a 
solution to satisfy the need and wants of the consumers.  This research seems to suggest a 
need for reconciling different perspectives for health claim regulations to progress.  This does 
not mean that total agreement among stakeholders is needed.  If the intention of the 
stakeholders is to have more health claims available for consumers, it is important to have 
platforms for the different clusters of stakeholders to communicate and brainstorm for 
possible solutions to mitigate the challenges faced by each cluster of stakeholders. 
A regional expert group consisting of the scientific experts from the SEA region should be 
established to evaluate health claims.  This regional scientific expert group could facilitate the 
cross-fertilisation of knowledge and potentially solve the issue when the limited availability 
of experts to evaluate health claims in individual SEA countries.  Aggett (2012) highlighted 
that it is critical that those who review and assess evidence for health claims to have the 
competency and appropriate knowledge to do so.   In addition, this group could be tasked to 
develop a consistent decision framework to approve new applications based on scientific 
consensus. This framework could address inconsistency on decisions when members in the 
evaluation committees change.  The international experts can be consulted/ invited on an ad-
hoc basic, subject to the approval of local regulatory bodies.  Although the ASEAN secretariat 
is the most ideal channel for this work, the organisation has limited resources as there are 
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other pressing issues to resolve in the SEA setting.  ASEAN operates differently compared 
with the European Union.  Unlike the membership of  EU, each member state in ASEAN pays 
the same amount for the annual full membership fee of $1 million which is affordable to all 
ASEAN members (Munthit, 1994; Grainger, 1995).  The International Life Science Institute- 
Southeast Asia (ILSI-SEA) or the ASEAN Committee on Science and Technology are also 
potentially a good platform to facilitate the formation of an advisory group for the time being.  
ILSI, as an independent organisation which receives funding from industry but which has 
independent academic advisors has already established the connections with well-known, 
well-respected scientific experts in SEA and it has been organising many scientific meetings 
including some on health claims harmonisation in this region.    In addition, the ASEAN 
Committee on Science and Technology which is funded by the governments in SEA, could 
have the resources to carry out the work to form an advisory group.    
More regular communication and collaboration among and across the different clusters of 
stakeholders can facilitate communication and understanding of health claims by the Asian 
consumers.  If shared, the most common mistakes identified in health claim application 
dossiers could help to create clarity in the research community and the industry.  This 
communication can be conducted via public consultation, official government website 
publications, and through direct connections with the local food associations.  A regional 
database with the consolidated approved health claims and country regulations and/ or 
guidelines on health claims can be developed for the ASEAN region.  This could provide a 
win-win situation for all stakeholders as the consumers can visit a public website to check if 
health claims on specific food products are indeed approved; the regulators are perceived to 
protect their consumers; and the industry has more health claims to communicate with the 
consumers and it could facilitate cross-border trade.   
3.6 Limitations and future research direction 
This qualitative study provides clear insights and helps to build further understanding on the 
research topic.  However, it does not fully represent the views on the whole ASEAN region as 
only six out of ten ASEAN countries participated in this study.  Furthermore, feedback was 
restricted to selected participants representing different stakeholders involved in the 
regulatory process of health claim approval and each type of stakeholder was not represented 
in each country.  It was challenging to achieve a well-balanced number of subjects with which 
to conduct the interviews due to busy work schedules and the different developmental stage of 
the health claims regulations in this SEA region.  Like any qualitative study, there could be 
self- reported bias as the data are based on self- reporting and personal viewpoints regarding 
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issues.  Future studies should be extended to study the factors why the potential participants 
declined to participate in the interview and expand to more stakeholders such as 
policymakers, or different disciplines related to nutrition that could obtain ideas on how to 
mitigate the existing challenges and issues on health claims on food.   
3.7 Conclusion 
This study aimed to shed new light on the current practices and perspectives on health claims 
in Southeast Asia.  The study was not intended as an attempt to determine which practice or 
perspective is ‘right’ but rather aimed to find the points where practices and perspectives 
converge and diverge and provide some suggestions to reconcile those.  In the light of the 
formation of Association of Southeast Asian Nations (ASEAN) Economic Community in 
2015, the regulatory systems play an important role to protect consumers, promote innovation 
and facilitate trade within the SEA region.  The availability of application processes, 
establishment of expert committee, and using Codex as the basis to evaluate scientific 
evidence for health claim application are seen as best practices.  Clearly, clarity and 
transparency on the existing health claims systems in SEA can be improved.  Nutritional 
science and food technology will continue to evolve and be influenced by the needs of 
changing demographics, lifestyle, economy, and knowledge etc.  Studies have shown that 
health claims educate the consumers on health benefits and may support healthy food choices 
(Wills et al., 2009; Wills et al., 2012; Richardson and Eggersdorfer, 2015; Tan et al., 2016).  
By allowing more health claims, the Southeast Asian consumers can be educated on new 
scientific insights on nutrition and health, and be supported in their ability to make informed 
food choices.    
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Chapter 4 Perception and understanding of health claims on milk powder 
for children: A focus group study among mothers in Indonesia, 
Singapore and Thailand3  
4.1 Abstract 
Health claim regulations and guidelines on food products have been established in some 
Southeast Asia (SEA) countries.  Health claims on food products aim to help consumers make 
informed food choices to achieve a healthy diet.  This study aimed to investigate the SEA 
mothers’ perception and understanding of health claims and the associated regulatory 
frameworks using semi-structured focus groups conducted in Indonesia, Singapore and 
Thailand.  Milk powder for children for three years and above was used as the product focus.  
The mothers recognised and recalled some specific nutrients by names but lacked full 
understanding of the function of these nutrients.  The findings indicated that the mothers in all 
three countries trusted health claims made on the products which were, in part, explained by 
their trust in their governments and the international brand manufacturers.  Their 
understanding of health claims was influenced by several factors such as the familiarity of the 
nutrient, previous knowledge of the nutrients, the perceived relevance of the nutrient, the use 
of scientific terms, the choice of words, and also the phrasing and length of the claims.  
Consumer education efforts via Public, Private Partnerships could be an approach to educate 
SEA consumers and help them to better understand health claims.  The findings of this study 
may be relevant to different stakeholders such as local regulatory bodies, policy makers, food 
industry, academia and non-profit organisations that aim to effectively communicate health 
claims.   
Keywords:  Health claims, Southeast Asia, consumers, perception, understanding, regulatory 
affairs 
 
  
                                                 
3 This chapter has been published in Appetite.  
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4.2 Introduction 
Health claims communicate a relationship between a food and health via i) nutrient function 
claims, ii) other function claims, and iii) reduction of disease risk claims (Codex 
Alimentarius, 1997 (last amended in 2013).  Research has suggested that health claims have 
an educational impact by informing consumers of previously unknown health benefits and 
diet-disease relations, with the potential to support healthy food choices (Wills et al., 2009; 
Wills et al., 2012; Richardson and Eggersdorfer, 2015).  Health claims can also create more 
favourable attitudes to products (Kozup et al., 2003) through potential positive framing 
effects (Van Kleef et al., 2005) as a heuristic to indicate perceived product healthiness (Roe et 
al., 1999) and via a ‘halo effect’ when a food is conferred with additional health benefits that 
were not mentioned in the claim (Roe et al., 1999).  Given the potential commercial benefits 
of products with health claims, health claims legislation typically aims to provide a regulatory 
framework in which consumers can confidently use health claims to make informed food 
choices via clear, accurate and scientifically grounded evidence to protect consumers, 
promote innovation and a fair, competitive environment (European Food Safety Authority, 
2006). 
Since 2014, the Association of South East Asian Nations (ASEAN) Economic Community 
(which includes the ten nations of Brunei Darussalam, Cambodia, Indonesia, Lao People’s 
Democratic Republic, Malaysia, Myanmar, the Philippines, Singapore, Thailand and 
Vietnam) has represented the third largest trading block globally, with a combined population 
of 622 million. The strategic forward plans for the region outlined in the ‘ASEAN Economic 
Community Blueprint 2025’ (Association of Southeast Asian Nations (ASEAN) Secretariat, 
2015a) have espoused the need for consumer protection, including the provision of adequate 
information to support consumers’ informed product choices.  At present, due to differences 
in cultures, languages and stages in economic development (Association of Southeast Asian 
Nations (ASEAN) Secretariat, 2015b), health claim regulations and guidelines which would 
support this consumer protection remit have only been established in five countries, namely 
Indonesia, Malaysia, the Philippines, Singapore and Thailand (Tan et al., 2015). To support 
both the free movement of goods and services within the ASEAN single market and the use of 
health claims as part of brand communications between the food industry and consumers, it is 
critical to understand how ASEAN consumers respond to and understand health claims.   
To date, most empirical research relating to consumer understanding of health claims has 
been conducted in western countries such as Germany (Grunert et al., 2011); Ireland (Lalor et 
al., 2011; Lynam et al., 2011), Sweden (Svederberg and Wendin, 2011), Denmark 
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(Aschemann-Witzel and Grunert, 2015; Orquin and Scholderer, 2015), Belgium (Verbeke et 
al., 2009), Canada (Wong et al., 2014),  the United States (US) (Wills et al., 2009), Italy, 
Germany, United Kingdom (UK) and US (van Trijp and van der Lans, 2007), including 
reviews of European consumers (Wills et al., 2012; Lähteenmäki, 2013).  This body of 
research has identified that consumers prefer short, succinct claim statements without 
scientific terminology on the front of the pack and context-specific health claims (Williams, 
2005; Verbeke et al., 2009).  Visual aids such as graphics and concise messaging in a 
prominent, typically front-of-pack location have been identified as improving the 
communication effectiveness of health claims (Geiger, 1998; Hooker and Teratanavat, 2008). 
Descriptive phrasing using simple language is recommended as the regulatory process and the 
level of scientific evidence required to approve claims is poorly understood by the consumers 
(Wills et al., 2009).  A further dimension of the usefulness and acceptance of health claims is 
the trust of consumers and food manufacturers in the health claim statements and the 
regulatory environment (Lalor et al., 2011; Svederberg and Wendin, 2011).  In order to 
understand the awareness, understanding and preferences for health claims within their 
cultural context, this study aimed to investigate South East Asian consumers’ perception and 
understanding of health claims and the regulatory settings of the local regulatory frameworks 
in Southeast Asia (SEA), using milk powder for children aged 3 years and above as a research 
focus.   
Milk powder was used as an elicitation prompt because it contains key nutrients to support 
growth and development among children (Food and Agriculture Organisation of the United 
Nations, 2013) and it is commonly used in SEA countries. In SEA, this category of food can 
display health claims on the food labels.  The objectives of this study were as follows: 1. to 
understand the current status of the knowledge, perception and attitudes towards health claims 
on milk powder for children among mothers in Indonesia, Singapore and Thailand using 
semi- structured focus groups; 2. to explore the mothers’ current knowledge and trust of the 
regulatory process and framework; 3. to identify factors affecting the understanding of health 
claims using three selected nutrients, calcium, iron and vitamin A as case studies.   
4.3 Materials and Methods  
Ethical approval for the study was provided by the Newcastle University (UK), Faculty of 
Science, Agriculture and Engineering Research Ethics Committee.  All participants gave 
written informed consent before taking part in focus group discussions. 
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4.3.1 Design and Setting 
This study was conducted in three SEA countries, Indonesia, Singapore and Thailand which 
were selected on the basis of the presence of established regulations and/or guidelines for the 
use of health claims on food in each country.  All three countries have a list of permitted 
health claims with precise wordings which must be stated exactly on the food labels and any 
form of consumer communication, as outlined in Table 4.1 (Agri-Food & Veterinary 
Authority, 2010 (with amendments to 2016); Ministry of Public Health Thailand, 2011; 
National Agency of Drug and Food Control of the Republic of Indonesia, 2011a).  For 
example, in Indonesia, nutrient function claims are allowed on products for young children 
aged one to three years old and no other function claims or disease risk reduction claims are 
allowed on products targeted for this age group.  In contrast, nutrient function claims and 
other function claims are allowed in Singapore and Thailand, provided they comply with 
requirements in the regulations and/or guidelines. 
Country  Established 
health claims 
regulations 
and  
guidelines 
 
Approved 
health claims 
to be stated 
exactly 
List of approved health claims 
Nutrient 
function 
Claims 
Other 
Function 
Claims 
Reduction 
of Disease 
Risk claims 
Indonesia    * * 
Singapore      
Thailand    × × 
- present in country indicated 
 ×- not present in country stated 
* Prohibits claims on processed food for babies, and other function claims and reduction of 
disease risk claims for processed food intended for young children aged 1-3 years old  
(National Agency of Drug and Food Control of the Republic of Indonesia, 2011a) 
Table 4.1: Summary of health claims regulations and guidelines in Indonesia, Singapore 
and Thailand 
4.3.2 Participants  
Forty-eight mothers were screened and recruited from Indonesia, Singapore and Thailand (16 
in each country) by an independent market research agency through telephone interviews.  
The inclusion criteria for participation were mothers aged between 21-40 years old, with at 
least one child aged three- six years, who were current users of milk powder for their children, 
and claimed to read food labels (including health claims).  It was assumed the mothers 
residing in urban areas would have greater access to information and more choices of brands 
compared with those residing in non-urban areas.  Research participants were therefore 
recruited from urban areas of Jakarta, Singapore and Bangkok and were purposively sampled 
to be socio-economically comparable with the ‘average’ monthly gross household income and 
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education level for each country; i.e. participants in Singapore and Bangkok had a gross 
monthly average household income of USD 3684- USD 7370 and USD856- USD1711, 
respectively.  For Indonesia, participants were recruited based on average household 
expenditure, brand of drinking water, types of fuel purchased and amount spent on food and 
non-food items to provide a realistic picture of status and consumption patterns of 
respondents due to some ambiguity with income levels.  The education level of the mothers in 
the three countries was mainly to a tertiary level.  Excluded from this study were women who 
worked for marketing agencies and the milk industry.  Before commencing each focus group 
the purpose of the study was explained again to the participants and each gave written 
informed consent to take part.  The recruitment strategy is outlined in Figure 4.1.  The focus 
group guide can be found in Appendix 2. 
 
Figure 4.1: Subjects recruitment criteria  
4.3.3 Choice of product and stimulus material 
It is common practice in SEA for mothers to continue to provide milk to children in this age-
bracket.  Milk powder is more commonly served than fresh cow’s milk as it is less perishable 
in the hot/humid weather conditions in SEA.  These products carry nutrient function claims in 
the three chosen locations and therefore the participants would have been exposed to them 
Mothers
(n= 48)
Group 1:
Test Calcium, followed by Iron, Vitamin A
Young Mothers
(21- 30 years old)
(n= 24)
Indonesia  
(n=8)
Singapore 
(n=8)
Thailand 
(n=8)
Group 2:
Test Iron, followed by Calcium, Vitamin A 
Older Mothers 
(31-40 years old)
(n=24)
Indonesia
(n=8)
Singapore 
(n=8)
Thailand 
(n=8)
Mothers with 3-6 years old
- Current User of Milk Powder for Children (> 3 years 
old)
- Socio- Economic Level: Medium income
- Education: Medium
- Urban (conducted in Jakarta, Bangkok, Singapore)
- Claimed to read food labels including health claim 
before purchase food and beverages for their children
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(based on their stated use of the products and that they read food labels and health claims on 
packaging). 
To investigate the factors affecting understanding of health claims, the standard SEA-
approved claims for three selected nutrients in milk powder, calcium, iron and vitamin A were 
used.  The nutrients were carefully considered before selecting them.  The selection of 
nutrients was based on the following two criteria: 1. the nutrients had similar health claims 
approved in each of the three selected countries; 2. the nutrients have significant impact on 
the growth and development of children aged 3-6 years old.   
There are only 11 nutrients that have permitted health claims across the three SEA countries.  
The health impact of the nutrient to the health of a child first guided the researcher, followed 
by the familiarity and/ or awareness of nutrients.  Several review papers have stated that 
familiarity with nutrients/ ingredients has an effect on the responses towards the health claims 
(Dean et al., 2011; Lähteenmäki, 2013).  The selected nutrients iron and vitamin A are 
commonly found to be deficient among children in SEA and calcium is commonly 
supplemented to pregnant women in the region (United Nations Children's Emergency Fund, 
2015).  Hence participants should have been exposed to information about these nutrients 
prior to their involvement in the study.   Further scientific rationale for the selection of these 
nutrients as case studies in the research is described below.  
1. Calcium 
Calcium is important for the development of bones and teeth during the growth of children 
(United States National Institute of Health Office of Dietary Supplements, 2013).  The latest 
National Nutrition Survey in Singapore in 2010 showed an improvement in calcium intake 
among the adult population over the last six years (Health Promotion Board Singapore, 2010).  
It is one of the common nutrients which is featured in nutrition education on the Singapore 
Health Promotion Board website (Health Promotion Board Singapore, n.d.).  The Thai Public 
Health Agency encourages milk drinking for people of all ages (Thai Public Broadcasting 
Service (ThaiPBS), 2016) and the school milk programme has been implemented since 1992 
to promote milk drinking among young people (Chungsiriwat and Panapol, 2009).  Similarly, 
the Indonesian government recognised the importance of milk consumption and co-operated 
with the dairy industry to promote the health benefits of milk (Vanzetti et al., 2013).  The 
demand for dairy products in Indonesia has grown 10% on an annual basis for the past decade 
(Askew, 2014).    
2.   Iron 
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Iron is a crucial nutrient in blood cell formation with a major impact on the long-term health 
of the baby.  The prevalence of anemia among children aged 6-59 months old in Indonesia, 
Thailand and Singapore was 32%, 29% and 19%, respectively and the World Health 
Organisation (WHO) classified the incidence of anemia in Indonesia and Thailand as 
moderate (World Health Organisation, 2015).  The improvement of iron status has been listed 
as one of the United Nations Millennium Development Goals for the improvement in 
maternal health (World Health Organisation, 2012) and is a WHO Global Nutrition target for 
2025 (World Health Organisation, 2014).   
3.   Vitamin A 
Vitamin A is an essential nutrient for vision, the immune system, reproduction and proper 
functioning of major body organs (World Health Organisation, 2011).  Vitamin A deficiency is 
a public health problem and it affects about 19 million pregnant women and 190 million 
preschool-age children, mostly in Africa and SEA (World Health Organisation, 2011).  The 
statements on Vitamin A are commonly used by milk companies in SEA. 
Three claim statements were presented for each nutrient and are classified as follows:  
1. The national approved claim for each nutrient which differed slightly in wording between 
each country;  
2. A short version of the claim derived by the research team which was made the same for 
each country and would be allowable under the current legislation for each country; 
3. A health claim contrived by the research team which was scientifically inaccurate and 
would not be substantiated under the current legislation in the three countries. 
The three types of claims were selected based on findings in the existing literature which 
investigated factors affecting perception and understanding of health claims (Grunert et al., 
2011; Lynam et al., 2011; Svederberg and Wendin, 2011).  The nationally approved claim 
and short version of the approved claim were selected to explore the consumers’ recognition 
and understanding the claims based on their knowledge of the nutrients and the expectation 
that they may have seen the claims while purchasing milk products.  The contrived claims 
were used to explore further whether the consumers’ knowledge was sufficient to recognise 
that the claims were inaccurate. Thus, a total of nine different health claims statements were 
presented to the mothers in each group (see Table 4.2, Table 4.3 and Table 4.4).  The claims 
were presented in Indonesian in Indonesia, English in Singapore and Thai in Thailand.  The 
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claim statements on Vitamin A were not tested in the first focus group discussion among the 
younger mothers in Singapore due to the available time when conducting that group.   
Country  Calcium 
Calcium 1 Calcium 2 Calcium 3 
 Approved local 
authority claim 
statement 
Derived short version of 
approved local authority 
claim statement  
Contrived, inaccurate 
claim statement 
 
Indonesia  
 
Calcium plays a role in 
the formation and 
maintenance of bone 
density and teeth. 
 
Kalsium berperan 
dalam pembentukan 
dan mempertahankan 
kepadatan tulang dan 
gigi 
 
Calcium makes strong 
bones and teeth. 
 
 
 
Kalsium membuat tulang 
dan gigi kuat 
Calcium contributes to 
the height of the 
children. 
(Calcium helps you to 
grow taller.) 
 
Kalsium berperan 
terhadap tinggi badan 
anak-anak 
(Kalsium membantu 
Anda tubuh lebih tinggi)  
 
Singapore  
 
Calcium helps support 
development of strong 
bones and teeth. 
Calcium makes strong 
bones and teeth. 
Calcium contributes to 
the height of the children. 
(Calcium helps you to 
grow taller.) 
 
Thailand 
 
Calcium contributes to 
the formation of healthy 
bones and teeth. 
 
มีส่วนช่วยในกระบวนการสร้างกระ
ดูกและฟันท่ีแขง็แรง 
  
 
Calcium makes strong 
bones and teeth. 
 
 
แคลเซียมท าใหก้ระดูกและฟันแขง็แรง 
  
 
 
Calcium contributes to 
the height of the children.  
(Calcium helps you to 
grow taller.) 
แคลเซียมช่วยเพ่ิมความสูง 
 
 
Table 4.2: Health claims statements on calcium tested in the three countries 
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Country  Iron 
Iron 1 Iron 2 Iron 3 
 Approved local authority 
claim statement 
 
Derived short version of 
approved local authority 
claim statement  
Contrived, inaccurate claim 
statement 
 
Indonesia  
 
Ferrum is a component of 
haemoglobin in red blood 
cells that carries oxygen to 
all parts of the body. 
 
Zat besi merupakan 
komponen hemoglobin 
dalam sel darah merah 
yang membawa oksigen 
ke seluruh bagian tubuh 
 
Iron helps your body to 
produce energy.  
 
 
 
Zat besi membantu tubuh 
Anda untuk 
menghasilkan energy 
 
Iron helps build strong 
muscles. 
 
 
 
Zat besi membantu 
membentuk otot-otot yang 
kuat 
Singapore  
 
Iron is an important 
component of red blood 
cells which carry oxygen 
to all parts of the body to 
help the body’s production 
of energy. 
 
Iron helps your body to 
produce energy. 
Iron helps build strong 
muscles. 
Thailand 
 
An essential component of 
haemoglobin in red blood 
cells. 
 
เป็นส่วนประกอบส าคญัของฮีโมโกลบิน
ในเมด็เลือดแดง 
 
 Iron helps your body to 
produce energy. 
 
 
ธาตุเหล็กช่วยร่างกายให้พลงังาน 
 
 Iron helps build strong 
muscles. 
 
 
ธาตุเหล็กช่วยในการสร้างกลา้มเน้ือให้แขง็
แรง 
 
Table 4.3: Health claims statements on iron tested in the three countries 
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Country  Vitamin A 
Vit A 1 Vit A 2 Vit A 3 
 Approved local 
authority claim 
statement 
Derived short version of 
approved local authority 
claim statement  
Contrived, inaccurate claim 
statement 
 
Indonesia  
 
Vitamin A can help to 
maintain the integrity of 
the surface layer (the 
eyes, gastrointestinal 
tract, respiratory tract 
and skin).” 
 
Vitamin A dapat 
membantu 
mempertahankan 
keutuhan lapisan 
permukaan.  
Anti-oxidants like 
carotenes and Vitamin E 
support your child’s 
immune system. 
 
 
 
Anti-oxidan seperti 
karoten menunjang 
kekebalan tubuh anak 
anda) 
 
Anti-oxidants like carotenes 
and Vitamin E reduce the 
chance of your child from 
falling sick.  
 
 
 
Anti-oxidan seperti karoten 
mengurangi kemungkinan 
anak anda untuk jatuh sakit) 
Singapore  
 
Anti-oxidants like 
carotenes and Vitamin 
E help to protect cells 
from free radicals that 
may have escaped the 
natural processes of our 
body system. 
Anti-oxidants like 
carotenes and Vitamin E 
support your child’s 
immune system. 
Anti-oxidants like carotenes 
and Vitamin E reduce the 
chance of your child from 
falling sick. 
Thailand 
 
To contribute to the 
body tissue 
maintenance. 
 
 
ช่วยเสริมสร้างเยือ่บุต่างๆ 
ของร่างกาย 
 
Anti-oxidants like 
carotenes and Vitamin E 
support your child’s 
immune system. 
 
อนุมูลอสิระอย่างเช่น แคโรทีน และ 
วติามิน อ ี
ได้มีการช่วยเหลอืระบบภูมิคุ้มกนัของ
ลูกคุณ 
Anti-oxidants like carotenes 
and Vitamin E reduce the 
chance of your child from 
falling sick.  
 
อนุมูลอสิระอย่างเช่น แคโรทีน และวติามิน 
อ ี
ช่วยลดโอกาสที่ลูกของคุณจะป่วยไม่สบาย 
Table 4.4: Health claims statements on vitamin A tested in the three countries 
4.4 Data collection  
Two focus groups were conducted in each city.  The mothers were divided into two groups; 
Group 1 consisted of the mothers aged 21-30 years old (Younger mothers) and Group 2 
consisted of the mothers aged 31- 40 years old (Older mothers) as shown in Figure 4.1.  
Each group discussion consisted of two parts.  The first part of the discussion focused on the 
current knowledge, perceptions and attitudes towards health claims on milk for children.  The 
mothers were also asked about their knowledge and trust of local food regulatory processes and 
the regulatory framework in their country.   
The second part of the discussion aimed to investigate the understanding of the specific health 
claims and factors affecting this understanding using the three selected nutrients.  In order to 
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reduce possible response bias, the nine statements were presented in a random order to the 
participants in each group.  Each claim statement was flashed one at a time to the mothers on a 
projector screen or using a show card, followed by discussion to test the understanding of each 
claim statement before the next claim statement was presented to the group.  The understanding 
of the claim statement was measured based on how the mothers would explain the claim to their 
friends.   
The data were collected in March 2015.  Each group discussion lasted approximately two hours, 
and all the groups were audio-recorded or video-recorded with permission of the mothers.   
4.5 Data analysis 
The focus group discussions were transcribed verbatim and translated into English.  Participants 
were allocated a code based on age (young mother or older mother), country and participant 
number.  For example, Y/T/4 refers to participant 4 in the younger mothers group conducted in 
Thailand.  Thematic analysis was applied to analyse the data.  The transcripts were analysed in 
an inductive process which began with open coding (Strauss and Corbin, 1990).  Through a 
process of comparative analysis similar codes were classified into categories from which 
themes were abstracted (Braun and Clarke, 2006; Fade and Swift, 2011).  The data analysis was 
facilitated using the qualitative software programme NVivo version 10 (QSR International Pty 
Ltd, Australia).  
4.6 Results  
There were no discernible differences in the responses between the younger and older mothers 
and a high degree of consistency among the mothers across the three countries so the results 
are presented and discussed across all participants within each country. 
Awareness of nutrients and other constituents associated with health claims  
The mothers were all aware of health claims on the milk powder for their children.  When asked 
to recall these health claims, they could easily name specific nutrients such as calcium, iron, 
docosahexanoic acid (DHA) and other constituents such as prebiotics/ probiotics: 
 ‘Because today milk contains a lot of things; calcium, AA (arachidonic acid), DHA 
(docosahexaenoic acid), Omega 3 too.’ (Y/ I/ 8) 
‘Milk provides nutrients like DHA (docosahexaenoic acid) and probiotic.’ (O/ S/8)    
‘Kids drink milk for calcium, Vitamin B, DHA (docosahexaenoic acid), Vitamin B12, Omega 3, 
6, 9.’ (Y/ T/ 8) 
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 In addition, the mothers associated these nutrients and other constituents to specific 
musculoskeletal or body organs such as calcium with bones and teeth, iron with blood, 
docosahexanoic acid with brain and the prebiotics/ probiotics with the digestion system, but not 
always their role in the body;  
 ‘Like vitamin A is for eyes, vitamin B1 is for something etc.’ (O/ I/8)   
The mothers recalled the nutrients and the claims mostly at a category level and this was not 
related to individual brands.  There was some confusion on the definition of ‘prebiotic’ and 
‘probiotic’ and the name of some nutrients such as arachidonic acid ‘ARA’ with alpha hydroxyl 
acids ‘AHA’ among the mothers: 
‘There is something else I can’t remember what supposed to help with the digest, Pre or Pro.’ 
(O/ S/ 8)    
4.6.1 Knowledge of health claims  
The main sources of information about health claims came from either the public domain or 
from the private/ commercial sector.  Within the public domain, key sources included 
information gathered in schools, books, when visiting the doctors, via the internet and from 
other mothers.  Product packaging and advertisements from the manufacturers also played a 
key role as sources of information.  ‘Halo’ effects from non-food categories such as health 
supplements and skincare products were observed, in providing the mothers with the 
information on the nutrients and the claims:  
‘I read from the Sangobion supplement product that iron helps you from sluggishness, tiredness, 
so the body stays fit.’ (O/ I/ 5);  
‘Antioxidant is for anti-aging products to eliminate wrinkles.’ (O/ I/ 7) 
‘Some supplement like carotene which is also the supplements for skin as well’. (O/ S/ 7) 
Web-based searches and on-line fora with other mothers were typically used when searching 
for information on health claims:  
“If I don’t get it clearly, I will search Google that what is good for. (O/ T/ 2)  
4.6.2 Health claims as educational and a point of differentiation  
In general, the mothers reacted favourably towards food related health claims which were 
viewed in three different ways. First, health claims were perceived as an educational tool, 
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providing information on nutrients which became learned through repeated exposure to the 
labelled products:  
‘Because we didn’t know or understand before. For laypeople, they don’t know what ARA 
(arachidonic acid) and DHA (docosahexaenoic acid) are for so this makes it clear.’  (Y/ I/ 4)  
‘This also serves as a reminder in case we forget.’ (Y/ S/ 1) 
Second, the health claims were regarded as a form of collaboration between local authority 
and food manufacturers.  Some mothers viewed the local authority was working with the 
manufacturers on health claims: 
‘I think the claim is based on the creativity of the producer, BPOM (Badan Pengawas Obat 
Dan Makananis also known as National Agency of Drug and Food Control of the Republic of 
Indonesia) is more responsible about the content.  BPOM will check whether the content of 
milk meets with the nutritional facts stated on the pack so it would danger the health. So there 
is a strong connectivity between two sides i.e. Producer and BPOM.”  (Y/ I/ 6)  
Third, the health claims provided the basis upon which to differentiate competing products:  
‘I look on the pack to see what it says.  Some brands have ingredients that nourish brain 
while others don’t.’ (O/ T/ 3)   
4.6.3 Health claims to guide purchase  
Most mothers viewed health claims as descriptions of the product benefits associated with the 
products and trusted the health claims on milk products.  In general, the mothers paid more 
attention to the product labels before their first purchase from the brand and were less 
involved with subsequent purchases of the same brand; unless there was a change in the 
product packaging.  Most mothers who read food labels wanted to get a better understanding 
of the products before making a first purchase: 
‘Before I let my child consume anything, I have to read the sides of the package or 
commercials.’ (Y/ T/ 8)      
4.6.4 Trust in health claims but no knowledge on the regulatory frameworks 
High levels of trust in the health claims on milk products were consistent across the three 
countries, provided that the products were from ‘international brands’.  High levels of trust 
were also voiced in the participants’ national governments and regulatory environments:  
‘I think that as long as it’s sold in Singapore, it should be safe.’(Y/ S/ 5) 
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‘So far I have no doubts towards current regulations.’(O/ I/ 8) 
Because it has FDA (Food and Drug Administration) approval, then it should be ok.’  (O/ T/ 
1)    
Despite this trust, most mothers had limited knowledge of the regulatory agencies or the 
processes and frameworks involved in health claim approval in these three countries.  Most 
mothers were confused between the product quality and the regulation of the information on 
the product.  However, the mothers believed the government bodies were mostly present to 
ensure food safety and quality: 
‘All I know, BPOM (Badan Pengawas Obat Dan Makananis also known as National Agency 
of Drug and Food Control of the Republic of Indonesia) regulates the product does not 
contain any substance that would damage the body.’(Y/ I/ 5) 
 ‘Food and Drug Administration is trustworthy and they monitor and control manufacture, 
materials and ingredients.’ (O/ T/ 3) 
4.7 Understanding of the health claims using three selected nutrients. 
All the mothers knew the selected three nutrients very well and could link the nutrients to 
certain benefits such as calcium with bones, iron with blood and vitamin A with eyes.  All 
mothers were most confident in the discussion on calcium claims, compared with iron and 
vitamin A in relation to milk powder.  The knowledge on calcium came from school 
education and the reinforcement of this information on the food labels.  In general, all the 
mothers agreed that the three selected nutrients were relevant for growth and development of 
children.  The participants reported that the nutrients were classic nutrients which were 
typically present in milk powder for children and these nutrients did not stir any specific 
purchase intention for the products.   
4.8 Factors affecting the understanding of the health claims  
4.8.1 Familiarity of the nutrient  
The familiarity of the nutrients had a great influence on understanding of the claim 
statements.   The mothers from all three countries recalled and paraphrased the statements on 
calcium without difficulty.  All the mothers felt very confident with regards to this nutrient as 
they were very familiar with the association between calcium, bones and teeth.  Mothers 
across the three countries took the longest time to recall the claim statements on Vitamin A.  
This may be explained by the fact that most mothers perceived Vitamin A as a relatively new 
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nutrient in the milk powder and the functions as stated in the claims were different from their 
prior knowledge e.g. Vitamin A is good for eyes.  The mothers were confused between the 
two terms such as vitamin A and carotenoids and these terms were used interchangeably by 
them. 
Finally, the mothers seemed to be receptive to more information on the nutrient which they 
were more familiar with.  The Singaporean mothers were able to accept more detailed claim 
statements, provided they were familiar with the nutrient such as ‘iron is an important 
component of red blood cells which carry oxygen to all parts of the body to help the body’s 
production of energy’.  For unfamiliar nutrients, the Indonesian and Thai mothers preferred a 
claim statement to state the nutrient functions and/ or tangible benefits of the nutrient clearly 
and more direct, such as ‘iron provides energy’ or ‘vitamin A support the body’s immune 
system.’   
4.8.2 Previous knowledge of the nutrient and observation  
The previous knowledge of the nutrient and observation triggered the mothers to rationalise 
the claims.  Notably, the mothers from all the countries agreed with both of the calcium 
statements related to strong bones and teeth as the statements were in line with their prior 
understanding.  The mothers rejected all the contrived inaccurate claim statements.  The 
mothers tended to rationalise the claims discussed using their knowledge and observations. 
For example, the majority indicated that there were other factors that contribute to height such 
as genes, other than the calcium intake from the diet.  Some mothers doubted the effects of 
calcium on height after comparing their own children with others who were milk-drinkers, but 
had short stature.  The contrived inaccurate statement on iron did not fit their existing 
knowledge on iron as playing a role in muscle building.  Singaporean and Thai mothers 
associated muscle development with protein and calcium, respectively.  The contrived 
inaccurate statement on Vitamin A was viewed as exaggerated.  Their knowledge of falling 
sick was related to multi-factorial facts such as personal hygiene, and not associated with just 
nutrients and intake of other food constituents.   
The understanding of claims was challenged when the information contradicted prior 
knowledge about the nutrients.  Most mothers tried to rationalise the statements on iron but 
some were unable to make the connection between iron and energy/ muscle as the statements 
contradicted their prior knowledge on iron.  All mothers associated iron with blood 
‘generation’ and/ or blood circulation only. 
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Incomplete explanations of the health effects impacted the perceived clarity of the claim.  The 
shortened claim statement on iron missed the link between iron and energy.  Some mothers 
did not know that iron was involved in carrying oxygen to all parts of the body and the 
function of oxygen in relation to energy: 
‘It only connects me to blood, it doesn’t connect me with energy so it will be question to me.’ 
(O/ S/ 8)  
The Thai mothers expressed reservations regarding the local authority approved claims on 
calcium as they felt calcium also functions to strengthen bones and teeth and not only 
contributed to the formation of healthy bones and teeth.  In addition, the Thai mothers had 
difficulty understanding the authority approved claim statement on iron.   The function of the 
nutrient was unclear, although they did recognise that the claim statement implied blood-
related benefits: 
‘Yes, but I don’t understand the benefits.’ (Y/ T/ 6)    
‘How does it help the body?’ (Y/ T/ 4)    
Most mothers related one nutrient to one function or body organ.  Some Indonesian mothers 
thought the approved claim on Vitamin A was exaggerated and doubted a role or function for 
other organs and systems.  Most mothers agreed with the authority-approved claim statement 
on Vitamin A and thought that Vitamin A was associated with the eyes.  Both Indonesian and 
Singaporean mothers believed the shortened claim statement on Vitamin A, as these mothers 
associated antioxidants with immunity.  The shortened claim statement on Vitamin A did not 
resonate with the Thai mothers.  The Thai mothers were uncertain how antioxidants were 
related to immune system or a reduction in the chances of falling ill.  For all mothers the link 
between vitamin A, carotenoids and antioxidants was unclear and was not explained in the 
focus groups. 
4.8.3 Relevance of the nutrient functions and benefits 
The perceived relevance of the claim statement led the mothers to pay more attention to the 
claim statement.  The mothers in Indonesia viewed the local authority- approved claim 
statement on calcium relevant as it was highlighting two ways through which calcium benefits 
bones and teeth, e.g. bone formation and maintaining bone density.  Most mothers in 
Indonesia and Singapore responded positively to the provision of energy by iron as this could 
support the active children.  The mothers could not relate to specific nutrient functions if they 
felt that the function was irrelevant such as muscles were important for adults, not children:   
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‘For adults I think not for kids. Kids don’t need muscles they need strong bones.’ (O/ S/ 4)  
4.8.4 Lexical issue such as the use of scientific terms and the choice of words 
The presence of scientific terms was a clear barrier.  Most mothers were confused about the 
scientific terms on the local authority- approved claim such as ‘haemoglobin’, ‘antioxidants’, 
‘carotenes’, ‘free radicals’, ‘natural processes of our body system’, ‘integrity of the surface 
layer’.  Some mothers commented that the scientific terms sounded scary. 
‘I think haemoglobin is a medical term.’ (O/ I/ 4) 
The choice of words affected perception.  The Singaporean mothers perceived the local 
authority- approved claim statement as credible due to the use of the scientific terms, despite 
the fact that they did not understand the scientific terms.  Only the mothers in Singapore 
perceived the word ‘make’ in the shortened claim statement on calcium too absolute: 
‘Strong bones and teeth need calcium. Strong bones and teeth doesn’t really make up with 
just calcium so cannot say made up.’ (Y/ S/ 4) 
4.8.5 Phrasing and length of the claim statement  
Phrasing and the length of the claim statements were critical as these factors strongly 
influenced the understanding and the acceptance of the claims.  For example, more lengthy 
claim statements reduced the ability to recall, whereas all mothers recalled the shortened 
claim statements. Mothers in Singapore understood and recalled the local authority-approved 
claim on iron but commented that the statement was too long.  Indonesian mothers had 
difficulty in recalling the local authority-approved claim.   
The Thai mothers found the shortened claim statement on calcium easier to understand and 
the statement communicated on the functions of the nutrient more directly compared with the 
local authority- approved statement: 
‘But they are talking about how to build too. It’s a bit academic.’  (O/ T/ 5) 
The mothers preferred the claim statements which were phrased positively.  The Indonesian 
and Thai mothers preferred the shortened claim statement on Vitamin A as it communicated 
the end benefit clearly, directly and positively.  For example:   ‘Immune system’ was selected 
over ‘falling sick’.  The Thai mothers commented that the local authority-approved claim 
statement on Vitamin A was too generic and the functions/ benefits were unclear, again 
highlighting the lack of understanding of the link between vitamin A, carotenoids and 
antioxidants.   
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4.9 Comparing observations between countries   
In general, most mothers in Singapore were more sceptical about the health claims.  The 
mothers were more individualistic and they focused on the performance of their own children 
to be equally important as the health of their children.  The mothers wanted to know the 
mechanisms underpinning the nutrient functions on claim statements in particular for 
nutrients they were familiar with.   
Mothers in Indonesia were not concerned about health claims as long as their children were 
happy and healthy, which included their emotional and social well-being.  Not all mothers in 
Indonesia knew that there was a regulatory agency to regulate and control food products.  The 
need for special dietary requirements such as halal food helped some mothers to know that the 
National Agency of Drug and Food Control of Republic of Indonesia (BPOM) was an agency 
regulating the food sold in Indonesia for food safety and halal certification.  A majority of the 
Indonesian population (88.3%) are Muslim and food consumed by Muslim consumers need to 
be certified halal to meet the religion needs (Pew Research Centre, 2011).  Indonesian 
mothers perceived that the manufacturers played a similar role as the government in educating 
them on the nutrients listed on the food labels (an educational tool).  
Compared with the participants from Indonesia and Singapore, the Thai mothers recalled the 
most nutrients and health claims and identified medical professionals, nutritionists and 
psychologists as the educators on the nutrition and health claims.  
The Indonesian and Thai mothers were more sociable and willing to share information in the 
discussion groups.  They were motivated to find out information when they came across 
unfamiliar or unclear nutrients.  Most of these mothers suggested that the claim statements 
which stated the functions of the nutrients were more direct and tangible.   
4.10 Discussion  
Health claims can refresh knowledge on specific nutrients and be a useful tool to educate the 
consumers on nutrient– function relationships.  Our study showed that middle-income 
mothers across Indonesia, Singapore and Thailand could recall most of the selected nutrients 
associated with milk powder and the corresponding officially approved health claims.  This 
could be due to the fact that more females generally read food labels, and were more 
awareness of health claims and as mothers they were particularly interested in identifying 
‘healthy’ foods for their children.  This is consistent with several studies which have shown 
that more females than males read food labels and were more favourable towards health 
claims due to their general interest in health (Lalor et al., 2011; Lynam et al., 2011; Nocella 
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and Kennedy, 2012; Wills et al., 2012).  The claims helped to increase their understanding of 
these nutrients.  This corresponds to research in Australia and New Zealand where caregivers 
found health claims information on follow-up formulas and toddler milks useful to identify 
the benefits of one product compared with another (Yockney and Venise, 2013).  A Danish 
study found the consumers were not misled by health and nutrition claims of a food (Orquin 
and Scholderer, 2015).    
The familiarity and previous knowledge of a nutrient, the relevance of the benefits, the use of 
scientific terms, the choice of words, the phrasing and the length of the claim statements all 
influenced the understanding of claim statements among the mothers in the three SEA 
countries included in this study.  Our findings were consistent with several papers reporting 
on consumer perception, attitudes and understanding of health claims in Western countries.   
Familiarity and previous knowledge of the nutrients have been reported to influence the 
understanding of health claims (Nocella and Kennedy, 2012; Lähteenmäki, 2013; Wong et al., 
2014).  This could be explained by the Elaboration Likelihood Model that the consumers 
process information and associate the existing knowledge to rationalise and facilitate 
understanding.  The benefits on the health claims need to be of relevance to the consumers 
and be able to generate interest and motivate them to find out more information to enhance 
understanding.  This study showed that the mothers could relate better on benefits they 
perceived to be important and relevant for their children and were interested to learn more 
new information such as the link between iron and energy which they were unaware of.  
Several reviews papers have highlighted that personal relevance of the nutrients and their 
benefits have a major influence on the perceived healthiness and intention to buy a product 
(Dean et al., 2011; Lähteenmäki, 2013).  A study conducted among Swedish consumers also 
showed that the concerns for family health influenced their decision to read and understand 
health claims (Svederberg and Wendin, 2011). 
Lexical issues such as use of scientific terms and choice of words are one of the factors 
influencing understanding.  Not all consumers have a science background, nor are trained in 
science at tertiary level.  This study demonstrated that the use of scientific terms such as 
haemoglobin, carotenes, antioxidants etc., was clearly a barrier to the understanding of health 
claims.  Others have also shown that scientific terms on claims such as ‘connective tissues’, 
‘platelet aggregation’ were not understood (Richardson and Eggersdorfer, 2015).  This study 
demonstrated that the choice of the words in a claim statement could result in different 
responses from different groups of consumers either positively or negatively.  Nocella and 
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Kennedy (2012) reported that the word ‘may’ received mixed responses from different 
consumers.  Some studies showed that the word ‘may’ reduced consumer confidence in the 
claim and it provided uncertainty on the statement while other studies did not show the effect.  
In contrast, the word ‘can’ was perceived as more credible and definite.  
Short claims potentially improve the understanding of health claims.  Previous research has 
suggested that consumers preferred short, succinct claim statements without scientific 
terminology on the front of the pack and context-specific health claims (Williams, 2005; 
Verbeke et al., 2009).  A study among Irish consumers suggested they had a preference for 
simpler nutrition and health claims such as structure-function and content claims (Lynam et 
al., 2011).  For US consumers, Wills et al. (2009) suggested that health claims should be 
phrased in simpler language as the regulatory process and the level of scientific evidence 
required to approve claims was poorly understood by consumers.  It has been suggested that 
the communication effectiveness of health claims could be improved by the use of visual aids 
such as graphic and concise messaging on a prominent location on the packaging (Geiger, 
1998; Hooker and Teratanavat, 2008).  The nature of the claim statements, the lack of 
education on health claims and/ or overestimate on the consumers’ ability to understand the 
scientific or technical terms negatively affects the understanding of the health claims.  A 
consumer-friendly claim statement should state the functions/ benefits of the nutrient in a 
clear, direct, short and simple language using non-scientific terms to help the consumers make 
informed food choices.   
Our findings could help to close some of the gaps on SEA consumers’ understanding of 
health claims and assist in the development of an action plan involving different stakeholders 
to educate the consumers.  Nutrients include macronutrients such as protein, fat and 
carbohydrate and micronutrients such as vitamins and minerals which are supported by an 
established science which is commonly found and explained in a number of different ways.  
These are mostly obtained from a variety of sources such as school, books, doctors/health 
professionals, and increasingly from the private sector and the internet.  Information on 
nutrients from the public domain could serve as the education platform while information 
from the private sector, such as the food industry, can help to reinforce the messages.  A 
closer collaboration between food industry and government bodies (including regulatory 
bodies) could help to build the understanding and awareness of nutrients and other 
constituents and their associated health benefits.  It is a win-win for the consumers, the 
government and the food industry. This could potentially strengthen the messages and 
information to consumers, preserving the balance between consumer protection and 
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dissemination of emerging knowledge on diet and health.  Other stakeholders such as 
academia, health professionals, consumer organisation could also contribute towards 
educating the consumers.  The education on nutrients should be in a holistic approach to 
include not only the benefit but also any side-effects related to overconsumption of the 
nutrient and in the context of a balanced, varied diet.    
The regulatory bodies and the marketers should take cultures and differences in languages 
into account when developing health claim statements, information and communication 
strategies.  Overall, this study did not find significant differences in the understanding of 
claim statements across the three SEA countries investigated.  This is likely to be due to the 
nature of the nutrients selected for this study which were all well-recognised nutrients.  
However, there were subtle differences in understanding and perceived credibility between 
the countries.  For example, the mothers in Singapore were sceptical on the use of absolute 
words such as ‘make’ and preferred to know the ‘how?’ in the claim statements while the 
mothers from the other two countries did not demonstrate such information needs.  
Previously, age and consumers’ self-confidence in information acquisition were reported to 
contribute towards Singaporeans’ scepticism toward health claims (Tan and Tan, 2007).  In 
contrast, consumer understanding of nutrition and health claims and perception of benefits 
differed substantially by country in a large scale cross national study in Germany, Italy, the 
United Kingdom, the United States (van Trijp and van der Lans, 2007).  In another cross- 
country study conducted in Denmark and the United States, the Danish consumers responded 
more positively towards the soft framing of information while the American consumers 
preferred the scientific framing of information (Aschemann-Witzel and Grunert, 2015).  
Cultural differences in SEA consumers’ response to food and health communication should 
be taken into account as there are different languages and cultures between the ten SEA 
countries.   
Food manufacturers should consider the relevance and appeal of the health motives from the 
perspectives of the target audience, and the claim statements need to be scientifically credible 
to consumers.  This study clearly showed that the mothers perceived that the need for strong 
bones is more relevant to the children instead of strong muscles.  The mothers in Singapore 
believed the claim statements with more complete and scientific information compared with 
the mothers in the other two countries.  Similarly, the focus groups conducted among 35 Irish 
women who were responsible for most of their grocery shopping in their home, found out that 
most participants had a more holistic approach to health and the total intake and the 
consumption of whole fresh foods were much more important and believed there was no 
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individual product which can improve one’s health (Lalor et al., 2011).   The carrier food 
could also have an influence on the mothers’ perception on the credibility of the health claims 
on the milk powder as the mothers had no doubts about most of the claim statements.  Several 
review papers have concluded that the base product or carrier food to which a health claim is 
attached, affects acceptance and is perceived more positively on food products with healthier 
images such as bread, yoghurt, cereals rather than less healthy images such as meat replacers, 
biscuits and ice-cream (Dean et al., 2011; Wills et al., 2012; Lähteenmäki, 2013).    
It is of note that in this study the trust of health claims stemmed from the ‘international brand’ 
manufacturers and the government, although the participants did not know the regulatory 
process and systems related to health claims on food.  Most of the participants in this study 
trusted the health claims they were used to seeing on milk products.  For example, the 
mothers placed high levels of trust in these ‘international brand’ manufacturers providing 
accurate information, perceiving a partnership with the government to provide accurate and 
truthful information.  Similar trends were identified in two studies conducted in Sweden and 
Ireland.  The Swedish study found the lack of understanding of the concepts was 
counterbalanced by confidence in the manufacturers, and/ or the Swedish food legislation 
(Svederberg and Wendin, 2011) while the Irish study found that more than half of the 
participants trusted big food companies to provide accurate information on the products as 
they have the financial ability to conduct research to substantiate claims (Lalor et al., 2011).    
However, some consumers in the Western countries did not trust the health claims (Verbeke 
et al., 2009; Van buul and Brouns, 2015).   
In this study, trust among the mothers in the regulatory process and the government was 
important for both the development of health claims as well as the education of consumers.  
The Japanese Food of Specific Health Use (FOSHU) programme is an interesting example of 
a public-private partnership to disseminate accurate information on ‘health food’ to the 
consumers.  The Japanese National Institute of Health and Nutrition entrusted the training of 
the health professionals on ‘health food’ to the private sectors and the consumers obtained the 
information from professionals.  In addition, a web-based database containing evidence-based 
information on the effectiveness, safety and interactions of ‘health food’ can be publicly 
accessed from the Japanese ministry’s website (Yamada et al., 2008).  This could potentially 
help the consumers to better understand the health claims on food.  
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4.11 Limitation of the study 
Focus group discussions provide a range of perceptions on a phenomenon of interest but caution 
should be taken when extrapolating the findings to the general population as the sample in this 
study is on very specific subgroup of the population.  The local authority- approved claim 
statements varied across the three countries which may have affected our comparison between 
countries.  Also, there might be different understanding and perception of wording of the claim 
statements due to the translations into the different Asian languages.  The participants recruited 
into the study were of middle income and the majority had a higher education level.  In addition 
they were recruited because they said that they read labels and health claims on food packaging.  
Whilst the purpose of the study was not explained to them during the recruitment process it is 
possible that their views were biased by their prior knowledge and may not be representative 
of the general population.  However, we believe that the results have broad applicability and 
form a strong basis for further research in SEA consumers. 
4.12 Implication for public policy 
Although the findings in the focus groups cannot be generalized to the whole population, the 
results may help to indicate directions for future research, particularly in SEA.   This study 
provided insight on factors affecting the understanding of health claims among SEA mothers.  
Our findings are relevant to the different stakeholders such as regulatory bodies, policy makers, 
the food industry, academia and non-profit organisations to develop effective communication 
with consumers.  It is necessary to monitor the consumer attitudes and education on health claim 
especially when the regulatory environment is evolving in SEA.  
4.13 Conclusion 
Food innovation as well as the regulations and/ or guidelines on health claims on food will 
likely continue to evolve in Southeast Asia.   There should be a balance between accurate health 
claims and understanding of them by the consumers.  Different stakeholders should work 
together to develop solutions to improve this understanding.  The high level of trust in the 
government and industry suggests that consumer education efforts via Public - Private 
Partnerships4 could be an approach to develop strategies to educate the Asian consumers to 
learn about and better understand nutrients and other constituents and their different functions.  
This cooperation among the public sector and private industry could potentially address national 
health issues by promoting health in the population, and working jointly on the same goals of 
the health ministries, for example by reducing non-communicable disease in the population.  
                                                 
4 Appropriate safeguards must be in place to ensure no conflict of interest; one such safeguard could be 
governance of this scheme by an independent committee. 
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This could help the government to reduce the healthcare cost (Umegaki, 2015) and achieve 
more efficient use of available resources.    
Health claims on food should help the consumers to make informed food choices to support a 
healthy diet, provided the consumers understand the intended health messages.  The current 
study has identified some gaps, and perhaps some opportunities in the Asian consumers 
understanding of the tested health claims.  This topic is currently under- researched in this 
fast-growing region and more research is needed to investigate SEA consumers’ 
understanding of the health claims.  Future studies could include the participants from a 
greater socio-economic status, investigate the rationale on the high level of the trust in the 
local regulatory authorities among the SEA consumers, understand why mothers do not read 
food labels and have a more consistent methodology to measure the consumer understanding 
on health claims.  This could help the regulators and the marketers to formulate health claims 
that consumers can understand and develop effective public health education and 
communication.   
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Chapter 5 Health Claims in Southeast Asia- Conceptual and Harmonised 
Regulatory framework 
5.1 Executive Summary 
The aim of this chapter is to propose a conceptual and harmonised regulatory framework on 
health claims for foods in SEA to support ASEAN economic integration.  The objectives of 
the framework are to provide a clear and transparent structure which provides confidence for 
the food consumers in health claims, and encourage innovation in the food industry in the 
development of healthy food choices.   This framework looks at the following key aspects 
from the strategies, tools, processes and key actors/ institutions.  The elements of good 
regulatory governance such as clear objectives, transparency, accountability, efficiency, 
effectiveness, responsiveness are also incorporated.  The key features of this framework are as 
followed, 1) introduce communication among the stakeholders at different stages of the 
framework, 2) state explicitly the clear objectives and principles of health claims on the 
regulation, 3) develop clear tools or resources for consistency such as the application forms, 
the guidelines on how to substantiate a health claim which could assist the applicants in the 
application procedure or certain topics, 4) establish an expert committee to provide scientific 
and technical expertise in the evaluation of the applications and identify key actors at the 
various stages with clear roles and responsibilities, 5) make available the regulatory 
documents, the approved health claims and update on regulations on the official governments’ 
or ministries’ webpages, and 6) include a time frame on the outcome of each claim 
application.  The impact of this framework is to promote scientific confidence and public trust 
through engagement with the stakeholder in a transparent manner and private-public 
partnership.  A concerted effort by all stakeholders is the way forward for consumers to 
benefit from credible health claims on food.   
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5.2 Introduction 
Food innovation begins with a food product concept and application of basic food science and 
it will be affected by new technologies, product development, and regulatory feasibility 
before any new product launches.  The Association of Southeast Asian Nations (ASEAN) has 
established the ASEAN Economic Community in 2015 with the aim of regional economic 
integration (Association of Southeast Asian Nations (ASEAN) Secretariat, 2015b).  There is 
inconsistency pertaining to the regulatory structures governing health claims in Southeast 
Asia (SEA) and this could potentially hinder trade across the region (Tan et al., 2015).  The 
aim of this chapter is to propose a conceptual and harmonised regulatory framework on health 
claims for foods in SEA.  The objectives of the framework are to provide a clear and 
transparent structure which provides confidence for the food consumers in health claims, and 
encourage innovation in the food industry in the development of healthy food choices.  The 
purpose of a conceptual and harmonised regulatory framework in this context is to propose a 
roadmap for the development of health claims on food in SEA with relevant structures and 
processes to facilitate health claim substantiation for industry and at the same time protect the 
consumer. 
5.3 Proposed regulatory framework  
An ideal regulatory framework needs to have clear objectives, developed with all relevant 
stakeholders in the society, supported by good science and in line with current international 
and regional regulations.  It needs to be practical and enforceable for the regulatory agencies 
to carry out the work.   This section will propose a regulatory framework for health claims on 
food in the SEA Region as described in Figure 5.1.  This framework will look at the following 
key aspects from the strategies, tools, processes and key actors/ institutions.  The elements of 
good regulatory governance such as clear objectives, transparency, accountability, efficiency, 
effectiveness, responsiveness are incorporated in the framework.  These elements are the 
principles for regulatory quality and performance published by the Organisation of Economic 
Co-operation and Development (OECD) and complement the ASEAN good regulatory 
practices (Organisation of Economic Co-operation and Development, 2005; Jacobzone, 2007; 
Association of Southeast Asian Nations (ASEAN) Secretariat, 2009a; Organisation of 
Economic Co-operation and Development, 2012).   
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Strategies 1.Develop the 
regulation  
2. Prepare the process 3. Establish procedure 4. Substantiate & 
evaluate 
5. Review & monitor 
system 
Description a. Examine existing 
food regulation based 
on Codex 
b. Develop regulation or 
alternatives 
c. Define objectives, 
scope and terminology 
d.Establish principles of 
health claims 
e. Review draft 
regulation against 
International standards 
a.  Identify types of 
application 
b. Decide on nature, 
and requirement of 
application 
c. Form advisory/ 
expert committee 
d. Establish terms of 
reference 
 
a.Establish application 
procedure 
b. Assign appropriate 
staff as secretariat 
c. Identify key contact 
for applicant  
d. Arrange meeting to 
review and evaluate 
application  
a. Develop criteria for 
substantiation of claims 
b.  Evaluate claims 
application and provide 
scientific and technical 
recommendation to 
ministry 
 
a.  Revise and update 
existing regulation  
b. Implement enforcement 
action (depending nature 
of policy) 
 
Tools  - Dialogue with 
stakeholders for public 
comments 
- Decision tree to 
differentiate food and 
drug/ health supplement 
- Application form 
- Guidelines on the 
documents required 
- Consult and 
communicate with the 
stakeholders 
- Clear application 
procedure with timeline 
- Consult and 
communicate with the 
stakeholders 
- Training stakeholders 
- Guidelines to 
substantiate claims 
- Guidance documents 
- Consult and 
communicate with the 
applicant 
- Publish list of approved 
claims on website 
- Consult and 
communicate with the 
stakeholders 
 
Institutions/ 
Key actors  
- Inter- ministries (food, 
public health. 
economic, legal) 
-  Stakeholders 
(industry, consumers, 
academia, interest 
groups) 
- Ministry in-charge of 
food or health  
(depending on the 
country) 
- Expert committee 
- Ministry in-charge of 
food or health  
(depending on the 
country) 
- Expert committee 
- Industry  
- Expert committee 
- Secretariat  
- Industry  
 
- Ministry in-charge of 
food or health  (depending 
on the country) 
- IT support  
 
 
Elements Transparency Accountability Timely Credible, Trust, 
Confidence 
Responsiveness 
Figure 5.1: Conceptual and harmonised regulatory framework on health claim 
Source:  Author constructed  
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The intention of this proposed framework is to address current limitations and aid in moving 
towards a more harmonised approach by identifying similarities and gaps in the systems 
which currently co-exist in Southeast Asia, for application across all the ASEAN nations.  
The best practices observed in major jurisdiction such as Europe, United States, Canada and 
Australia and New Zealand are suggested for inclusion in this framework.  The existing 
regulatory framework for health claims in various Southeast Asian countries such as 
Indonesia, Malaysia, Singapore, Thailand and the harmonised regulatory framework on health 
claims proposed by the International Life Science Institute  (ILSI) Southeast Asia Region 
were taken into consideration when constructing this framework (Ministry of Health 
Malaysia, 2010; Agri-Food & Veterinary Authority, 2010 (with amendments to 2016); 
Ministry of Public Health Thailand, 2011; National Agency of Drug and Food Control of the 
Republic of Indonesia, 2011a; Chan, 2013).  The safety of the food constituent/ product is not 
part of this framework as it is assumed to have been evaluated before any health claim is 
applied for in most SEA countries.   The term ‘regulation’ will be used throughout this 
chapter and it refers to regulations or alternatives such as guidelines and standards.    
5.4 Key features in this proposed framework  
The key features of this framework are to; 
1) introduce communication among the stakeholders at different stages of the framework,  
2) state explicitly the clear objectives and principles of health claims on the regulation,  
3) develop clear tools or resources for consistency such as the application forms, the 
guidelines on how to substantiate a health claim which could assist the applicants in 
the application procedure or certain topics,  
4) establish an expert committee to provide scientific and technical expertise in the 
evaluation of the applications and identify key actors at the various stages with clear 
roles and responsibilities,  
5) make available the regulatory documents, the approved health claims and update on 
regulations on the official governments’ or ministries’ webpages, and  
6) include a time frame on the outcome of each claim application 
5.4.1 Communication with the stakeholders involved in health claims regulation  
(refer to the proposed framework, under Tools for all strategies) 
Communication among the stakeholders involved is essential for any regulatory system to be 
successfully implemented and to benefit the target audience.  This could be conducted via 
mapping out the key stakeholders such as the private sector, academia, interest groups, and 
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lay public to engage in dialogue with them at the different stages of the process.  There are 
various channels of communication to explore and it could be in the form of dialogue 
sessions, seeking public comments and, establishing guidance documents.  For example, the 
Asia roundtable on food innovation for improved nutrition consists of senior representatives 
from government, academia, industry and civil society, and allows the multi-stakeholders to 
exchange views on the role of food innovation  in tackling obesity and chronic diseases (Asia 
roundtable on food innovation for improved nutrition (AROFIIN), n.d.).    
This communication promotes transparency as it provides an insight on whether the 
regulation is clear, practical and meets the intended objectives based on the feedback and 
suggestions received.  It helps to make the regulation more robust with the perspectives from 
different stakeholder involved.  It will indirectly improve awareness and encourage 
compliance towards the regulation as it cultivates the same common understanding of the 
regulation.  An example from Europe is that the European Food Safety Authority (EFSA) has 
conducted several rounds of scientific and technical consultation with the stakeholders on 
health claims on general scientific guidance, related to different health topics such as 
cardiovascular health, gastrointestinal tract, immune system to assist the industry in preparing 
the applications dossier for scientific evaluation (European Food Safety Authority, 2011a; 
European Food Safety Authority, 2016b; European Food Safety Authority, 2016c).  In order 
to protect consumers from misleading claims, EFSA requires that the claims on foods can be 
understood by the consumers (European Food Safety Authority, 2006).  For SEA, it could be 
worthwhile to consider allowing the applicant to present their application to the expert 
committee at the early stage of the application process to clarify any issue or doubts that the 
expert committee might have on the application due to differences in languages and cultures.   
Effectiveness and efficiency of the system will increase when the regulation has clear 
objectives, principles, terminology, scope and regulation, coupled with dialogue with the 
stakeholders on the draft regulation before implementation.   
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Figure 5.2 illustrates the relationship among the key stakeholders involved in health claims 
regulation.  There are also other stakeholders such as policymakers, key opinion leaders, 
academia, scientific institutions and various interest groups involved in health claims 
regulation.  
 
 
 
 
 
 
 
 
 
Figure 5.2: Relationship between the key stakeholders involved in health claims 
regulation   
5.4.2 Clear objectives of the regulation 
(refer to the proposed framework, under Strategy 1 develop the regulation, Description point 
1c & 1d) 
Clear objectives of the regulation and principles of health claims should be stated explicitly as 
they form the key fundamentals of the regulation.  These fundamentals will serve as a guide 
for all the stakeholders to align the understanding and mindset of the regulation and affect the 
implementation and enforcement of the regulation.  The clear objectives for the regulatory 
framework should be to protect consumers, promote public health, facilitate trade or stimulate 
innovation and research (European Food Safety Authority, 2006; United States Food and 
Drug Adminstration, 2009; Health Canada, 2015; Food Standards Australia and New Zealand, 
2016b).  The principles of health claims should be clear, truthful, scientifically substantiated, 
non-misleading and do not imply to prevent, cure, treat a disease(s) which is aligned with 
International Standards such as Codex Alimentarius (Codex Alimentarius, 1997 (last 
amended in 2013).    
The definition of technical terms and the scope of the regulation have to be clearly defined to 
help the applicant understand what information needs to be submitted and when.  The 
definitions have to align with the international and regional regulations or standards to 
Science & 
Technology 
Development  
Bridge the gap between policy and science 
Consumers 
Regulators Food industry 
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facilitate the trade.  The scope of the regulation should provide the applicant an idea on the 
boundary and the types of materials which required to be submitted for regulatory approval or 
how to apply the approved health claim.   
5.4.3 Develop resources for consistency 
(refer to the proposed framework, under Tools at Strategy 2, 3, 4) 
Resources such as the application form, guidelines on the evidence required for scientific 
substantiation, guidance documents on the application or certain health topics, are good tools 
to guide the applicant when applying for new health claims.  These resources provide 
consistency on the information required and they save time for the regulators from answering 
the same questions from the interested applicants. This probably explains why most of the 
major jurisdictions such as the European Union, United States, Canada, Australia and New 
Zealand have established application forms and/ or published guidance papers and frequently 
asked questions on their official websites (Health Canada, 2009; United States Food and Drug 
Adminstration, 2009; European Food Safety Authority, 2016b; European Food Safety 
Authority, 2016c; Food Standards Australia and New Zealand, 2016b).  The guidance papers 
from the EFSA and Health Canada provide the industry with insights on the application such 
as examples of ‘specific’ health claims and ‘vague’ health claims, factors affecting the 
outcome of the scientific evaluation like bias in the studies, relevance and appropriateness of 
the target group (Health Canada, 2015; European Food Safety Authority, 2016b).   The 
industry professionals would then be able to understand the current thinking of the regulators 
and expert committee and the critical points in each application to help them in preparing an 
application dossier with required information for submission.  It is vital to have the date- 
marking on the documents to help identify the updated documents to use.  This helps the 
interested parties identify the updated information as the regulatory environment on health 
claims evolves rapidly.     
5.4.4 Scientific substantiation of health claims  
(refer to the proposed framework, under Strategy 4 Substantiation and Evaluation) 
Scientific substantiation has been highlighted as a key element for all health claim 
evaluations.  In principle, the application needs to answer these following basic questions:   
1) What food constituent is added?,  
2) What is the proposed benefit of the food constituent?,  
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3) Who is the target audience?,  
4) How much of ‘the food constituent’ was added and needs to be consumed, in order to have 
the proposed health benefit?,  
5) Can the cause-effect health relationship be scientifically substantiated, preferably by 
human studies?,  
6) Are the studies relating to the proposed ingredient and its effects of high quality and 
published in peer-reviewed journals?,  
7) Are the outcomes of the total available studies consistent?,  
High quality studies generally evaluate the factors such as i) study design and methodology, 
ii) appropriate number of, and relevant subjects, iii) availability of control group, iv) 
appropriate duration of exposure, v) generally recognised biomarkers and/ or surrogate 
endpoints, vi) consumption of food/ constituent consistent with the studies of appropriate 
dosage, vi) effect of food matrix and dietary context has been considered, vii) have obtained 
ethical and other approval such as registration with appropriate agencies ie. US Clinical 
Trial.gov, International Standard Randomised Controlled Trial Number (ISRCTN) and viii) 
are appropriately statistically powered.  
Wider scope and different level of scientific evidence can be considered to be accepted for 
scientific substantiation for health claims.  The Codex Alimentarius classifies health claims 
into three types; nutrient function claims, other function claims and reduction of disease risk 
claims (Codex Alimentarius, 1997 (last amended in 2013).  Different types of health claims 
could require different levels of scientific evidence.  For instance, reduction of disease risk 
claims are generally considered high level claims as they are linked to diseases. Therefore 
these require to be substantiated by more rigorous types of evidence such as human 
intervention studies while human observation studies are accepted for substantiation of other 
function claims.   This approach could address one of the biggest challenges faced by the food 
industry and nutrition scientists.  Unlike drug trials, there are a number of difficulties in 
conducting food-based human intervention trials such as ethical issues, identify the specific 
benefits linked to specific nutrients/ food constituent since food contains many nutrients 
(Tapsell, 2008; Aggett et al., 2012; Richardson, 2012).   Authoritative reference texts, 
scientific opinion from scientific organisation and regulatory authorities, scientific review and 
documented history of use are valuable information that should be considered as supporting 
evidence for some types of health claims instead of relying on human intervention studies 
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alone for all types of health claims.   The evidence required to support different types of 
health claims (refer to Figure 5.3) published in the ASEAN guidelines on claims and claims 
substantiation for health supplements, could be a good reference point (Health Sciences 
Authority of Republic of Singapore, 2015).  The definition of health claims in these ASEAN 
guidelines follows the same as the Codex Alimentarius guidelines on nutrition and health 
claims.  
 
Figure 5.3:  Evidence required to support the different types of Health Supplement 
claims          
Source: adapted from ASEAN Guidelines on Claims and Claims Substantiation for Health 
Supplements (Health Sciences Authority of Republic of Singapore, 2015) 
A decision tree on how to classify food and health product can be developed to assist in 
differentiating food and health products as food innovation is advancing rapidly.  Some SEA 
regulators had encountered difficulties in categorizing claims between foods and drugs when 
they were being interviewed in this research (refer to earlier chapter 3 of this thesis).  For 
A proposed health supplement claim
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nutritional Claims
Substantiation evidence
At least 1 of the 
following evidence (as 
determine by the 
regulatory authority 
of each member 
state):
- Authoritative 
reference texts
- Scientific opinion 
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organisations
- Documented history 
of use 
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At least 1 compulsory 
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authority of each 
member state):
- Good quality human 
study
- Authoritative reference 
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- Scientific opinion from 
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instance, a drink containing Coenzyme 10 could be considered either as a food or a health 
product.   The form in which the product is being consumed such as tablet, drink, the nature 
of constituent added to it and the benefit claimed are some factors used for comparison 
between food and health products.  Notably, the words used in the health claims on food 
should not imply therapeutic claims linked to prevention, treatment or cure of a disease or 
illness.  Food authorities in Canada and Singapore considered several factors to identify food 
and natural health products (Health Canada, 2015).  Health Canada considered the factors 
such as product composition, product representation, product format and perception of history 
and use.   While in Singapore, the classification tree between food and health products jointly 
developed by two regulatory agencies which regulate medicinal health products and food such 
as Singapore Health Sciences Authority and Agri-food Veterinary Authority respectively, 
considered the role of the product as part of a diet or supplement, product presentation or 
format and restriction on the dosage to consume (Health Sciences Authority of Republic of 
Singapore, n.d.)).   The expert committee established in evaluation of health claims, could be 
consulted to provide different perspectives and assessment in this matter.      
5.4.5 Establish expert committee to provide scientific and technical expertise  
 (refer to the proposed framework, under Stage 2 Prepare the process, Description point 2c 
and 2d) 
The members in the expert committee play an important role to provide scientific and 
technical expertise on the application.  The regulatory agency of each SEA country should 
appoint the panel of experts in this committee and these experts should be independent from 
the regulatory agency.  This panel should represent the different stakeholders involved such as 
the different ministries, food regulators (pre-market approval and enforcement), public health 
policymakers, food industry associations, academia, scientific institutions, consumer groups 
and should be composed of people with multi-disciplinary skills and expertise such as 
nutrition, toxicology, risk assessment, public health, communication to provide holistic and 
comprehensive evaluation of the different health claims applications.   To further increase the 
scientific confidence and credibility in the assessment of new health claims, co-opting experts 
of the certain discipline on an ad-hoc basis depending on the nature of the health claim 
application is a valuable alternative.  For instance, if a person has been detected to have heart 
problem, they will be referred to consult a heart specialist or cardiologist for further 
investigation.  There are many different specialities in medical and nutrition- related fields 
which could be represented in this way.   
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The terms of reference of the expert committee need to be established so the members know 
their roles and responsibilities.  This provides a guide to the applicant on ‘who is doing what’ 
and who to approach when they apply for health claims.   In most existing frameworks such 
as Europe, Australia and New Zealand, Indonesia, Malaysia and Singapore, the expert 
committee evaluates the science and make recommendation to the regulatory agency 
(National Agency of Drug and Food Control of the Republic of Indonesia, 2011a; Eksan, 
2015; Food Standards Australia and New Zealand, 2015b; Neo, 2015; European Food Safety 
Authority, 2016b).  The regulatory agency makes the final decision to adopt the 
recommendation from the expert committee and approve the application.   
5.4.6 Make available the information such as the approved claims and update on 
regulations  
(indicated in all strategies on the proposed framework)  
Transparency can be improved when information is readily available.  The provision of these 
documents helps the stakeholders to be connected with the development of the subject and 
provide feedback or concerns.  Transparency provides an insight on the current thinking and 
opinions on the subject matters for the stakeholders. The consumers can better understand and 
trust the list of approved health claims which have undergone rigorous scientific assessment 
by the regulatory agency to protect their interest.   The food industry should be informed on 
the development on the regulation and receive updates on recent health claims.  The food 
industry and researchers are aware of how to plan their research to be able to communicate to 
the consumers accurately.  A good example to illustrate the current thinking of the regulatory 
agency is the Guidance for industry on the evidence-based review system for the scientific 
evaluation of health claims published by United States Food and Drug Administration (2009) 
that contained non-legal binding recommendation which covered the legal implication 
(United States Food and Drug Adminstration, 2009).  This is also an effective channel of 
communication and engagement with the stakeholders.  At present, most of the information 
on health claim in SEA is not readily available on the internet.   
5.4.7 Time frame on the outcome of each claim application  
(refer to the proposed framework, under Stage 3 establish procedure) 
A system without a definite time frame would pose challenges to the stakeholders in the food 
industry.  It is also an indicator on the quality of the system in terms of efficiency and 
effectiveness.   Time is extremely critical for the food industry as there is a need to develop a 
detailed plan with timeline before a new product is launched in the marketplace for the 
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consumers.   The new product needs to be relevant to meet the current consumer needs when 
it is launched and the food industry needs to manage all the other issues such as research and 
development, supply chain, production, regulatory approval.  Hence a time frame will provide 
an idea to the applicant whether the new product with the new health claim can be launched in 
time or to terminate the idea to have new health claim.  The time required for health claim 
application could either encourage food innovation and research or hinder and dampen it if 
the timing were perceived to be unachievable to have a new health claim.  Having no time 
frame indicated in the application procedure has the potential to breed stagnation. 
Figure 5.4 illustrates an application procedure with a time frame of 6- 9 months for the 
applicant to know the outcome of the application and the key actors at each stage indicated on 
the procedure.  It is developed based on the existing procedures and the average time frame in 
selected Southeast Asia countries such as Indonesia and Singapore.  The Indonesian 
regulation stated that a maximum time frame of 6 months is required for new health claim 
applications to be processed (National Agency of Drug and Food Control of the Republic of 
Indonesia, 2011a) and the Singapore regulatory agency took around 9 months to complete the 
system depending on the complexity of the claims and turn-around time by advisory members 
(Neo, 2015).   The information on the time frame for health claims application was 
unavailable for Malaysia and Thailand while the other SEA countries do not have processes 
on health claims application. 
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Actors Submission Evaluation Outcome
Applicant
Ministry at 
individual 
country
Expert
committee 
Ministry at 
individual 
country
Complete 
info
Screen and check 
completeness
Evaluate
15 days
Meet criteria 
based on 
substantiation 
of evidence
Prepare & 
submit petition
Questions
(face-to-
face/ 
email)
Yes 
No 
Publish approved 
claim
estimate 6-9 
months
Meet and 
discuss 
Can write in to 
reconsider claim 
Not well-documented claim 
with reasons for reject
No
Yes
Yes
Well- documented 
Claim
Approve by 
regulatory 
agency
No
 
Figure 5.4: Proposed application procedure      
Source:  Author’s construction  
5.4.8 Review and monitor the system 
(refer to the proposed framework, under Strategy 5 review and monitor of system) 
The review of health claims regulations are good initiatives to ensure the intended objectives 
of the regulation and the interest of the stakeholders are met.  The ability to respond to 
societal changes and the willingness to re-examine the existing policies, institutions or 
procedures is important to protect the general public interest with the rapid changes in the 
demographic and health trends in the society.  For example, there is a need for consumers to 
obtain the sufficient information to assist them in making food choices to support healthy diet.  
Consumers are getting more health-conscious due to the increase in diet-related chronic 
diseases, and the shift towards an aging population (Kearney, 2010; Baroke, 2014; Futures 
Centre, 2014).  More innovative, healthier food products with health claims have been 
actively developed by the food industry.  Thereby it is important to protect the consumers 
from over-claimed or unsubstantiated health claims in food products and provide consumer 
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confidence on the food sold in the country.  This approach achieves a secondary purpose, in 
that it facilitates a level playing field for the industry, provided that the regulation (from 
conception till implementation) had had open consultation with the stakeholders involved.  
The system needs to be reviewed periodically to make sure it remains relevant and responsive 
to the current and anticipated trend of the society.  The OECD recommends for each member 
country to appoint a specialised department or group of experts in each line ministry and 
regulatory institution to conduct regulatory impact analysis (OECD, 2008; Jacobzone, 2007).  
This aims to evaluate the effectiveness and efficiency of the existing regulation.  For example, 
Australia has already established the Office of Best Practice Regulation to assist the regulators 
in assessing the regulations (Asia Pacific Economic Co-operation Secretariat; 2010).  
5.4.9 Integration of the regulation  
(refer to the proposed framework, under Strategy 1 develop the regulation, description point 
1e.) 
The regulations or guidelines should be developed, in a manner that is consistent with the 
other regulations and policies in the country, and aligned with International Standards.  The 
ASEAN Good Regulatory Practice (2009) recommends ‘the regulation to be based on 
international or national standards that are harmonised in international standards, except 
where legitimate reasons for deviations exists’ to be least trade restrictive.  The standards 
from Codex Alimentarius, an body established by Food and Agriculture Organisation and 
World Health Organisation is a good reference point when developing regulations (Codex 
Alimentarius, n.d.).   The World Trade Organisation recognises standards from Codex 
Alimentarius (World Trade Organisation, n.d.-b).   The regulations from major jurisdictions 
such as Europe, Canada, Australia and New Zealand and most of Southeast Asia countries 
such as Indonesia, Malaysia, Singapore share similarities with the standards on health claims 
by Codex Alimentarius.   
5.5 Discussion  
The development of health claims regulatory framework in SEA has come a long way and has 
progressed rapidly in the last few years.  SEA countries such as Indonesia, Malaysia, 
Singapore, Thailand and Vietnam have established regulatory frameworks on health claims on 
food to ensure claims are truthful and non-misleading, although there is different regulatory 
development among the ten ASEAN countries.  The regulatory systems in these countries 
differ considerably.  The key features of the proposed regulatory framework that could 
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address the differences among the health claim systems in SEA5.  Firstly, the clarity in the 
regulation is fundamental.  It can be achieved by having clear purpose and objectives of the 
regulation with working principles.  This will align the mindset of all stakeholders involved 
such as the industry, academia and regulators and facilitate working together for the same 
purpose such as to benefit the consumers, facilitate trade and / or support innovation.  
Secondly, the communication and consultation with the stakeholders is essential for 
transparency.   Consultation with different stakeholders, including private sectors and 
institutions can help to identify potential issues at the earlier stage of the regulation and 
develop possible solutions which are aligned with the interest of the stakeholders.   There are 
many channels of communication among the stakeholders which can be achieved across the 
different groups such as the regulators, experts, food industry and consumer groups at a 
national level.  The different groups will disseminate the information within this group 
through working groups, advisory groups that are set up at national and regional level. For 
instance, the establishment of the Food Industry Asia (FIA) allow the food companies based 
in Asia to share information and discuss common issues faced (Food Industry Asia (FIA), 
n.d.).  The formation of business advisory groups comprised of small-medium enterprises can 
be a way to reach out to this sector of food manufacturers to increase awareness and gather 
feedback on new regulations.  Most of the time, the small-medium enterprises are greatly 
affected when new regulations are implemented as they are either unaware or have not reacted 
to meet the regulation.  A phase- in time of a minimum six months should be in place before 
the full implementation of the regulations and standards (Association of Southeast Asia 
Nations Secretariat, 2009).  This would allow time for the regulators and the industry to adapt 
to the new regulation, provided the regulations and relevant documents are publicly available.     
To achieve the ASEAN Economic Community (AEC), there is a need for communication at a 
regional level.  The existing Prepared Foodstuff Product Working group under ASEAN 
Consultative Committee on Standards and Quality (ACCSQ) can be leveraged as a platform 
for the ASEAN regulators to discuss on health claims on food and relevant regulations.  A 
regional ASEAN expert committee such as the ASEAN Committee on Science and 
Technology can be asked to facilitate the sharing of expertise across the SEA region.   Due to 
the different languages used in SEA, the ASEAN website can be used as a contact point to 
direct the interested parties to the official government websites in SEA and obtain the English 
version of the regulations and relevant documents issued by the regulatory agencies in the 
various SEA countries.  This ASEAN or Asia Pacific Economic Co-operation (APEC) 
                                                 
5 Roadmap/ framework to adopt at national level, then at the ASEAN level. 
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secretariat should lead on the development of this website as it will potentially increase trade 
within the ASEAN region which align with the aim of AEC.  Each country can learn and 
adapt the best practices on health claims in major jurisdiction such as Europe, United States, 
Canada, Australia and New Zealand and related industries such as the pharmaceutical, health 
supplement instead of reinventing the system.  The best practices include consulting 
stakeholders, making available regulations and relevant documents, guidance papers on the 
key critical point for each application, clear processes, and requirements for scientific 
substantiation.  This could optimise the existing resources available for health claims 
administration as regulatory agencies might have other priorities.  A key area of discussion is 
to identify the current best practices which can best fit to be adapted in SEA. The legal aspect 
of the regulation or alternatives has to be considered.  The implementation which could be in 
the form of regulation or regulatory alternatives such as co-regulation, quasi-regulations such 
as standards, guidelines or code of practices or self-regulations such as code of conducts 
provides flexibility to the regulators, policymakers depending on how the country would like 
to deal with the issue (Asia Pacific Economic Co-operation Secretariat, 2010).  The country 
needs to consider how the regulation or alternative could influence the enforcement actions to 
be taken.  For example, can enforcement action be taken if there is non-compliance observed, 
but the guidelines are not legally binding?         
A Public- Private Partnership should be considered to ensure that the health claims process 
works.  The food industry can be a valuable partner to the regulators in contributing to the 
system.  It is imperative to engage with the food industry at all different stages through fora, 
roundtable discussions or dialogue sessions.  The academic partners or research institutions 
such as Institute of Southeast Asian Studies (ISEAS)- Yusof Ishak Institute or ASEAN 
studies centre could help in drafting the guidance papers or even start with frequently asked 
questions to aid the process. Implementation of a regulation and framework is only a starting 
point.  The system need to be reviewed on an agreed basis to make sure it is still relevant and 
workable.  Educating the systems to all the stakeholders is equally important as educating 
health claims to the consumers.  Capacity building and training of the relevant key personnel 
and enforcement agencies involved could be made available to carry out the process smoothly 
and consistently.  It is the responsibility of the local food regulatory body to do so.  Although 
this framework does not cover education of health claims to the consumers, this aspect should 
also be addressed jointly with the different ministries such as health, education and with the 
industry partners.  Figure 5.5  summarises the next steps in which movement towards 
standardisation can be achieved (as presented in the discussion).  
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Aim: Conceptual & harmonised regulatory framework on health claims  
on food for SEA6 
  
Strategy: Clarity in regulations Stakeholder engagement 
  
Action 
plan:  
- Have clear purpose and  objectives  
- Working principles 
- Phrase-in time before implement 
- Consider the legal aspect 
- Decide on types of regulations and 
alternatives 
- Identify the Best Practices from 
major jurisdictions that ‘best-fit’ 
for ASEAN 
 
- Communicate and consult via 
various channels  such as fora, 
business groups, ASEAN ACCSQ 
- Educate stakeholders  on systems 
- Capacity-building and training for 
enforcement 
- Partner with academic / research 
institutes to develop guidance 
documents, and cross-ministries 
with industry to educate health 
claims to consumers 
- Develop ASEAN website with 
consolidated relevant regulations 
and guidance documents 
  
Rationale: - Align mindset of all stakeholders 
- Affect enforcement actions 
- Optimise existing resources 
- Achieve a transparent, relevant, 
workable system 
- Align interests among stakeholders 
  
Outcome: Scientific confidence and public trust through engagement in a transparent 
manner and private-public partnership 
 
Figure 5.5:  Summary diagram on the next steps in which movement towards 
standardisation can be achieved 
5.6 Conclusion and future perspectives  
The proposed regulatory framework on health claims in this chapter emphasizes the processes 
needed when working towards a harmonised approach.  A harmonised regulatory framework 
in this context does not mean harmonised regulations in SEA.  This harmonised regulatory 
framework provides a concept for discussion among the regulatory agencies in SEA.  The 
food industry still needs to apply health claims in each SEA country as the charter for 
ASEAN states that each Southeast Asia nation has its national sovereignty (Association of 
Southeast Asian Nations (ASEAN) Secretariat, 2008).  This framework could ignite more 
discussion on this topic and could be used it as a reference for the rest of the Southeast Asian 
countries which do not have existing health claim regulatory frameworks.  Health claims on 
food might not be a priority at present in all countries as Southeast Asian countries are still 
                                                 
6 Prepared Foodstuff Product Working Group under ASEAN Consultative Committee on Standards and Quality 
(ACCSQ-PFPWG) 
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grappling with food safety and more general labelling issues.  Discussion on health claims can 
be initiated gradually starting from now as regulations take time to develop.  ASEAN 
platform is the most suitable platform to further discuss this topic in working towards 
achieving the aim of ASEAN Economic Community. 
A regulatory framework on health claims serves as a guide to protect consumers, support 
research and product innovation and facilitate fair trade.   The impact of this framework is to 
promote scientific confidence and public trust through engagement with the stakeholder in a 
transparent manner and private-public partnership.  A concerted effort by all stakeholders is 
the way forward for consumers to benefit from credible health claims on food.  Ultimately, 
health claims on food products aim to assist the consumers to make informed food choices for 
a healthful diet.    
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Chapter 6 Conclusion and recommendation 
This research is a study in the topic of health claims on food in SEA which are likely to have 
a significant impact on health, trade, innovation and is currently under-researched.  Health 
claims on food have potential to impact not only on one’s health, but they influence many 
areas including research, innovation, public health policy, legal policy, trade and economics 
in a wider perspective.  This final chapter concludes this thesis by providing an overview of 
the research carried out with the main findings of the research summarised in three key points.  
Prediction of the future developments of health claims regulations/ guidelines on food 
products in SEA are discussed.  Recommendations for future research and limitations of the 
study are included.  The contribution and concluding thoughts of this research are highlighted 
and reflected upon to summarise the findings from this research. 
6.1 Background information  
Health claims on food products facilitate communication of nutritional benefit of high-value 
specialist food products for the food industry.  The food industry needs to generate evidence 
to substantiate health claims for regulatory approval from most countries, in order to be able 
to communicate health benefit of a product or a nutrient/ ingredient to the consumers.  
ASEAN aims to achieve free movement of goods under the ASEAN Economic Community 
by 2015. There is a need to understand the regulatory frameworks for food products with 
health claims to be sold in various ASEAN countries.   
According to Codex Alimentarius, health claims on food products are a tool to help 
consumers make informed food choices.  The different stakeholder such as regulatory bodies, 
food industry has invested resources to make health claims available to the consumers.  To 
date, there are no data on whether Asian consumers understand health claims. Most consumer 
studies on health claims are conducted in Western countries.  It would be useful to know 
whether health claims on food products are reaching out or benefiting the Asian consumers.   
6.2 Research aims and objectives 
The research topic is on the health claims on food products in SEA, with the aim of having a 
clear situation awareness of how the information flow through the existing regulatory 
frameworks in SEA effectively communicates understanding to the consumers.  To achieve 
this aim, the existing regulatory frameworks of health claims on food products in SEA and 
from the major jurisdictions such as European Union, United States, Australia and New 
Zealand were reviewed; the practices and perspectives were elicited from the stakeholders 
with professional interests in health claims; and as a counter-balance of viewpoints, the 
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perspectives of Asian mothers’ understanding of health claims as well as their understanding 
of the regulatory settings of the local regulatory frameworks were explored.   
The stakeholders identified in this research, play an important role in helping the consumers 
to make informed food choices through using health claims.  The stakeholders were grouped 
into different clusters; based on the work flow of the health claim application process and the 
end users of health claims.  These range from the representatives from the food association 
filing in the application, to the regulators involved in the administration, to the key opinion 
leaders, policy makers, and representatives from scientific organisation involved in the 
evaluation of health claims in the country, and last but not least, to consumers represented by 
the Asian mothers.   
Two key research questions guided the collection of the data and perspectives from the 
different clusters of stakeholders; ‘how are health claims on food products in SEA 
substantiated and evaluated in SEA?’; and ‘Do the Asian consumers’ understand health 
claims?’. 
6.3 Main findings 
The findings of this research can be summarised in three key points; namely 1) variations in 
the existing regulatory frameworks and the perspectives of the stakeholders, 2) building 
bridges of communication and 3) consumer education effort via public and private 
partnerships.  The conceptual, harmonised regulatory framework for health claims (as 
proposed in chapter 5) could create opportunities to close the gaps found in the existing 
systems in the SEA.  
6.3.1 Variations in the existing regulatory frameworks and the perspectives of the 
stakeholders 
The differences identified across countries in this study, fall into three categories, starting 
from the SEA countries with or without the health claim regulations/ guidelines, followed by 
the details listed in the health claim regulation/ guidelines, and finally the perspectives on the 
challenges faced by the different clusters of stakeholders. 
Firstly, the regulation / guidelines of health claims are at different stages among the ten SEA 
countries.  There are six of the ASEAN countries Indonesia, Malaysia, Singapore, the 
Philippines, Thailand and Vietnam with health claims regulations/ guidelines whereas the 
other four ASEAN countries do not currently have regulations.  This could be due to the 
different levels of economic development of each SEA country.  Figure 6.1 illustrates the 
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status of the health claims regulations in the 10 SEA countries under ASEAN according to the 
perspective of the author. 
 
 
 
 
 
 
 
 
 
Figure 6.1:  Status of health claims regulations/ guidelines in the 10 SEA countries 
Source:  Author’s personal construction drawing based on the existing literature on health 
claims regulations in SEA and previous work experiences when managing the regulatory 
issues in the countries (Ministry of Health Malaysia (2010); National Agency of Drug and 
Food Control of the Republic of Indonesia (2011a); Agri-Food & Veterinary Authority (2010 
(with amendments to 2016)); Agri-Food and Veterinary Authority of Singapore (n.d.-b); 
Ministry of Public Health Thailand (2011); Ministry of Health Vietnam (2014)) 
Secondly, the regulations/ guidelines on health claims that currently co-exist in SEA, had 
some areas of convergence and divergence (as explained in Chapter 2).  The areas of 
convergence among SEA countries with health claims regulations/ and guidelines include the 
establishment of an expert committee in each SEA country to evaluate health claim 
applications, publication of a list of approved health claims permitted in each SEA country 
and the requirement on the approval status of the health claims from the major jurisdictions in 
each application.  On the other hand, the areas that diverge in the health claims regulations/ 
guidelines among the SEA countries are unclear scope, objectives and principles in health 
claims regulations/ guidelines, inconsistencies on types and amount of evidence required for 
health claim substantiation, and different languages used on the health claims in different 
SEA countries.   
Thirdly, the semi-structured interviews conducted in this study draw a distinction between the 
perspectives on the challenges faced by the stakeholders among the different clusters (as 
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described in Chapter 3).  In this study, the regulators faced difficulties in differentiating health 
claims and medical claims in more complex applications as well as allowing more compelling 
health claims and flexibility of rewording approved claims for commercial viability, while 
most key opinion leaders commented they could not evaluate new health claim applications as 
the applications were ill-prepared and lacked strong evidence to substantiate the claimed 
benefits.  Apparently, some regulators and key opinion leaders had different expectations on 
the robustness and rigor of scientific evidence depending on the types of health claims 
submitted.  The representatives from the food association consistently raised the rigorous, 
pharmaceutical approach to substantiate health claims for food, which they described as being 
challenging for the industry to achieve.  Their view was that food was not a drug, and that 
scientific evidence should not stringently follow the pharmaceutical standards which are 
considered relevant for treatment in medical-concerned population.  Clearly the differing 
viewpoints outlined by this study could potentially affect the availability of health claims on 
food for the consumers.   
The different perspectives and viewpoints shared by the clusters of stakeholders could have 
resulted from the different professional training and/ or field of expertise, and job 
responsibilities of the stakeholders, and not their individual competencies.  All of the 
interviewees were scientifically-trained and had extensive experience in their field.  The 
differing perspectives from the stakeholders could be contrasted with differing professional 
approaches, for example when a medical doctor will look at heart disease from the 
perspectives of diagnosis and treating the disease, a dietitian will look at the dietary intake to 
manage the risk of the disease and a country’s health minister will look at the prevalence and 
implications of heart disease in order to reduce the national healthcare cost.  The different 
ways of looking at an issue could be due to years of their specialist training that mould the 
thoughts to function in a certain manner, and their job responsibilities to perform certain 
expected tasks.  Hence it is understandable that there are different perspectives among the 
different clusters of stakeholders as the key objective of the regulators is to protect consumers 
from being misled, while the key opinion leaders need to uphold the highest scientific 
standards and the food industry has to provide a solution to satisfy the need and wants of the 
consumers.   
In a positive light, there was similar current thinking and issues about this topic among the 
stakeholders across the SEA in Chapter 3.  These issues include the factors affecting the 
approval of new health claims applications such as the common errors which occur in health 
claim applications, or having a coherent opinion on the objectives and principles of health 
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claims, using the guidelines established by Codex as a basis to evaluate new health claims and 
the challenges faced by the different clusters of stakeholders.  These commonalities create 
opportunities to narrow the variations in the existing regulatory frameworks and perspectives 
of the stakeholders in SEA.  All forms of communication among the stakeholders such as 
dialogue sessions or availability of guidance documents to apply health claim, are necessary 
to pave the way for the development of health claims in SEA.   
Table 6.1 summarises the commonalities and divergences found in the regulations/ guidelines 
(Chapter 2) and the current practices and perspectives on the health claims administration 
among the key stakeholders in SEA (Chapter 3). 
Topic Commonalities Divergences 
Regulatory 
frameworks on 
health claims 
 List of approved claims 
 Expert committee to evaluate 
health claim applications 
 Regulatory status/ approval of 
health claim application issued 
by national/ international 
bodies 
 Different definitions, scopes, 
objectives  
 Principles of health claim 
 Languages used 
 Inconsistent types and amount 
of evidence for substantiation 
 
Current 
practices and 
perspectives 
from key 
stakeholders 
 Congruent opinion on the 
objectives and principles of 
health claims 
 Codex as basis for evaluate 
new application 
 Similar criteria applied when 
evaluate claims such as quality 
of studies, human intervention 
studies, proposed wording, 
condition of use, totality of 
evidence, approval of health 
claim by issued by national/ 
international bodies 
 Comprehensiveness of data, 
common errors such as ill-
prepared dossiers, outdated 
data, availability of experts 
affect approval 
 Request for local data  
 Different development in health 
claims regulations/ guidelines 
 Expectation on scientific 
substantiation depending on 
types of claims 
 Time for approval process 
 Challenges faced by the clusters 
of key stakeholders 
    Regulators/ Policymakers:  
- Differentiate health claims and   
medical claims 
- Allow compelling/ flexibility in 
health claims 
    Key opinion leaders:  
- Difficulty in evaluating health 
claim applications 
 Representatives from food 
associations:  
- Challenging to meet the 
pharmaceutical-like approach to 
support applications  
- Difficult to understand the 
rejection of claim applications 
 
Table 6.1: Summary on commonalities and divergences in the regulatory frameworks 
and current practices and perspectives from the key stakeholders in SEA 
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6.3.2 Building bridges of communication  
Bridges of communication should be built to help the different stakeholders better understand 
the perspectives from one another.  More regular, open communication and collaboration 
among the stakeholders should take place in different forms such as roundtable discussions, 
public consultation on draft regulations/ guidelines etc.  The flow of exchange includes 
vertical communication among the individual cluster of stakeholders and horizontal 
communication between the different clusters of stakeholders.  Sharing the common issues 
and viewpoints such as the objectives and principles of health claims, the expectations of a 
well-prepared dossier (in Chapter 3) explicitly can be a starting point for this information 
exchange.  Insight on the current thinking of the different stakeholders would be provided 
through the different platforms e.g. guidance documents, meetings with the different clusters 
of stakeholders etc.  Potential solutions could be developed with the knowledge of the 
different issues under discussion and engaging the stakeholders involved to discuss the issues.  
More trust and development of partnership among the stakeholders could be established 
during the process.   
The proposed harmonised regulatory framework in Chapter 5 provides suggestions on the 
approaches to bridge the gaps identified on the different regulatory frameworks on health 
claims that currently co-exist in SEA.  This conceptual regulatory framework contains the 
elements of good regulatory governance such as clear objectives, transparency, accountability, 
efficiency, effectiveness, responsiveness.  In addition, the proposed framework looks at the 
following key aspects from the strategies, tools, processes and key actors/ institutions.  The 
key features of the framework include 1) introduce communication among the stakeholders at 
different stages of the framework, 2) state explicitly the clear objectives and principles of 
health claims on the regulation, 3) develop clear tools or resources for consistency such as the 
application forms, the guidelines on how to substantiate health claim which could assist the 
applicants on the application procedure or certain topics, 4) establish expert committees to 
provide scientific and technical expertise in the evaluation of applications and identify key 
actors at the various stages with clear roles and responsibilities, 5)  make available the 
regulatory documents, the approved health claims and update on regulations on the official 
governments or ministries’ webpages, and 6) include a time frame on the outcome of each 
claim application which could encourage the food industry to have more food innovation.  
This proposed framework should be led by the individual SEA country, followed by ASEAN 
level.  The regulators in the 10 SEA countries under ASEAN could apply the framework to 
review the current status of the local regulatory framework on health claims, identify gaps 
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which can be improved and align the mindsets of the stakeholders on the basic concept of 
health claims using a common basis.  Involving different stakeholders is fundamental in the 
development of regulations to allow successful implementation.  The perspectives from the 
various key stakeholders such as industry, consumers, and scientific organisations should be 
incorporated during the development of the regulatory framework, provided active 
participation and comments from the key stakeholders are taken seriously by the regulatory 
agencies.  Eventually, such a regulatory framework will provide confidence for consumers in 
health claims and encourage innovation in the food industry in development of healthy food 
choices.  
6.3.3 Consumer education efforts via Public and Private Partnerships      
Consumer education via Public and Private Partnership7 can help the SEA consumers more 
effectively understand health claims.   Most mothers in this research could recall health claims 
but did not have full understanding of the health claims.  Knowledge on the nutrients was 
obtained from a variety of sources such as school, books, doctors, and increasingly from the 
private sectors.  Information from the public domain could serve as the education platform 
while information from the private sector such as food industry can help to reinforce the 
messages.  The Asian mothers trusted the health claims on the milk powder for their children 
and this trust stemmed from the ‘international brand’ manufacturers and the government.  The 
trust in the government and the ‘international brand’ manufacturers suggest opportunities for 
collaboration between the public sector and private sectors to educate the consumers for 
mutual benefits.  Several factors affecting the understanding of health claims such as the 
familiarity and previous knowledge of the nutrient, the perceived relevance of the nutrient, the 
use of scientific terms, the choice of words, and also the phrasing and length of the claims 
should be taken into consideration by marketers and food regulators when formulating and 
approving new health claims.  Cultural differences in SEA consumers’ response to food and 
health communication should be taken into account due to different languages and cultures in 
the 10 SEA countries under ASEAN.  Provision of education to consumers on the nutrients 
and food constituent should be in a holistic approach to include not only the benefit but also 
any side-effects related to overconsumption of the nutrients and/or food constituent.  
Consumers should also be given a chance to provide feedback on health claims through public 
consultation, direct contact with the regulatory agencies or food companies if the approved 
health claims are unclear.   
                                                 
7 Appropriate safeguards must be in place to ensure no conflict of interest such as governance of this scheme by 
an independent committee. 
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6.4 Prediction on the future development of health claims regulations in SEA 
In the opinion of this author, the future of health claims regulations in SEA can be analysed 
from two perspectives; 1) the presence and development of health claims in SEA and 2) the 
administrative approaches of health claims regulations and guidelines.  Firstly, there is likely 
to be a trend for more SEA countries to develop and publish health claim regulations and 
guidelines.  The development on the ASEAN Economic Community (AEC) and the free 
movement of the goods could partly contribute to the trend.  The priority sectors identified in 
AEC such as pharmaceutical, cosmetics and electronics have developed harmonised 
regulatory frameworks and standards across the SEA countries to facilitate inter- country in 
SEA.  It is worth noting that food is also identified as one of the twelve priority sectors under 
AEC (Association of Southeast Asian Nations (ASEAN) Secretariat, 2015b).   
Secondly, in the personal opinion of the author, there are two possible scenarios on the 
administration approach to health claims regulations in SEA.  The approach could be either 
more industry-friendly or very stringent like the pharmaceutical standards.  If the approach is 
to be more industry-friendly, this could suggest the potential for different levels of approval.  
For example, different types of health claims could require different levels of substantiation or 
scientific evidence ranging from textbooks/ published reviews and articles for nutrient 
function claims to specific evidence from human intervention trials for reduction of disease 
risk claims.  In addition, there will be more nutrient function claims in the approved list as 
there could be adoption of health claims that have been approved in major jurisdictions 
outside SEA.  There is a recent development that the food regulatory agencies in Australia 
and New Zealand and Singapore have increased the number of approved nutrient function 
claims by adopting selected nutrient function claims that have been approved in major 
jurisdictions.   
On the other end of the spectrum, a more stringent approach to regulate health claims on food 
could happen as a result from the increasingly blurred boundary between food and medicine 
to protect consumers especially for other function claims and disease- risk reduction claims.  
Such an approach will imply that more high quality human intervention trials are required 
using pharmaceutical-like procedures and standards.  In view of this matter, communication 
of the benefit of the nutrient/ other constituent will be impacted and possibly restricted to 
health professionals only.  The restriction on communicating the benefits of food constituent 
is similar to the current practices in the pharmaceutical industry where the drug representative 
will communicate the information on the drugs to the health professionals and this 
information is censored to the consumers.  Food manufacturers put health claims on food with 
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the aim of helping the consumers to make informed food choices.  The food regulators and the 
food industry are serving the consumers.  It is better to provide consumers with reliable 
sources of information instead of driving them to obtain misleading information from 
unreliable, non-credible sources that could result in public health problems.  There is a need to 
have a balance between consumer protection and the rights of the consumers to know the right 
information.  
Harmonising the regulatory frameworks on health claims in SEA is challenging to achieve for 
the stakeholders.  Different issues such as food safety, food and nutrition labelling are given 
differing priorities by each country to resolve in this region.  The movement to harmonise 
health claims on food could potentially take at least 5-10 years to take place unless there is a 
push from the regional food association or international, government-linked trade councils or 
through a ‘top-down approach’ from the ministerial level to expedite the topic.  The food 
industry and/ or research institutions should continue to engage with the regulatory agencies, 
using consistent messages to understand on the current thinking and processes of health 
claims, with the interests of the consumers in mind.  
6.4.1 Other influential factors  
Other factors have direct and indirect influence on the approaches and implementation rate of 
health claims regulations and guidelines in SEA. These key factors are health policy, 
economic/ trade policy, national issues and political environment of the country.   
The targets and objectives of local health policies and global health trend could affect the 
health initiatives to be executed in a country.  A sugar tax is a good example of one of the 
health policies initiated by the governments in Mexico, United Kingdom and highly possibly 
in Thailand to reduce obesity rates in each of these countries (Brownell  et al., 2009; Sarlio-
Lähteenkorva and Winkler, 2015; Colchero et al., 2016; Tan, 2016).  A ban on trans fat in 
food is another example taken by some governments such as the Danish, New York state in 
US to reduce healthcare cost on cardiovascular diseases, resulted from consuming trans-fat in 
the diet (Mozaffarian  et al., 2006; Restrepo and Rieger, 2016a; Restrepo and Rieger, 2016b).  
There is also global movement to consume more wholegrains in the diet to reduce 
cardiovascular disease, manage weight etc. and this recommendation has been incorporated in 
the dietary guidelines in many countries (Seal et al., 2016).  This could infer there is a need 
for health claims regulations, in order to communicate the health benefits of not taking too 
much sugar or trans-fat and eat more whole grains in the diet to the consumers.   
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From trade perspectives, the standards and regulations are important to protect the consumers 
and facilitate fair trade.  Standards and regulations are established to make sure the consumers 
have access to a product of certain quality, and this product can be traded freely across the 
different countries.  For example, milk powder is required to meet the Codex/ national 
standard on milk powder.  The standard on milk powder includes different requirements such 
as nutritional level before the product can be sold as a milk powder for infants.  This product 
will be allowed to be sold in all countries which adopt Codex standards on milk powder.  In 
the implementation of AEC, some sectors such as cosmetics, electronics applied a mutual 
recognition agreement to remove regulatory and technical barriers. This approach will help 
with the integration with regional and international standards to facilitate trade.  In contrast, 
this would also mean the regulatory agency of each country has to accept what has been 
approved by another SEA country which has been effectively achieved in the European Union 
(EFSA).  The development in the priority sectors of similar nature could also have an 
influence on each other such as the ASEAN traditional medicine and health supplement which 
are related to health, just like health claims on food.  The priorities or resources of the 
ASEAN secretariat office could sway the development of regulations in different ways.  
Other than AEC, global trade development such as the Trans-Pacific Partnership (TPP), the 
biggest trade agreement in history will have significant impact on the existing free trade 
agreements in SEA.  Four out of 10 SEA countries namely Brunei, Malaysia, Singapore and 
Vietnam signed up to the TPP agreement in early 2016.  The TPP could potentially tamper the 
existing ASEAN free trade agreements, if not managed properly.  Barriers in the inter- 
country trade within ASEAN could be resulted. 
Next, the political environment and national interest in the country will affect the priorities 
given to address certain issues as the issues require efforts and time.  For instance, the 
progress of AEC has been criticised to be slow due to different level of commitment from the 
ASEAN countries.  Myanmar which is slightly more politically stable in last two years, is 
progressive in trying to meeting the integration while Malaysia, the ASEAN chair in 2015 has 
been in political crisis in these two years (Pang, 2015).  Nationalism and protectionism 
reported in some SEA markets such as Indonesia has caused barriers in the integration of 
AEC (Food Industry Asia., 2013).    The political environment and national interest add to the 
difficulty to harmonise the standards to meet the goals of AEC.  
Ultimately, each SEA government will have to decide the future of health claims regulation/ 
and how to proceed from here for their countries at their comfort level.  Maybe it could be as 
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simple as the consumers are willing to pay for high-specialised nutritious food for good health 
and the government can collect taxes to run the country.  In whatever way, health claim 
regulations/ guidelines involves more stakeholders and not just the food regulators, key 
opinion leaders, health policymakers, food industry, academia and consumers.  It is important 
to bear in mind that the SEA will never operate like the European Union on the basis of the 
ASEAN charter which states each member state has its own sovereignty.  The registration and 
approval of health claims would still be required in each SEA country. 
6.5 Limitations of the research 
This qualitative research has gained in-depth insight and detailed understanding on the 
research topic.  The findings are responsive to local situations, condition and the perspectives 
of the stakeholders involved.  The limitations of this study include limited amount of 
participants, self- reporting bias, lack of prior research studies in SEA to compare and 
different languages and cultures in SEA.   
This research should not be viewed as representing the whole SEA region on health claims on 
food.  The data was collected from a limited number of participants and the information 
reflected the opinions of the people who have agreed to be interviewed.  Three SEA countries, 
Laos PDR, Cambodia and Myanmar are not represented in this research as it was not possible 
to recruit participants for the research.  These countries do not have health claims regulations/ 
guidelines at the time of this research was completed.  There could be bias in self- reported 
data as it is based on what the participants say due to the methods used in this research which 
include semi-structured interviews and focus groups discussions.   
There is limited or no prior research on health claims on food in SEA available in English at 
the point when the thesis was prepared.  The data from this study, therefore, had to be 
compared with other major jurisdiction worldwide.  It would provide a clearer comparison on 
the development on health claims regulations in SEA and the Asian consumers’ 
understanding on health claims if the data of this study could have been compared with other 
publication in the SEA context.   
The different cultures among the SEA and languages used in Southeast Asia could affect the 
understanding of certain words and restrict the search for more information.  This could result 
in bias or differences in understanding the responses as many of whom were native English 
speakers.  The translation to a different language could further filter and change the meaning 
of information.  There could be existing non-English literature available in the local 
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publications and/ or new draft regulations or guidelines on health claims in the SEA countries 
available in other SEA languages.   
More development and changes on the regulations on health claims in various countries could 
take place during the submission of this thesis such as the publication of regulations in 
Vietnam which occurred after Chapter 2 was completed.  The regulatory environment on 
health claim regulations is evolving rapidly in major jurisdictions worldwide and/ in SEA 
countries.  Consistent effort was required to access the official information sources regularly 
to monitor and keep updated with the changes on regulations or government documents 
during the course of this study.    
6.6 Future studies  
This research leads to more questions and creates opportunities to discover more information 
on health claims on food in SEA.  Future work on this research should, if possible, extend the 
interviews to more clusters of stakeholders such as the trade ministers, economists, consumer 
associations, ASEAN secretariat, and academia in SEA to bring in different facets in this 
discussion. Those SEA countries without health claim regulations/ guidelines should also be 
re-approached to understand their perspectives. The association of health claims in health 
policy of the country could be interesting to investigate to better understand the influence of 
policy on regulation.   
More studies on the understanding of health claims among SEA countries are needed to better 
understand SEA consumers due to different languages, cultures in this region. These studies 
could be conducted in different SEA countries, using different stimuli, demographics such as 
socio-economic status, gender, education etc. for effective communication to the SEA 
consumers.  It will be useful to understand the culture and SEA consumers’ perspectives on 
food, traditional herbs and medicines which are commonly consumed in this SEA region to 
promote normal well-being and how these relate to products carrying health claims.  These 
factors could influence the food choices and purchase behaviours of the consumers.  The 
findings of this study could be used as a basis for a larger scale questionnaire-based survey in 
the various SEA countries. 
It could be of interest to investigate the paradigm between ‘Western’ and ‘Asian’ types of 
health claims.  The different concepts of Traditional Chinese Medicine (TCM) and Ayurvedic 
medicine which are accepted and commonly practiced in Asia for well-being, could face 
difficulties in obtaining an approved health claim.  It is challenging to conduct clinical trials 
using the ingredients in the TCM or Ayurvedic medicine.  The active constituent in each of 
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the ingredients need to be identified first, to meet the fundamental requirement for health 
claim applications.   
6.7 Contribution of this research  
This research is a pioneering work in the research field.  The findings in this study are 
important in the light of recent development in health trends, food innovation and changes in 
the regulations on health claims.  This research has contributed in the following ways: 
1. Provide clear direction and strategy for innovation, and help industry to focus resource 
on research and better planning to generate evidence for health claim application.   
2. Provide guidelines for regulatory community in food industry to better support 
innovation, taking into account the perspectives and expectations from different 
clusters of stakeholders, including the consumers.  
3. Bring knowledge for regulators, researchers, food industry into Singapore and 
establish connections of the regulators from SEA & major jurisdictions 
4. Create opportunities for more future research in this topic and in SEA region 
6.8 Concluding thoughts 
Active engagement and inclusive consultation with all key stakeholders is critical to shape the 
regulatory development of health claims in SEA.  Clearly, the relationship between nutrients 
and health is a complex issue. It involves many key stakeholders such as the consumers 
themselves, food industry, food regulatory agencies, academia, policy makers from social, 
health and economic sectors, educators, health professionals.  Although food regulatory 
bodies in some SEA countries are still grappling with food safety and general labelling issues, 
it is timely to initiate discussion on health claims to protect the SEA consumers and facilitate 
trade in this fast-growing region. 
For health claims to truly benefit consumers, it is important to be clear and align on the aim of 
using health claims that is to help the consumers make informed food choices.  There are two 
contrasting sayings to describe and summarise this phenomenon.  The sayings go “A boat 
doesn’t go forward if each one is rowing their own way.- Proverb” and "Alone we can do so 
little, together we can do so much - by Helen Keller”. 
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Appendix 1: Health Claim Application Forms for three SEA countries: 
Indonesia, Malaysia and Singapore   
Indonesia: 
REGULATION OF THE HEAD OF THE DRUG AND FOOD SUPERVISORY AGENCY 
NUMBER HK.03.1.23.12.11.09909 YEAR 2011  
ON THE CONTROL OF CLAIMS IN LABELING AND ADVERTISING OF PROCESSED 
FOOD 
 
 
Form  A 
 
To 
Head of the Drug and Food Supervisory Agency 
Cq. Director of Food Products Standardization 
Jl. Percetakan Negara No. 23 
Jakarta 
Dear Madame, 
Enclosed please find: 
Application 
1. Applicant’s Data 
Name   : …………………………………………………………….. 
Position  : …………………………………………………………….. 
Acting on behalf of the business entity : 
Name   : ……………………………………………………………. 
Address  : …………………………………………………………… 
     …………………………………………………………… 
Telephone  : ………………………………………………………….. 
Fax   : ………………………………………………………….. 
E-mail   : …………………………………………………………. 
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2. Product specifications and product data 
Type of product : ………………………………………………………………. 
Trade brand  : ………………………………………………………………… 
Net weight  : ………………………………………………………………… 
Type of packaging : ……………………………………………………………….. 
Product composition : ……………………………………………………………….. 
 
3. Name of component added with / without chemical structures 
…………………………………………………………………………………………
………………… 
4. Objective of the Addition 
.................................................................................................................................................................... 
…………………………………………………... 
 
5. Claims filed 
………………………………………………………………………………………… 
……………………………………………….. 
 
6. Daily intake of components 
………………………………………………………………………………………… 
…………………………………………………. 
 
7. The production process 
………………………………………………………………………………………… 
……………………………………………………. 
 
8. Regulatory status of the component/claims filed in various countries 
………………………………………………………………………………………… 
……………………………………………………. 
 
9. Methods and results of analysis of nutrients and other components in the finished 
product 
………………………………………………………………………………………… 
…………………………………………………………. 
 
10. History of use as food 
………………………………………………………………………………………… 
……………………………………………………….. 
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   Jakarta, (date, month, year) 
    Applicant 
 
 
 
   ( …………………………………….) 
    Full Name 
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Form  B 
 
 
Evidence and or Scientific Reference 
 
Document evidence and or scientific reference : 
 
Title of document : ………………………………………………………………. 
 
Date of publication : ………………………………………………………………. 
 
Author : ………………………………………………………………. 
 
Published in the media: ………………………………………………………. 
 
Summary information : ………………………………………………………………. 
 
Note : This sheet may be reproduced, if the evidence document and or scientific reference is  
             more than one. 
 
HEAD OF THE DRUG AND FOOD SUPERVISORY 
AGENCY OF THE REPUBLIC OF INDONESIA 
 
        w.s. 
KUSTANTINAH 
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Malaysia: 
APPLICATION FOR NUTRITION CLAIMS (REG 18C, 18D, 18E) 
 
Guide for application: 
i. All sections in this form must be completed. 
ii. Where relevant, provide summaries of information required so as to assist the Committee 
members in understanding the 
application. 
iii. Submit copies of all references cited in the text as appendices. 
iv. If the nutrient concerned is already in the NRV list, information for item numbers 9, 10, 
11, 15, 16 and 17 need not be 
provided. 
v. All information requested in this format must be submitted in Bahasa Malaysia or English. 
vi. Twenty copies of this format must be submitted together with the necessary supporting 
document. 
 
Application should be addressed to: 
Senior Director 
Food Safety and Quality Division 
Ministry of Health Malaysia 
Level 3, Block E7, Parcel E 
Federal Government Administration Centre 
62590 PUTRAJAYA 
 
1. Name of applicant (in full and in block letters) *: 
2. Business address: 
3. Mailing address: 
4. E-mail address: 
5. Telephone number: Fax Number: 
6. Type of business: 
* State: 
a. Whether applicant is manufacturer or its agent. 
b. Whether this application is on behalf of a single firm or organization. 
c. Whether this application is on behalf of a food processing industry or other firms or 
organizations. 
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d. If on behalf of the food processing or other industries or organizations, names and 
addresses of these. 
7. State the nutrient concerned and the proposed nutrition claim (nutrient content claim, 
comparative claim or nutrient 
function claim). If the said nutrient is to be added to food and it is not listed in Table (I) of 
Twelfth Schedule as a permitted 
nutrient supplement, a submission for its inclusion to the list has to be made to Ministry of 
Health Malaysia using the format 
entitled Application for Addition to Nutrient Supplement List [Table (I) of Twelfth Schedule]. 
8. Name the food(s) to which this nutrient is to be added. 
9. State the limits of the probable daily intake of the nutrient in the diet. 
10.State the chemical structure and formula of the nutrient(s) and describe it in precise 
chemical terms and state all physical 
properties. 
11.Provide detailed information on the physiological role(s) of this nutrient. 
12.If proposing a “nutrient content claim” or “comparative claim”, state the proposed criteria 
for making these claims and 
provide scientific justification. 
13.If proposing a new “nutrient function claim” and the level of that nutrient to be considered 
as a “source” of that nutrient 
per 100 g or per 100 ml of the food, if it is not already in Table (II) in the Fifth A Schedule. 
Provide scientific justification for 
the proposed level. 
14.If proposing a new “nutrient function claim”, provide sound scientific evidences for the 
claim. All available literature 
including both positive and negative findings on the proposed claim must be provided. If the 
list is too extensive, provide 
hard copies only for more recent studies. Other studies can be provided in a bibliographic 
listing. Data from human 
intervention trials are preferred. Epidemiological and experimental studies and reviewed 
papers may be included as 
supportive evidences. Studies should include those conducted by other organizations or 
institutions. Result of all thesestudies 
should be published in refereed journals. 15.Show information regarding the stability and 
bioavailability of the nutrient(s) in the food(s) in which it is to be added. 
159 
 
16.State the analytical method to determine the amount of the nutrient(s) in the raw, processed 
and/or finished food 
17.Submit all data on safety evaluation derived from both chronic and acute studies conducted 
on the nutrient(s). 
18.Give examples of approval by other countries or recognized international agencies of this 
application. 
19.Provide other relevant information. 
 
Declaration: 
I _____________________________________________________ (full name), identity card 
/ passport number 
_________________________, hereby declare: 
a. that this application is made by myself / on behalf of 
__________________________________________________________ 
b. that all particulars given in this form including all appendices attached are true and correct. 
Signature: 
Name (capital letter): 
Designation: 
Official stamp: 
Date: 
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Singapore: 
APPLICATION FOR USE OF HEALTH CLAIMS FOR  
FOOD INTENDED FOR SALE IN SINGAPORE 
The guidance information, application form and checklist incorporated in this document are 
meant for applications for use of health claims on food products.   
"Food" means any substance, liquid, product or preparation which is intended for human 
consumption through ingestion and includes —  
(i) any form of chewing gum; and 
(ii) any substance or preparation that is used or intended for use as a colouring agent, 
condiment, preservative or additive in the preparation of any substance, liquid, 
product or preparation intended for human consumption; 
but does not include — 
(i) any medicinal product (whether or not such medicinal product has been licensed 
under Section 5(1) of the Medicines Act (Cap. 176) and registered under Section 10 
thereof, or exempted from such licensing under Section 8 or 9 of that Act); 
(ii) any substance, liquid, product or preparation which is documented in the latest 
edition of the “Martindale Extra Pharmacopoeia”, “A Dictionary of Chinese 
Pharmacy”, “The Chinese Herbal Medicine Materia Medica” or such approved 
pharmacopoeia as a bulk laxative or as a substance, liquid product or preparation for 
use for a medicinal purpose; 
(iii) any substance which is listed in Part I of the Schedule to the Poisons Act (Cap. 234); 
or 
(iv) any substance, liquid, product or preparation which, although intended for human 
consumption, is excluded from this definition by the Minister by order published in 
the Gazette. 
 
Applications involving products containing non-permitted food ingredients will not be 
considered.  Applicants must first seek approval from AVA for use of these ingredients in food 
before applying for use of health claims for these products. 
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The completed application form should be submitted to the following contact: 
egulatory Administration Department  
Agri-Food & Veterinary Authority  
52 Jurong Gateway Road, #13-01,  
Singapore 608550  
Tel: 68052914/68052915 
For clarification, please write to AVA_LabelsAndClaims@ava.gov.sg  
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GUIDANCE INFORMATION 
The application form consists of the following seven sections: 
Part A: Applicant information 
Part B: Summary of proposed claim 
Part C: Summary of studies submitted 
Part D: Table of content of supporting documents submitted 
Annex 1: Synopsis of individual studies 
Annex 2: Summary of application 
Annex 3: Checklist  
 
Applicants are required to follow the steps listed below in completing the application form: 
Step 1: Complete all information required under Part A to Part D of the application form.  
 
Step 2: Systematically review all available studies and select only relevant studies which 
substantiate the proposed claim for completion of Annex 1. These studies provided should 
preferably be well designed human intervention studies. Human observational studies alone are 
not adequate but may contribute to the totality of the evidence. Animal model studies, ex-vivo 
and in-vitro studies may be provided only as supporting knowledge to illustrate the relationship 
between the food/food constituents and the proposed health effects.  There should be at least 5 
relevant studies, preferably published within the recent 10 years. Applicants should also ensure 
that the studies submitted best substantiate the proposed health claims.  
 
Step 3: Summarise all studies submitted using Annex 2. 
 
Step 4: Provide other supporting documents, for example, approval letter/document from 
national food authorities on the proposed claims, verification of proprietary/ confidential data 
etc. 
163 
 
 
Step 5: Use Annex 3 to countercheck if all necessary information or documents have been 
submitted.  
 
Please indicate ‘Nil’ if the information required is not available. A separate application form is 
required for each health claim. Failing to provide information required may prolong the 
evaluation or disqualify the application. 
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APPLICATION FORM 
 
Company Name: 
Address: 
Contact Person Name: 
Company Name (if different from above): 
Address (if different from above): 
E-mail: 
Telephone: 
Fax: 
 
 
Types of claims (please tick where relevant):  
 Nutrient function claim 
 
 Other function claim  
 
 Disease risk reduction claim 
 
 
Part A: Applicant Information 
Part B: Summary of Proposed Claim 
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Food or food constituent (eg. nutrients, other substances, or a combination of nutrients/ other 
substances) for which the claim is made (to define): 
 
Targeted consumers (age/ gender/ recommended for specific medical condition etc): 
 
Proposed wording of the claim: 
 
Description of the relationship between the active component(s) and the health claim: 
 
Conditions of use: (indicate quantity of the food/food constituent and pattern of consumption 
required to obtain the claimed effect; and whether this quantity could reasonably be consumed 
as part of a balanced diet)  
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Declaration of proprietary data  
 Yes No 
 
The application contains proprietary data   
 
If yes, has the verifiable justification/ declaration 
been provided? 
 
  
If yes, has the proprietary data in the application 
been located? 
 
  
 
National and International Regulatory Status  
 
State whether this claim has been assessed and approved for food use by any national regulatory 
body and provide evidence of approval, if any. Fill out relevant boxes under “Effective Date” 
to reflect the dates when the processes took place.  
Regulatory Body Effective Date 
Accepted Rejected Under 
consideration 
Withdrawn 
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All published or unpublished human and non-human studies that are relevant for substantiation 
of the proposed claims should be submitted for consideration. Both data in favour and data not 
in favour should be included. To facilitate the evaluation, applicants should submit the deemed 
most relevant and not repeated information of at least 5 independent peer-reviewed reports of 
studies, preferably published in the last 10 years. Applicants may be requested to submit more 
information if necessary.  
 
Important notice: 
 Abstracts and articles from in-house reports, newspapers, newsletter, magazines that have 
not been peer-reviewed should not be cited. 
 Books or chapters of books for consumers or the general public should not be cited. Classic 
texts or textbooks for professional trainings maybe submitted as side references. 
  
Part C: Summary of studies submitted 
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Study type Full citation  
(to provide original papers) 
Information provided 
(a) Characteristics  of 
food/food constituent 
(b) Consumption pattern or 
quantity to consume to 
obtain the claimed 
benefit 
(c) Relationship between 
food/food constituent 
with the proposed health 
claim 
(please tick where appropriate) 
 
(a) (b) (c) 
 
1. Human 
studies:  
a) Experimental 
intervention 
studies eg. RCT, 
RT 
  
  
   
     
b) Observational 
studies eg. cohort 
studies, case-
control studies, 
cross-sectional 
studies 
  
  
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2. Non-human 
studies eg. 
animal,  ex vivo, 
in vitro studies 
  
  
   
     
3. Systematic 
reviews such as 
pooled analysis, 
meta-analysis 
  
  
   
     
4. Contradictory 
information 
  
  
   
 
 
Title Page 
  
  
  
  
Part D: Table of contents of the supporting documents 
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ANNEX 1: SYNOPSIS OF INDIVIDUAL STUDIES 
Please provide one synopsis for each study. 
 
1. Identification of study 
Authors: 
Article titles: 
Source/ Year/ Volume/ Pages: 
Declaration of interests: 
Source of funding: 
Good Clinical Practice status/ ethical approval: 
 
2. Objective(s) of the study 
 
3. Description of the study population 
DECLARATION AND SIGNATURE 
 
I hereby confirm that to my best knowledge, all relevant data to support use of the 
proposed health claim have been submitted in the application.  
 
Signature: 
Name: 
Designation: 
Date: 
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Population (for example, general population, sub-population with particular medical 
condition) and number of subjects under studied: 
Age range: 
Gender: 
Ethnicity: 
Geographical region: 
 
4. Study design 
Brief description of the methods used from sampling till analysis of results. This should 
also include design information (for example, randomized control trials, cohort studies, 
cross-sectional studies, meta-analysis). 
 
5. Study results 
Include all results supporting the proposed claims such as: 
 Comparison of pre- and post-test values 
 Levels of intake in order to deliver the function claimed 
 Adverse effect reported, if any 
 
6. Summary 
Describe the key findings of the studies that are in favour and not in favour for 
substantiation of the proposed claim. 
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ANNEX 2: SUMMARY OF APPLICATION 
 
Characteristics of foods/ food constituents (eg. nutrient or other substance or a 
combination of nutrients/ other substances) 
Name/ characteristics/ bioavailability 
 
List down individuals studies by the study types given. Provide summary of the key findings 
of each study and discuss the quality of the studies. 
  
Full citation of studies 
 
Key findings Study quality1 
A) Human studies 
  
  
  
B) Non-human studies 
  
  
  
C) Systematic review 
  
  
  
D) Contradictory 
information 
  
  
  
 
Overall conclusion (should not exceed 1 A4 page) 
Proposed wording of the claim:  
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1 Discuss the study quality by addressing areas below: 
 Study limitation (eg. method of randomization, blinding, case-control)   
 Risk of bias (eg. selective outcome reporting) 
 Consistency of results (eg. dose-response relationship) 
 Directness of evidence (eg. differences in population, interventions, interpretation of results 
to demonstrate the functions claimed) 
 
174 
 
ANNEX 3: CHECKLIST 
 Items Yes No 
 
1)  Has the food/food constituents for which the health claim is 
made been characterized? 
 
  
2)  Has the specification of the food/food constituents for 
which the health claim is made been provided? 
 
  
3)  Has the bioavailability data of the food/food constituents for 
which the health claim is made been provided? 
 
  
4)  Has the food or food category for which the health claim is 
made been provided? 
 
  
5)  Has a synopsis been provided for each study submitted? 
 
  
6)  Have the copies/ reprint of full study reports been provided 
and annexed? 
 
  
7)  Have other supporting documents such as approval letter 
from national food authorities been provided? 
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Appendix 2: Interview Guide for semi- structured interviews with key 
stakeholders 
 
Structure and rationale of the interview: 
 
- Understand  their 
roles 
- Break the ice and 
gain trust (ethic, 
use of data, 
consent form) 
- Understand the 
scope and 
objective of the 
health claim 
regulations 
 
- Understand the 
criteria for screening 
- Understand the 
timeline for approval 
- Understand the 
selection of the 
members in the expert 
committee 
 
- Understand how 
regulators review health 
claim application  such 
as the key information 
- Understand the 
concerns of the 
regulators when they 
review health claim 
application  
 
- Understand the problems 
faced by the regulators and 
possible solutions they 
suggest 
- Engagement after the 
interview (have the 
opportunity for clarifying 
information, sharing of 
data,  request for the 
report) 
 
  
Introduce Procedure
Scientific substantiation 
and evaluation
Conclusion
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Sample of the interview and questions 
 
 
 
 
 
 
 
 
 
 
 
 
  
Thank you so much for accepting this interview.  
Hello, my name is Ms Karin Tan.  I am currently a full-time PhD candidate with the Newcastle 
University UK and formerly an employee of Danone Asia Pacific Holdings Pte Ltd whom is currently 
on study leave to complete my PhD study.  This research is mainly funded by the Singapore 
Economic Development Board, a government statutory board in Singapore and Danone Asia Pacific 
Holding Pte Ltd.   
My research is designed to understand the different aspects of the regulatory frameworks on health 
claims in Southeast Asia.  During the interview, I would like to discuss on the following topics:  the 
procedures on applying for new health claim, the types of scientific evidence required for health 
claim substantiation, the evaluation of the scientific evidence which lead to the approval or rejection 
of the new health claims and the enforcement actions in place in your country.   At the end of the 
study, you can request for summary finding of the study.  
With these topics in mind, I would like to start the interview.  You can choose not to answer any 
question which you are not comfortable with and do feel free to ask any questions at any point of 
time.  
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1. Introduce 
Main questions Additional questions Clarifying questions 
 
 Can you tell me what do you do 
in your current role? 
 
 
 What are you trained in? 
 
 How many years have you been in 
your current role dealing with 
health claims? 
 
 
 Can you expand a 
little on this? 
 
 Can you give me 
more examples? 
 
 Can you provide me 
more information on 
this point? 
 
 
 In your opinion, what does the 
word ‘health’ mean to you? 
 
-  
 What is the scope of the health 
claims in the regulations/ 
guidelines? 
 
 What elements are considered 
under the scope?  
 
 What are the objectives of health 
claims? 
 
 Why? 
 
2. Procedure of health claim application  
Main questions Additional questions Clarifying questions 
 
 Can you tell me when is the last 
time you processed the health 
claim from receiving the claims 
until informing the applicant on 
the outcome?  
 
 
 How long does it take to finish the 
process?  
 
 
 What are the factors that could 
affect the approval time?   
 
 In your view, should the applicant 
consult the authority, prior to the 
submission or before the result of 
the outcome?  
 
 Can you expand a 
little on this? 
 
 Can you give me 
more examples? 
 
 Can you provide me 
more information on 
this point? 
 
 What do you screen for in the 
application before it is submitted 
to the expert committee for 
evaluation? 
 Why?  
 
178 
 
Main questions Additional questions Clarifying questions 
 What are the criteria for selecting 
the experts in the expert 
committee?   (eg. expertise, 
multi-government agencies, 
academic, consumer group,  
industry association) 
 
OR 
 
 How do you select the experts to 
be in the expert committee?   (eg. 
expertise, multi-government 
agencies, academic, consumer 
group,  industry association) 
 
 Why? 
 
 Can you co-opt other experts in 
your expert committee?   
 
 Do you know whether the 
applicant need to state the 
claims exactly as it is being 
approved?   
 
 
 What are the enforcement 
actions if there is a violation?    
 
 
 
3. Scientific substantiation and the evaluation of the health claim application 
Main questions Additional questions Clarifying questions 
 
 What information do you look 
out for in the petition or dossier 
submitted?   
 
 OR 
 
 Which are the most important 
types of scientific information 
you look for in the application 
 
 Why?   
 What is considered as the 
appropriate and relevant target 
group?  
 How do you view the strength of 
evidence from the human 
observation studies to substantiate 
nutrition research?   
 
 Can you expand a 
little on this? 
 
 Can you give me 
more examples? 
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Main questions Additional questions Clarifying questions 
to prove the cause-and-effect 
relationship?    
 
 Do you accept studies conducted 
by industry and are published in 
scientific journals?   
 How do you evaluate health claim 
on the food component such as 
ginger which has long history of 
use and has limited scientific 
evidence?   
 
 Question for Indonesia only:  
What is considered under certain 
conditions when the local studies 
are required? 
 
 For Malaysia, Singapore, 
Thailand:  Do you accept studies 
conducted in other countries and 
are published in scientific journal?   
If not, what are the conditions 
when you require the studies to be 
conducting using local 
population?   
 
 For Malaysia, Singapore and 
Thailand only:   How much 
emphasis does the authority put on 
the number of studies to be 
submitted? 
 
 Can you provide me 
more information on 
this point? 
 
 Why do you require the 
‘rationale to add’ and the 
‘Approval by other regulatory 
authority’?  
 
- 
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Main questions Additional questions Clarifying questions 
 How does the expert committee 
review the scientific evidence?  
 
OR 
  
 What are the guiding principles 
to evaluate health claims? 
  
 How do you evaluate whether the 
claims are non-misleading or it 
can be understood by the 
consumers?  
 
 
 What are the challenges you 
face when you evaluate health 
claims? 
 
 Why? 
 
 
 
4. Conclusion of interview  
Main questions Additional questions Clarifying questions 
 In your opinion, what area(s) 
do you think the existing 
process have done well and 
what can be improved? 
 
 Why? 
 
 Can you expand a 
little on this? 
 
 Can you give me 
more examples? 
 
 Can you provide me 
more information on 
this point? 
 How can the food industry 
work with you to improve the 
process or make your work 
easier?  
  
 Why? 
 How can my research help you 
and the food industry?  
 
 Why? 
 
 How can we educate 
consumers to better understand 
health claims?  
 
 
 Do you want to add any other 
comments on health claim?  
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Appendix 3:  Focus Group Discussion Guide 
Note: This discussion guide is intended as a “checklist” for the moderator. The objective, during the 
time of the interview, is to make the discussion as relaxed and natural as possible in order for the 
respondent to feel able to open up and share their experiences and attitudes.   
The moderator will treat this as a menu from which to select topic areas and guide the general flow of 
discussion. The guide is thus a springboard for discussion; respondents’ responses may often lead the 
discussion in new directions or change the order of topics. Some questions or techniques may be 
skipped if issues have already been sufficiently covered at an earlier stage. 
SUMMARY FLOW OF DISCUSSION 
Section Time allocation Objectives 
1. Introduction & warm up 10 minutes  Introduce market research, and 
acquaint each other 
 To build rapport between respondents 
and cue them towards the context of 
discussion 
 Introduce discussion rules   
2. Usage & attitude towards 
child’s diet 
10 minutes  Understand the role of milk in child’s 
diet 
3. Areas of consideration in 
selecting milk powder 
20 minutes  Identify the areas of consideration in 
choosing milk powder 
 Understand the role of that product labels 
shape consumer decisions in their choice 
of products 
4. Consumers’ understanding of 
product labels 
30 minutes  Understand the role of product labels  
 Understand respondents’ expectations 
of local food regulations 
5. Comprehension of Calcium 
& Iron 
5 minutes  Understand current perceptions of 
Calcium & Iron 
6. Claims testing 40 minutes  Assess claims test in terms of how well it 
resonates with respondents  
 Identify areas of improvement 
7. Decision Making Process 5 minutes  Understand the decision making 
process in milk powder purchase 
8. Wrap Up 5 minutes 
 
 End discussion 
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1. Introduction & warm up 
 Introduce market research, and acquaint each other  
 To build rapport between respondents and cue them towards 
the context of discussion 
 Introduce discussion rules   
Duration: 10 minutes 
Cumulative: 10 minutes 
Warm welcome! 
 
Explain market research 
 Purpose of discussion 
 Safe & confidential environment 
 No right or wrong answers, merely gathering point of views 
 Inform respondents that session will be recorded – both audio and video 
 
Quick round of introduction 
 Name 
 Age 
 Occupation  
 Number of children and respective age 
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2. Usage & attitude towards child’s diet 
 Understand the role of milk in child’s diet 
Duration: 10 minutes 
Cumulative: 20 minutes 
 
All of us here have young children. For the purpose of this study, let us concentrate on your child 
age 3 to 6 years. So if you have a child age 2 and another age 4, please respond based on the 4 
year old child. 
 
I would first like to understand their typical diet. This covers their main meals, snacks, 
beverages…basically everything edible!  
 What do you feed your child with?  
 How are these F&B given out? 
o Breakfast  
o Lunch  
o Snack 
o Dinner 
o Others 
 
 [Moderator to probe for milk if not mentioned] 
o How often do you give your child milk? 
o What are your reasons for giving your child milk? [Listen for: calcium, iron etc] 
o What is the difference between a child who takes milk and a child who does not? 
o Do you mix anything with the milk to feed your child? 
o Why do you do so?  
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3. Areas of consideration in selecting milk powder 
 Identify the areas of consideration in choosing milk 
powder 
 Understand the role of that product labels shape 
consumer decisions in their choice of products 
Duration: 20 minutes 
Cumulative: 40 minutes 
 
When it comes to purchasing milk powder, I would like to know what do you look out for…  
 [Moderator to list factors on the board] 
 Probe for:  
o Brand [Listen for: popular, well-known etc] 
 Why is this an area that you look out for?  
 How is branding important to you? 
 What are the brands that you consider? Why? 
 What are the brands that you would not consider? Why? 
o Price  
o Nutritional value [Listen for:iron, calcium, etc] 
 Why is this an area that you look out for?  
 How do you know if this is available? [Listen for:food labels] 
 From what source? 
 What do you understand from the nutritional value? How do you think it 
will impact your child? 
 To what extent would you believe it? 
o Health benefits [Listen for: bone growth etc] 
 Why is this an area that you look out for?  
 How do you know if this is available? [Listen for: food labels] 
 From what source? 
 What do you understand from it? 
 How believable is it? 
 
o Recommendations [Listen for: by family/friends, doctor etc] 
 Why is this an area that you look out for?  
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 What exactly did that person share with you? 
o Taste 
 Why is this an area that you look out for?  
 How do you know how it’ll taste like? [Listen for: food labels] 
o Availability [Listen for: specialty stores only, supermarkets etc] 
 Why is this an area that you look out for?  
o Country of manufacture 
 Why is the country of manufacture important? 
 How do you know where is the country of manufacture? [Listen for: food 
labels] 
 What are some of the countries that you prefer to buy from? 
 What are some of the countries that you would never buy from? 
 When you come across a product made in Country A and sold in your home 
country, in your opinion, which country’s regulation does the product comply? 
Home country? Or the country of manufacture?  
 
 Can you rank the top 3 factors? 
o Why this ranking?  
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4. Consumers’ understanding of the role product labels 
and regulations  
 Understand the role of product labels  
 Understand respondents’ expectations of local food 
regulations 
Duration: 30 minutes 
Cumulative: 70 minutes 
 
Earlier, you mentioned that you look at product labels when shopping for milk powder. 
 What type of information do you expect to get from the product label? [Listen for: weight, 
nutritional value, benefits claim, ingredients etc] 
 How useful do you find the information from the product label? 
o Did you learn something new from reading product labels? 
 If yes, what was it? 
 If no, what else would you like to know?  
o Are you happy with the content of product labels? 
o Do you understand what is written on the label?  
 If no, what was not clear to you?  
 How did you cope with it? [Listen for: made the effort to find out more 
information, leave it alone] 
 Was there a time when you went to a store with a certain product in mind but bought something 
else, after reading the food label?  
o If yes, what happened?  
 
Now I would like to discuss about health claims. Health claim refers to the health benefits of the ingredients 
in the milk.  
 
 What do you think when you see health benefit claims? [Listen for: healthier choice etc] 
o What do you think is the purpose of having health benefit claims on product labels? 
[Listen for: marketing, raise awareness] 
o What do you think of products with health claims? 
 What do you understand from it? 
 What happens when you don’t understand it?  
 Would you want to find out more information? 
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 If yes, what sources do you go to? 
 If no, why not? 
o Does health benefit claims influence your decision to buy the product in any way? How 
so? 
o How credible are these health benefit claims? 
 Do you trust the health benefit claims on the product if it’s permitted to be sold 
in <country>? 
 Are there any health benefit claims regulations in <country>?  
 If yes, what do you think is the regulation for health benefit claims?  
 Which organization would oversee these regulations? Overall, what do you 
think the role of this organization is? 
 How keen would you be to see more health benefit claims on your product? 
Please rate on a scale of 1 to 10 with 1 being least keen and 10 being most 
keen. 
 What are your reasons for giving this score? 
 Is there any way that the regulators can help you understand health benefit 
claims better? 
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5. Comprehension of Calcium & Iron & VIt A  
 Understand current perceptions of Calcium & Iron & Vit A  
Duration: 5 minutes 
Cumulative: 75 minutes 
[Moderator’s note: probe if not covered earlier] 
Could you tell me what you do understand of the following? 
 
[Moderator’s note: please rotate below order for every FGD] 
 Calcium 
 Iron 
 Vit A  
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6. Claims testing 
 Assess claims test in terms of how well it resonates with 
respondents  
 Identify areas of improvement 
Duration: 40 minutes 
Cumulative: 115 minutes 
For the next exercise, I am going to show you some health benefits claims. 
 
Firstly, I wanted to know if you had seen any health benefits claims relating to calcium/iron before 
this discussion? 
 If yes, where did you see/hear about it? 
 What do you recall about it? 
 
[Moderator’s note: please test in following order:  
Group 1: Calcium 1, Calcium 2, Calcium 3  
Group 2: Iron 2, Iron 1, Iron 3 
 
Claim on Calcium Claim on Iron Claim on Vit A 
1) Calcium helps support 
development of strong 
bones and teeth.  
1) Iron is an important 
component of red blood cells 
which carry oxygen to all parts 
of the body to help the body’s 
production of energy.  
1)Anti-oxidants like carotenes 
and Vitamin E help to protect 
cells from free radicals that 
may have escaped the 
natural processes of our body 
system. 
 
2) Calcium make strong 
bones and teeth.  
2) Iron helps your body to 
produce energy.  
2) Anti-oxidants like 
carotenes and Vitamin E 
support your child’s immune 
system. 
3) Calcium contributes to 
the height of the children.  
(Calcium helps you to grow 
taller.)  
3) Iron helps build strong 
muscles.  
3) Anti-oxidants like 
carotenes and Vitamin E 
reduce the chance of your 
child from falling sick. 
For each claim, moderator to flash claim on board then cover slide. i.e. hide it from respondent  
 [Write on paper] What do you recall seeing from the health claim?  
 
For each claim: 
 On the whole, what do you think of this claim?  
o [Write on paper] What is it trying to say to you?  
o Do you agree with the claim? 
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o Is this claim in line with what you know? 
o Is this clear to you?  
o Any questions that you have?  
o How can this claim be improved? 
o How unique is this compared to what you already seen in the market?  
o Does it, in any way, affect your decision in purchasing the product?  
o How credible is this to you? 
o How do you think this claim can be improved to be more relevant to you?  
o Imagine if you have a friend who would like to know more about calcium/ iron, what 
would you say to them?  
 
[Moderator to complete all claims before proceeding] 
 Ask separately for calcium, iron &  Vit A: 
o For claim 1 and 2: Does 1 and 2 refer to the same health benefit? What makes you feel 
this way?  
o Which claim is the most compelling in getting you to try a product for your kids? Why is 
that so?  
o Which claim is most relevant to you? Why is that so?  
 
If time permits  
[Moderator to split respondents into 2 groups and provide paper, markers etc] 
 Now imagine that you are a milk powder manufacturer and you need to finetune the product 
claim. 
o How would you change the claim?  
o Why is that so? 
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If time permits  
7) Decision making process  
 Understand the decision making process in milk powder 
purchase 
Duration: 5 minutes 
  
 
[Moderator to draw out purchase journey on board] 
 How do you go about purchasing your milk powder? [Listen for: talk to friends/family, buy 
from specialty stores, supermarket etc] 
o [Probe if respondents purchase online] 
 Specifically, where do you obtain the information on milk powder from? [Listen for: word-of-
mouth, doctor, product label, company website, sales person etc] 
o What made you go to these sources?  
o In your opinion, how credible are they? 
o How do they influence your purchase decision?  
Probe if not mentioned, do you read the product labels?  
8) Wrap up 
 End discussion 
Duration: 5 minutes 
Cumulative: 120 minutes 
We’ve come to the end of our session! Do you have anything else you would like to add? 
 
Thank you! 
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